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GLOSSARY  
Key terms used in this thesis are defined in this table.  Definitions were derived directly (or with 
minor adaptations) from the sources as indicated.a Terms relating to problems associated with 
drugs (eg, adverse drug events) have been variously defined in the literature, therefore, for 
consistency, their use in this treatise accords with the definitions set by the Australian 
Commission on Safety and Quality in Healthcare (ACSQHC), unless otherwise stated.  
 
Adverse Event 
(AE)  
An incident in which unintended harm resulted to a person receiving health 
care. (1) 
 
Adverse Drug 
Event (ADE) 
A particular kind of adverse event where a drug or medication is implicated 
as a causal factor in the adverse event.  This encompasses both harm that 
results from the intrinsic nature of the medicine (an adverse drug reaction) 
as well as harm that results from medication errors or system failures 
associated with the manufacture or distribution or use of medicines.(1) 
 
Adverse Drug 
Reaction (ADR) 
A response to a drug which is noxious and unintended, and which occurs 
at doses normally used or tested in man for the prophylaxis, diagnosis, or 
therapy of disease, or for the modification of physiological function.(1) 
 
Consultants 
(Medical) 
Doctors who have completed an extra six years or more of training after 
their initial university medical training to become qualified physicians (or 
medical specialists).(2) 
 
Drug-Related 
Problem (DRP) 
A DRP exists when a patient experiences or is likely to experience either a 
disease or symptom having an actual or suspected relationship with drug 
therapy (3) 
 
Electronic 
Prescribing 
Decision 
Support (EPDS) 
Rule-based systems designed to present prescribers with patient specific 
information, such as allergies, and drug-specific information, such as drug 
interactions, in a format that prevents prescribers from writing incorrect or 
inappropriate prescriptions (4) 
 
High Reliability 
Organisations 
(HRO) 
Organisations that are mandated to do everything possible to avoid certain 
kinds of negative outcomes because risk of error involves dire 
consequences (5) 
 
Junior Doctors Medical trainees in postgraduate years 1 or 2 (PGY1 or 2). The term is 
synonymous with junior medical officer (JMO) or prevocational medical 
trainee.  Internship is the first postgraduate year (PGY1) and in NSW, the 
succeeding year(s) is termed residency (6). 
 
 
 
 xi 
Medication 
Incident 
An incident associated with a medication. Incident is an overarching term 
used to describe problems that cause actual harm and “close calls” where 
harm was averted either by defences built into the system or by chance.  
Close calls are often indistinguishable from adverse events in all but 
outcome. (7) 
 
Medication 
Error 
A failure in the (drug) treatment process that leads to, or has the potential 
to lead to, harm to the patient and includes an act of omission or 
commission.  Errors rarely occur as the result of the actions of a single 
individual.  They are usually the result of a series of system failures (7) 
 
Medicines 
management 
(hospitals) 
The entire way that medicines are selected, procured, delivered, 
prescribed, administered and reviewed to optimise the contribution that 
medicines make to producing informed and desired outcomes of patient 
care (8) 
 
Near miss or 
close call or 
potential ADE 
Incident in which harm was averted either by defenses built into system or 
by chance (7) 
 
 
Over-the-
counter 
medicine (OTC) 
Health care product that can be purchased without a prescription.(7) 
 
 
 
Patient harm Death, disease, injury, suffering, and/or disability experienced by a person 
(1) 
 
Preventable 
adverse events  
Error in management due to a failure to follow accepted practice at an 
individual or system level.  Accepted practice taken to mean the current 
level of accepted performance for the average practitioner or system that 
manages the condition in question.(9) 
 
Resident 
Medical 
Officers (RMOs) 
 
Doctors who have completed their internship and who are undertaking 
further general hospital training (PGY2-4), NSW only (6). 
Registrars 
(medical) 
Doctors who have completed at least one postgraduate year of training 
(usually more) and have entered a physician training program.  In NSW, 
also used to describe doctors (PGY2-4) who have a general training post 
at a hospital.(6) 
                                               
a(1) ACSQHC. Definitions of Safety and Quality in Health Care. Website of Australian Commission on 
Safety and Quality in Health Care. URL:www.safetyandquality.org/internet/safety/publishing.nsf. Last 
updated 28 August 2006. Accessed 04 February 2007. 
(2) Royal Australian College of Physicians (RACP). Requirements for Physician Training. 
URL:www.racp.edu.au/training/adult2003/advanced/general/intro.htm. Last updated 12 Sep 2003. 
Accessed 06 March 2007. 
(3) Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD et al. Drug-related problems: their 
structure and function. DICP 1990; 24(11): 1093-7 
(4) Bomba D, Land T. The feasibility of implementing an electronic prescribing decision support system: a 
case study of an Australian hospital. Australian Health Review 2006;30(3):380-8. 
 xii 
                                                                                                                                                        
(5) Clark G. Organisational culture and safety: an interdependent relationship. Australian Health Review 
2002;25(6):208-16 
(6) National Training and Assessment Guidelines for Junior Medical Doctors PGY 1 and 2. 
Commonwealth Department of Health and Ageing, 2003. Resource 1: Prevocational and Vocational 
Training Post Definitions.[Accessed 01/07] 
(7) Australian Council for Safety and Quality in Health Care. Second National Report on Patient Safety 
Improving Medication Safety. Annual Report to Health Ministers. Canberra: Australian Council for Safety 
and Quality in Health Care; 2002. 
(8) Audit Commission. A spoonful of sugar - improving medicines management in NHS hospitals. Report. 
London: Audit Commission; 2001 December 2001. 
(9) Wilson RM, Runciman WB, Gibberd RW, Harrison BT, Newby L, Hamilton JD. The Quality in 
Australian Health are Study. Medical Journal of Australia 1995;163(9):458-71 
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SYNOPSIS 
Medicines are a fundamental healthcare intervention, but the benefits they provide depend 
entirely on the way in which they are used.  This begins with prescribing, a complex task with 
substantial risks.  Systematic evaluation of biomedical factors may be viewed as an essential 
component of this task, but prescribers also integrate an array of individual, social, cultural, 
environmental and commercial factors into their prescribing decisions.  Furthermore, social and 
cultural characteristics of the prescriber’s workplace may influence how well prescribing 
decisions are carried out.  Whilst numerous research efforts have helped to construct an in-
depth understanding of non-biomedical influences on GP’s prescribing patterns, the 
characteristics of corresponding sorts of influences in teaching hospitals have not been well 
determined.  In hospitals, supervised medical trainees, registrars and consultants prescribe 
within the framework of medicines management systems involving nurses, pharmacists and 
patients.  Currently, little is known about whether each of these groups has distinct beliefs, 
attitudes and values that may affect either prescribing behaviour or how prescribing skills of 
medical trainees are acquired. 
 
The aim of this study was to explore the social and cultural dynamics of prescribing and 
prescriber training in teaching hospitals. To do this, established qualitative methods were 
employed.   Junior doctors, registrars, consultants, nurses, and pharmacists from two 
metropolitan teaching hospitals were sampled purposively and invited to participate in semi-
structured interviews.  A brief questionnaire was used to collect demographic and contextual 
information.  In the interviews, participants were asked about their attitudes towards prescribing, 
their perceptions of roles and responsibilities, how they communicated prescribing decisions, 
their perceptions of influences on prescribing, and their perceptions of factors contributing to 
 15 
prescribing errors.  Participants were also asked for their opinions on various aspects of new 
prescriber training. Sampling proceeded until redundancy of themes was established. 
 
A pilot study was conducted with one participant from each professional group to optimise the 
interview schedule, and then using this tool, a further 38 participants were interviewed.  In total, 
eight consultants, eight registrars, nine junior doctors, eleven pharmacists, and seven nurses 
participated.  Using reiterative content analysis of a third of all transcripts, a coding scheme was 
developed, which was used to label and categorise the remaining transcripts.  Categories were 
further developed and refined.  The resultant core themes were cross indexed against the five 
different health professional types using thematic charts to explore patterns. The main lines of 
enquiry for this research were mapped, the properties of these categories and interrelationships 
explored in detail, and a model of the prescribing process was developed. 
 
Prescribing at the teaching hospitals was a complex process consisting of multiple steps 
undertaken by several different health professionals of varying levels of experience from three 
different health care disciplines.  Because of the intricate separation of responsibilities, the 
operation of the process was highly reliant on the behaviours of each player and their 
relationships with each other.  Key prescribing decisions associated with patient admissions 
were made, almost exclusively, by medical teams.  Prescribing was therefore chiefly 
characterised by factors influencing the behaviours of the doctors.  Their behaviours were 
influenced by factors relating to their individual characteristics (eg, knowledge, skills, 
experience); but also by a web of socio-cultural determinants inherent to the environment in 
which they worked.  These factors were related to: the organisational structure of the prescribing 
process; the knowledge characteristics of the doctors; the communication patterns they used; 
the underlying assumptions they made about prescribing; and the work environment. 
 16 
1. CHAPTER ONE: LITERATURE REVIEW 
1.1. INTRODUCTION 
Use of medicines is an integral part of Australian health care.  It is the most common health-
related action with spending on medicines accounting for over 14% of recurrent health 
expenditure.1  In 2004, over 230 million prescriptions were dispensed - that is about 11 
prescriptions per person.2  Ensuring the quality use of these medicinesi is a challenge for 
healthcare professionals and consumers alike.  A key objective is to reduce the incidence of 
harm caused by medicine use.  In Australia, an estimated 150 000 hospital admissions per year 
are associated with medicines, and most of these admissions are considered avoidable.3   
 
In recent years, community based prescribers (ie, general practitioners) have been the major 
targets of interventions to improve the use of medicines.  With an understanding of influences on 
prescribing in this setting, the National Prescribing Service (NPS)ii and others have reported 
success with some interventions 4, 5, but changing the established behaviours of experienced 
prescribers is challenging 6 and difficult to sustain.7 
 
Teaching hospitals are unique environments for prescribers.  Specific social, cultural, and other 
workplace factors affecting prescribing in the community may not apply.  Patients may be 
acutely ill, have multiple co-morbidities, with rapidly changing therapeutic needs.  Several health 
professionals with different levels of expertise and experience may be involved in various 
                                               
i
 Quality Use of Medicines (QUM) is a defined objective of the National Medicines Policy and refers to the 
judicious selection of management options, appropriate choice of medicines - where considered 
necessary, and their safe and effective use. [Australian Government Department of Health and Ageing. 
The National Medicines Policy 2000, 1999] 
ii
 NPS is an independent Australian organisation funded by the Australian government to provide QUM 
services to health professionals and consumers [National Prescribing Service Limited. Evaluation Report 
No 8, 2005] 
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prescribing activities, which together form part of complex medicines management systems.  
Historically, this is the environment where doctors learn to prescribe.  
 
The traditional internship and residency is a formative time for medical trainees; behaviours, 
beliefs, values and norms they encounter may be powerful determinants of future practice. 8  For 
junior doctors, training in prescribing occurs concurrently with performing a key role in hospital 
medicines management.9  It is surprising then that during this particularly impressionable time of 
their careers in such a highly interactive environment, very little is known about the “prescribing 
culture” in teaching hospitals and its potential impact on the way in which doctors learn to 
prescribe. 
 
In this research, weiii set out to explore two dimensions of prescribing culture in teaching 
hospitals; firstly, factors that may influence the prescribing process and secondly, factors that 
may directly affect the training experience of junior doctors in prescribing.  To begin, the 
literature was reviewed with the aim of gaining a detailed understanding of the central issues 
related to this research topic. 
1.1.1. Search strategies 
Two approaches were used to gather information from the worldwide literature base; the choice 
depending on whether the objective was to provide pertinent background information or to 
establish the existence of specific gaps in the literature.   For all searches, the method was 
systematic and involved use of electronic databases as well as manual searching of 
bibliographies.  The main resources utilised were: Medline, Embase, Australasian Medical Index 
(AMI), Australian Public Affairs Information Service (APAIS), and internet resources (eg, 
government and professional organisation websites).  In the main, coverage was limited to 
                                               
iii
 MP (author and primary researcher), BB and JB (co-researchers and supervisors) 
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publication years 1985-2006 and the English language.  Primary consideration was given to 
locating and evaluating Australian data and hospital-based studies.  Where considered 
necessary or relevant, international studies and/or community-based studies were retrieved to 
provide a more complete picture. 
 
To retrieve background information, the approach involved identifying studies, commentaries, 
reports and reviews pertaining to the research topic.  Following retrieval, papers were initially 
assessed on the basis of title and abstract.  The full content of pertinent articles was reviewed.  
The decision to cite articles was based on whether they adequately represented the broader 
body of literature or whether they provided a notable alternative finding.  In some instances, 
search strategies were broadened to provide context to the wider provision of healthcare.   An 
example of this strategy was the review of literature pertaining to risks associated with 
prescribing. Medline subject headings used included ‘Medication Errors’, ‘Drug Therapy/ae 
[Adverse Effects]’, ‘Adverse Drug Reporting Systems’, ‘Iatrogenic Disease’, ‘Quality of Health 
Care’, ‘Hospitals’.  Health department websites of Australia (eg, Australian Institute of Health and 
Welfare, UK (eg, Audit Commission) and US (eg, Institute of Medicine) were consulted.  To 
provide context to risk of interventions in health care, the search was broadened to include 
‘Medical Errors’.  
 
A more exhaustive strategy was used to form a thorough knowledge and understanding of two 
critical elements of the research question: social and cultural influences on prescribing in 
hospitals, and the prescribing practice of junior doctors.  In the first instance, the search focused 
on social interactions, social influences and cultural factors (such as attitudes, values and 
beliefs) pertaining specifically to medicines management.  The scope was limited to those health 
professionals at the operational level of health care delivery10 (ie, those involved in direct patient 
care, not those involved in hospital administration).  Medline subject headings included: ‘Drug 
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Therapy’,  ‘Drug Utilization’, ‘Medication Systems, Hospital’ , ‘Personnel, Hospital’, 
‘Organizational Culture’, ‘Social Behavior’ , ‘Culture’, ‘Attitude of Health Personnel’, ‘Social 
Psychology’ . Terms were “exploded” to retrieve findings published on subcategories.  Additional 
text words used were:  prescri$, influen$, relat$.  All papers identified were reviewed, but the 
focus was on findings from original studies, rather than commentaries.  Because few studies 
were located, the search was subsequently broadened to identify any cultural analyses of 
hospitals that may provide insights into cultures affecting medicines-related processes.  
 
In the search for literature on prescribing practices of junior doctors, Medline subject headings 
included: ‘Internship and Residency’, ‘Drug Therapy’, ‘Prescriptions, Drug’, ‘Drug Utilization’, 
‘Medication Errors’, ‘Hospitals’.  Additional text words were used; eg, prescri$, influen$.  A 
modified strategy was used to identify interventions aimed at improving the prescribing practice 
of junior doctors and other Medline subject headings were incorporated: ‘Education, Medical, 
Undergraduate’, and ‘Curriculum’.  Additional text words included: intervention$, strateg$, 
course$, train$, education$.  Again, all papers identified were reviewed, but emphasis was 
placed on results of original studies. 
 
These approaches to the literature allowed a comprehensive review of four central issues 
relating to the research topics, which are discussed in detail below:  (1) the challenges of 
prescribing, (2) methods used to deal with these challenges, (3) the environment of teaching 
hospitals for prescribing; and (4) the prescribing practice of junior doctors. 
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1.2. CHALLENGES OF PRESCRIBING 
1.2.1. WHAT IS INVOLVED? 
Whilst the term ‘prescription medicineiv’ has a specific meaning, the act of ‘prescribing’ is less 
well defined.  Few have attempted to propose what steps it should involve or comprehensively 
observe how prescribing is done.  Yet, the burgeoning number of drug choices would suggest 
that the task is growing in complexity 11 [Figure 1] 
Figure 1. Number of Medicines on Australian Register of Therapeutic Goods 
[Data provided by the Therapeutic Goods Administration11] 
 
Various academics, policy makers and educators have put forward approaches to prescribing 
based upon beliefs of what constitutes ‘rational prescribing’ or ‘good prescribing.’  In the main, 
these have consisted of avowed principles, general guidance, and specified benchmarks for 
improving prescribing quality. 
 
                                               
iv
 The Standard for the Uniform Scheduling of Drugs and Poisons (SUSDP), which informs Australian 
legislation, defines ‘Prescription only medicines’ as “Substances, the use or supply of which should be by 
or on the order of persons permitted by State or Territory legislation to prescribe and should be available 
from a pharmacist on prescription.”  
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1.2.1.1. National policy  
 
In 1999, the Commonwealth Government of Australia formally launched the National Medicines 
Policy (NMP), which had four central aims.  The fourth arm of the NMP set an objective for 
prescribers as well as all other “key partners” in medicine use, that being to achieve the Quality 
Use of Medicine (QUM).12  QUM is defined as: the judicious selection of management options; 
appropriate choice of medicines, where a medicine is considered necessary; and safe and 
effective use. 13  The principles of QUM promote: the primacy of consumers; active and 
respectful partnerships; consultative, collaborative and multidisciplinary activity; support for 
existing activity; and system-based approaches.  These principles have been incorporated into 
various educational tools on prescribing.14, 15  
1.2.1.2. Educational tools  
 
A model developed by the World Health Organization (WHO) is one attempt at detailing what 
prescribing should involve. 16 It was developed in the mid 1990s in response to a perceived lack 
of educational materials specifically devoted to the practice of prescribing as opposed to just 
knowing pharmacological or therapeutics facts.  From the first step of setting a therapeutic 
objective through to monitoring for effectiveness and tolerability, good prescribing requires 
careful systematic evaluation of numerous patient-related and drug-related factors [Figure 2].  
Although intended as a practical training manual for medical students, the model represents a 
highly idealised version of prescribing.  It provides some “real world” clinical context, but little 
sense of the real workplace.  The lack of focus on non-biomedical influences on prescribing is 
deliberate - the theory being that promoting a stepwise approach to prescribing will arm students 
with a method to handle potential influences. 17 
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Figure 2. The Process of Rational Treatment 
[adapted from the WHO “Guide to Good Prescribing”16] 
Step One  Define the patient’s problem 
Step Two  Specify the therapeutic objective 
    Choose a treatment from personal inventory (information or advice; non-
drug treatment; drug treatment; referral) 
 
 
 
If drug treatment, select a drug from personal inventory (having previously 
considered: comparative efficacy, safety, suitability, cost). Also select 
dosage form, dosage schedule, and duration according to therapeutic 
objective. 
Step Three  Verify suitability of drug selection for patient (check above plus: indication; 
convenience; contraindications; interactions; high risk grouping) 
Step Four  Start treatment (write prescription) 
Step Five Give instructions, advice, information to patient 
Step Six  Monitor results and determine further action: stop; alter; continue drug 
treatment 
  
 
The WHO model also illustrates the inherently complex nature of prescribing.  The multiple steps 
in the process, the numerous choices that need to be made, the duration of the task, and the 
variety of information that needs to be assessed are all recognised components of a complex 
task.18   
 
In another model, Barber defines the goals of good prescribing – these being : to maximise 
effectiveness, minimise risks, minimise costs, and respect the patient's choices.19  By proposing 
goals rather than a recipe for how to prescribe, the author argues that prescribers will better 
recognise “complex trade offs” between conflicting aims rather than thinking that the “right 
answer exists.” Like the WHO model, this approach sees good prescribing as a continuum of 
medicines management and therefore includes monitoring of treatment. Since its publication in 
1995, this approach to prescribing has gained wide acceptance in the literature. 
 
An Australian handbook on prescribing advocated a systematic problem-based approach with 
incorporation of QUM principles. 14   Prospective prescribers are encouraged to ask themselves 
a series of questions about medicine use, specifically designed to help them minimise harm, 
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maximise benefit and respect their patient’s view.  The approach, which acknowledges a general 
practitioner (GP) perspective, identifies consulting skills as the core issue affecting prescribing 
with a particular emphasis on incorporating patient’s views and utilising the doctor-patient 
relationship.  Mant’s approach aims to give prescribers “conscious control” when prescribing, so 
that the tendency for prescribing to be done “almost as an afterthought, on automatic pilot” is 
avoided. 
 
In a recent editorial on the unpreparedness of UK medical students for prescribing, Aronson 
describes the task of prescribing as “formidable for even the best-trained prescriber.” 20  By 
emphasising the need for a thorough understanding of the pathophysiology of the disease,  the 
pharmacology of the drug, as well as attention to key processes before prescription writing, he 
depicts prescribing as a challenge to an individual’s ability to apply knowledge through 
development of clinical reasoning skills.     
1.2.1.3. Performance markers  
The quest for developing quality standards for prescribing has further expanded the picture of 
what constitutes good prescribing.  Quality in prescribing has proven notoriously difficult to 
define.  A 1991 review of studies measuring markers of quality concludes that “a global measure 
of quality in prescribing is probably ephemeral. The transaction is so multifaceted that a single 
criterion of quality can hardly be valid.” 21  Nevertheless, indicators for measuring quality or cost 
of specific prescribing practices have been used for over 20 years in the UK 22 and more recently 
in Australia.23 Ideally, a quality improvement indicator represents a prescribing behaviour that is 
closely associated with a clear clinical outcome, which is supported by strong evidence. 24  An 
example of a quality indicator developed for elderly medical inpatients is “Appropriate use of 
antithrombotic stroke prophylaxis in atrial fibrillation.”25 
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In 2006, the National Prescribing Service launched a manual of indicators for GPs to measure 
the quality of their own prescribing.  Two types of indicators were developed to give prescribers 
an insight into their own prescribing and to identify areas for quality improvement.26 Structure 
indicators were designed to provide prescribers with an assessment of their practice 
infrastructure to support quality use of medicines; for example, “Does the practice have a policy 
on prescription of benzodiazepines and opioids?” Process indicators were designed to evaluate 
how well a process is carried out and can quantify changes over time; for example, percentage 
of patients prescribed an antihypertensive agent who are not at their target blood pressure.”  
 
The development of quality prescribing indicators has promoted the importance of determining 
precise clinical objectives.  Furthermore, regular review of prescribing decisions as well as 
maintenance of tools that support prescribing are seen as pivotal to improving quality in 
prescribing. 
1.2.1.4. Prescribing curricula for non-medical practitioners  
 
Historically, prescribing has been viewed as the domain of medical practitioners.  Further 
insights into the act of prescribing may be gained, however, by looking at the involvement of 
other professions in drug therapy management.   
 
Under Australian legislation, medical practitioners are the only health professionals with full 
independent prescribing authority, but limited prescribing rights exist for accredited nurses 
(nurse practitioners), and Australian pharmacists have the authority to prescribe pharmacy only 
and pharmacist only medicines.v 27  
                                               
v
 SUSDP classifies “Pharmacy only medicines” as “Substances, the safe use of which may require advice 
from a pharmacist and which should be available from a pharmacy or, where a pharmacy service is not 
available, from a licensed person.  “Pharmacist only medicines” are classed as “Substances, the safe use 
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In other countries, pharmacists and nurses have extended prescribing authority.  For example, in 
the UK, Canada (some provinces) and the US (some states), accredited pharmacists are 
currently involved in collaborative drug therapy management.  Because they do not have sole 
authority to make treatment decisions, they are termed dependent or supplementary 
prescribers.vi  In general, they are involved in various prescribing activities subsequent to the 
diagnoses being made. 27, 28  The nature of these proposed activities can be surmised from a 
competency framework, which was developed by the National Prescribing Centre in the UK.  
The competencies are broad ranging and are organised under three major elements: the 
consultation, prescribing effectively, and prescribing in context.  Some examples include: taking 
medication histories, generating treatment options, helping patients to make informed decisions 
about treatment options, checking doses and calculations, working within professional and 
organisational standards, understanding and using tools to improve prescribing, recognising and 
dealing with pressures that might result in inappropriate prescribing, and so on.  Some of these 
activities – albeit not conventionally recognised as part of prescribing - are already performed by 
nurses and pharmacists in Australia as part of medicines management. 
 
Therefore, whilst doctors may instigate most drug therapy, pharmacists and nurses are also 
involved in some prescribing activities.  Of course consumers also select and self-monitor 
various unscheduled medicines.  Arguably, all “prescribe” in some way: either by deciding to 
commence drug therapy, choosing a drug, or being involved in supporting decisions or activities. 
                                                                                                                                                        
of which requires professional advice but which should be available to the public from a pharmacist 
without a prescription”. 
 
vi
 Although there are plans to extend prescribing privileges of accredited nurses and pharmacists in the UK 
toward independent prescriber status. (A guide to implementing nurse and pharmacist independent 
prescribing within the NHS in England: April 2006) 
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1.2.1.5. Observational research 
Contrary to notions of what prescribing should be, an educationalist’s observations of “how 
prescribing gets done” are that GP prescribing was a “materially hybrid practice” and not the 
“rational cognitive practice” that is conventionally conceived. 29  Based on her observations of 
GP consultations, as well as interviews and questionnaires, Deveny argues that despite the 
desire of academics to portray prescribing as a linear sequential process, this was seldom 
supported by her data.  She concludes that prescribing could be only “partially understood from 
a purely clinical perspective” and that “practice defies algorithmic reasoning”.  No corresponding 
forms of observational research into prescribing in hospitals were able to be located. 
1.2.1.6. Other perspectives 
There are other forms of research that help to define what prescribing involves including 
attempts to map how prescribing is done from the perspective of key decisions that are made, 
such as how doctors choose drugs.30-32 Studies analysing causes of prescribing errors33, 34, 
research examining pharmacist interventions on prescribing 35-38, and investigations into 
inappropriate prescribing practices 39, 40 reveal problems with how particular prescribing activities 
are sometimes performed.  Research examining potential influences on prescribing 32 and 
studies measuring the impact of interventions 41 provide insights into behavioural aspects of 
prescribing.  These are reviewed later. 
 
In summary, prescribing is a complex and interactive task – one that ideally involves a clear 
series of decisions and activities to help achieve clinical and, if possible, economic aims, all the 
while incorporating the patient in these decisions - but in reality appears to involve a less explicit 
and multifaceted practice that is difficult to characterise. 
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1.2.2. WHAT ARE THE RISKS? 
1.2.2.1. Patient harm 
Hospital admission statistics and medical record examinations have shown that use of 
medicines is a risky intervention.  The Harvard Medical Practice Study (HMPS), involving 
retrospective review of medical records during 1984 from hospitals in New York State, raised 
worldwide awareness of medical intervention as a cause of patient injury.  This study found that 
nearly 4% of patients admitted had an accidental injury, the most common type being a drug 
complication.42 
  
In the last twenty years, there has been a wide variation in internationally reported incidences of 
drug-related hospital admissions.  Pooled data (1980-1999) indicate that hospitalisation due to 
adverse drug events is common in developed countries, and may account for between 3 to 9% 
of admissions.43  In Australia, an analysis of over 20 studies (1988 – 2001) found that drug-
related problems (adverse drug events, over-use and under-use of medicines) accounted for 
between 2 and 3% of all hospital admissions. 44  In the UK, a recent analysis of admissions to 
two Merseyside hospitals during the winter of 2001- 2002 found that up to 6.5% of admissions 
were related to an adverse drug reaction.45  The incidence of drug-related hospitalisation has 
been found to be higher in the elderly. One Australian study found that nearly sixty percent of 
such admissions involved patients over 60 years, with the highest rates in patients aged 80+ 
years.46 
 
The severity of patient harm caused by drug therapy can be significant.  The HMPS found that 
most drug complications resulted in minimal impairment, but in 14% of cases, the outcome was 
a serious disability.42  The Quality in Australian Health Care Study (QAHCS) involved review of 
over 14 000 admissions to 28 hospitals in New South Wales and South Australia during 1992 
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and found around a sixth of all admissions were due to health care management (ie, adverse 
eventsvii). In this study, over 10% of adverse events were due to drugs, and a quarter of these 
were severe enough to cause permanent disability or death. 47  In the Merseyside study cited 
above, over 2% of drug-related admissions resulted in death.45   
 
In the community, harm caused by medicine use is common 48-50 and it is estimated that 
approximately 400 000 ADEs are managed each year by Australian GPs.44  Furthermore, a 
recent Australian study reported that 10% of all patients attending general practices experienced 
an ADE within the previous six months.48   
1.2.2.2. Hospital costs 
The hospital costs of ADEs are high.  Based on ICD-10-AM viii diagnoses coding (which identifies 
less than half all adverse events 3) the Australian Institute of Health and Welfare (AIHW) 
reported almost  320 000 hospital separationsix associated with an adverse event for 2003-04, 
and over a quarter of these involved adverse effects of drugs, medicaments and biological 
substances.2  Assuming a seven day length of stay per drug-related hospital admission 51, and 
using further AIHW data for 2003-4 to calculate a national average daily cost of stay 2x, the 
hospital costs of 83 000 medication-related hospital admissions would be in the order of 
$AUS560 million annually.   
                                               
vii
 In this study, adverse event was defined as an unintended injury or complication, which resulted in 
disability, death or prolonged hospital stay and was caused by health care management.  
viii
 ICD-10-AM: International Statistical Classification of Diseases and Related Health Problems, 10th 
Revision, Australian Modification. 
ix
 Separation is the term used to refer to the episode of care which can be a total hospital stay or a portion 
of a hospital stay beginning or ending in a change of type of care. [Australia’s Health, 2006] 
x
  The national average case mix separation ($3293) divided by national average length of stay (3.4 days) 
= $968.50 per day. 
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1.2.2.3. Other adverse consequences 
Other adverse consequences include: increased length of hospital stay 52; other health care 
costs 44, 52;  social costs – for example, increased drug-resistance of bacteria due to poor 
prescribing of antibiotics; 53 and human costs.  
1.2.2.4. What is the trend?  
 
In Australia and internationally, there are indications that rates of ADEs requiring or extending 
hospitalisation are increasing 44, 46, 54, but whether or not this reflects an exposure effect (ie, 
related to increased medicine use) is unclear. 55  South Australian admission data for the years 
1988 to 2001 show a steady increase in adverse drug reactions associated with 
hospitalisations44, and an admission study in Western Australia found a five-fold increase in 
adverse-drug reaction related hospital stays in people aged 60 years and over between 1981 
and 2002. 46  In the UK, the Audit Commission reported a five-fold increase in the number of 
deaths in England and Wales due to adverse effects of medicines between 1990 and 2000.  The 
Commission also reported an upward trend in the number of deaths due to medication errors 
over the same period.54 
1.2.2.5. How much is preventable? 
Although some adverse consequences of medicine use are inevitable, resulting from calculated 
risks with accepted standards of care, studies have found that many – if not most – ADEs are 
avoidable.  The QAHCS rated 43% of drug-related AEs as highly preventable.47 Other Australian 
studies have also reported high rates of preventability for drug-related problems or ADEs 48, 56 
and one review suggests up to 75% are potentially avoidable.3  Consistently, anticoagulant, anti-
inflammatory, and cardiovascular drugs together make up half of all potentially preventable 
ADEs.3 
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The picture is similar in other developed countries.  A US study rated 28% of drug-related 
admissions as preventable 57; 72% of ADR-related admissions were considered at least possibly 
avoidable in a more recent UK study.45 Pooled analysis of admission studies internationally 
(1980-1999) suggest over half drug-related admissions are preventable. 43  
 
These statistics do not represent a new phenomenon.  In 1971 Melmon suggested that about 
70% of adverse drug effects were predictable and preventable through logical application of 
existing information.58 A resolve to improve medication safety at governmental levels of 
healthcare provision has been more recent.44, 54, 59  
 
To sum up the hazards, prescribing is a high risk activity with potentially serious and costly 
consequences.  The worldwide literature indicates that the rate of patient harm due to drug-
related therapeutic interventions is increasing.  The majority of adverse drug events leading to 
hospitalisation are considered to be avoidable. 
1.2.3.   MINIMISING ERRORS IN PRESCRIBING 
1.2.3.1. Defining prescribing errors 
According to a UK expert consensus, “a clinically meaningful prescribing error occurs when, as a 
result of a prescribing decision or prescription writing process, there is an unintentional 
significant (1) reduction in the probability of treatment being timely and effective or (2) increase 
in the risk of harm when compared with generally accepted practice.”60  Historically, however, 
medication error research has focused more on errors that increase harm than on errors that 
reduce efficacy, and more on administrative and procedural tasks (such as prescription writing) 
than on problems with decision-making or communication.  Conversely, decision-making and 
communication skills have been studied within frameworks of quality improvement or 
appropriateness in prescribing rather than the context of medication safety.   Yet in a recent 
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study, most serious prescribing errors resulted from prescribing decisions rather than medication 
ordering. 61 As is discussed below, through the growing interest in medication safety and 
systems analysis of errors, the importance of workplace influences on ill-conceived prescribing 
decisions as well as unintended actions in hospitals is being recognised. 
1.2.3.2.  Size of the problem 
Prescribing errors are a proven major cause of preventable ADEs.  Just over half of preventable 
ADEs were associated with drug ordering in one US study 57, and problems with prescribing 
were the leading cause of preventable drug-related admissions in a UK study.62   
Errors that result in ADEs represent approximately 1% of all medication errors, but a further 7%  
of errors have potential to cause harm (“near misses”).63 Although there are inadequate data to 
estimate the incidence of prescribing errors in Australian hospitals, research indicates that 
prescribing errors are ubiquitous 64-68 and that errors with potential to cause patient harm are not 
uncommon.38, 67  Medication incidents represent the second most common type of notification to 
hospital incident reporting systems 69, 70, and according to the NSW Incident Information 
Management System, most of these originate from drug administration and prescribing 
problems.70 
 
Internationally, incidence studies of prescribing errors in hospitals vary greatly depending on the 
study design and definitions of error.  Investigators, however, agree that the frequency of 
potentially serious prescribing errors represents a significant healthcare problem. 61, 63, 71, 72 A 
rate of 0.4% of potentially serious errors detected in one UK hospital, for example, equated to an 
average of five potentially serious prescribing errors per day.61  
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1.2.3.3. Types of errors  
In Australian hospitals, dose errors (including omission of strength) are the most common type of 
prescribing error 36-38, 65, 67, 73, which is consistent with reports from other countries. 33, 57, 61, 74, 75 
Other notable prescribing errors from studies internationally include: prescription of a drug when 
patient is documented as allergic; incorrect frequency of administration of therapy; duplication; 
and dosage form unspecified. 67, 74, 76 There is great variation in the most common types of drugs 
found to be associated with clinically important medication errors. 77 Because the clinical 
significance of errors varies greatly depending upon the type of drug, current emphasis for 
surveillance of errors is on drugs with a greater potential for harm (for example, potassium 
chloride, morphine, warfarin, vincristine) than those that may be involved in the greatest number 
of errors (eg, paracetamol61, antimicrobials78, or ACE inhibitors36). 
1.2.3.4. Systems analysis 
The widely accepted approach for preventing patient injury due to medical interventions in 
hospitals is to use incident or error surveillance not only to monitor rates of error, but to identify 
weaknesses in medical management systems. 59, 79 This system approach has been adopted 
from other high reliability industries, such as the nuclear power and aviation industries.80  
Historically, the common practice within health care systems has been to blame individuals for 
making mistakes, but this does not prevent similar errors from occurring again.80  The system 
perspective on errors assumes that most people working within a system are doing their best.   It 
acknowledges that humans are fallible and that errors seldom result from a single mistake but 
from a system that makes slips, lapses and mistakes easy to occur or difficult to detect. 33, 59, 79  
1.2.3.5. Conditions that lead to prescribing errors 
In the last ten years, national medication safety reports 44, 54 and other literature have raised 
awareness of factors that make prescribers working in hospitals vulnerable to error.  The most 
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frequently cited are: workload and staffing 34, 81-83; individual factors, such as lack of skills and 
knowledge 33, 34, 54, 76 and the health of the prescriber, in particular tiredness and stress.34, 54, 82, 84  
 
In relation to individual factors, a number of studies have examined the link between level of 
experience and prescribing errors, but interpretation of these data is difficult because: junior 
medical staff write most prescriptions 71, error severity is infrequently related to experience level, 
and some studies have not taken place under workplace conditions.85  Overall, however, there is 
adequate evidence to suggest that first year postgraduate medical trainees are more likely to 
make errors than more experienced staff 71, 86, particularly at the start of the academic year.87 
 
Of growing interest, many cultural factors have also been linked to prescribing errors in hospitals 
including: team factors (such as responsibilities34, communication34, 88, and supervision 34, 83); 
and attitudinal factors, such as a low perceived importance of prescribing 34, 89, hierarchical 
medical team 34, 89, transcription viewed as lesser form of prescribing 33, 34 and an absence of 
self-awareness of errors.34 
 
Other error-producing conditions in hospital that have been cited include: lack of accessibility to 
drug and patient information 33, 34, inadequate training 34, 54, distractions and interruptions 54 and 
the physical environment 34 – especially unfamiliar surroundings. 54  
 
In short, evidence for casualness in prescribing is abundant.  Prescribing errors may result from 
poor decisions, miscommunication or poor attention to procedural tasks.  Prescribing errors can 
have serious consequences and are the biggest source of preventable drug-related hospital 
admissions.  A range of conditions within hospitals have been linked to prescribing errors; whilst 
individual factors such as lack of knowledge and skills are important, a mass of factors 
associated with the structure, organisation, and culture of the workplace have been implicated.    
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1.2.4. MAKING APPROPRIATE DECISIONS 
1.2.4.1. Defining inappropriate prescribing 
In addition to error, there are other prescribing behaviours that fall short of an accepted standard 
of care.  Various terms such as “suboptimal”, “inappropriate”, “irrational” and “poor” have been 
used to describe this type of prescribing behaviour.  Because standards of care vary – 
depending on the setting, resources and evidence available at the time – concepts of 
appropriateness and inappropriateness in prescribing have proved difficult to globally define.  
Tully and Cantrill 90 described appropriate prescribing in holistic terms as “the outcome of the 
process of decision-making that maximises net individual health gains within the society’s 
available resources.”  Dartnell 91proffered that drug use problems arise from practices that fail to 
meet any one or more of Barber’s goals of good prescribing, ie, maximising effectiveness, 
minimising risk, minimising cost, and fulfilling patient’s choice.  Others have emphasised the 
differences between patient and health professional perspectives of appropriateness. 92, 93  
 
For the purpose of evaluating drug use quantitatively, a dichotomous definition has been used to 
aid ease of data collection.  In these circumstances, inappropriate drug use is defined as a lack 
of concordance with an agreed treatment protocol. 94 But this definition ignores patient 
acceptability of treatment, and can be disputed on the grounds of the strength of the evidence 
base for the protocol, opinions about those who agreed on it, and relevance to the local 
situation.  Also, whilst consensus might easily be achieved when evidence stacks up clearly on 
the side of a particular drug choice, dispute is likely in cases where safety data are similar and 
where efficacy data do not allow direct comparison of options. 
 
“Appropriateness” might be a “slippery customer” 92, yet when a choosing treatment, a clear 
understanding of this concept is important as uncertainty about what constitutes the best 
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possible therapy for an individual may increase a prescriber’s vulnerability to environmental 91 or 
social influences.8  
1.2.4.2. Examples of inappropriate prescribing 
Despite recent improvements in prescribing in some therapeutic areas (eg, benzodiazepine 
prescribing in the elderly 5, 95), suboptimal prescribing persists in others (eg, antibiotic prescribing 
for upper respiratory infections 53).  Also, the impact of strong marketing of new therapeutic 
entities (eg, coxibs – COX-2 inhibitors) illustrates the way in which prescribing practices can be 
readily swayed, at the expense of considered evaluation of added benefit.96   
 
There are a range of problems with quality of prescribing, but the potential consequences are 
the same as for errors.  For example, failing to prescribe or adequately manage anticoagulants 
(heparin and warfarin) accounted for up to one third of potentially preventable adverse 
medication events in the QAHCS.3  Other major problems with prescribing include: inappropriate 
use of antibiotics 97, use of a potentially toxic drug when a less toxic one would work as well 98, 
insufficient monitoring99, prescribing unnecessary drugs or polypharmacy in the elderly 39,  
prescribing excessive doses, particularly in the elderly 23, prescribing unnecessarily expensive 
drugs 40, and lack of patient participation.100   
1.2.4.3. How prescribing decisions are made 
Understanding how prescribing decisions are made is viewed as a critical step to improving 
prescribing behaviour. 21  Two pivotal decisions in the process have been examined in detail: (1) 
the decision to treat (or selection of a management option) and (2) the drug selection process. 
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Deciding to treat.  According to recent Australian data, 83 out of every 100 encounters with 
GPs results in a drug prescription 2xi which is typical of historically reported rates of prescribing in 
primary care.21, 101 This propensity to write prescriptions coupled with the reluctance of 
prescribers to consider non-drug options 102 has stimulated sociological analysis of doctor-
patient interactions that may influence the decision to treat.  A range of social, logistical and 
prescriber-related factors have been proposed including use of the prescription to: fulfil the 
patient’s expectation, resolve conflict with the patient, deal with uncertainty, save time, and to 
end the consultation.21  Furthermore, concern for preserving the doctor-patient relationship was 
cited by GPs as one of the main reasons for difficulty experienced in making decisions about 
treatment options.103, 104  
 
Research into factors affecting treatment option decisions in hospital settings is scant, possibly 
because the option of not prescribing a drug is less feasible or because of assumptions about 
the powerlessness of hospitalised patients to affect decision-making. 
 
Choosing a drug. The drug selection process has been intensively studied in both community 
and hospital settings.   A number of drug choice models have been developed for predicting 
prescribing patterns or as a framework for understanding influences on prescribing.30, 31, 105-107  
These so-called ‘expectancy-value’ models are based on cognitive theories modified from social 
learning theory 108, and have been used to test whether prescribers use reasoned action 
(stimulus-cognitive response) or habit (behavioral response) when choosing drugs. 106 31 
According to cognitive theories, doctors choose drugs in a rational way by balancing cognitions 
(conscious knowledge, beliefs and assumptions) of probabilities that various outcomes will occur 
(expectancies) and attaching a value to these outcomes. 109 In other words, they weigh up the 
                                               
xi
 This does not include medications that are advised.  BEACH (Bettering the Evaluation And Care of 
Health) study data from 2004/5 puts the rate of medications prescribed, advised or supplied at 104 
medications per 100 encounters.  
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pros and cons of various drug treatments and choose the treatment with the highest weighted 
score.   
 
Collectively, drug choice models reveal prescribing outcomes and drug attributes that are 
important when doctors make prescribing decisions.109 However, the models vary in terms of the 
range of outcomes considered, whether or not outcomes were presented to or evoked by 
prescribers, and their predictive success.  For example, one drug-choice model, which includes 
respondent-derived outcomes (control of disease state, compliance, side effects, cost, patient 
demand and criticism from colleagues), correctly predicted 72% of therapeutic decision made by 
12 doctors for the treatment of mild hypertension in a simulated case.106  Another model, tested 
on 72 hospital-based doctors found that biomedical expectancies and values predicted preferred 
treatment of eight specific therapeutic scenarios in 53% of cases, but by adding in aspects of the 
social environment (particularly opinion of colleagues) and experiences (particularly personal 
experiences) prediction was improved to 77%. 30 
 
Overall, the predictive power of some drug-choice models has leant support to the view that 
prescribing is substantively a cognitive rather than habitual process.106, 110 However, few models 
have been tested on actual prescribing practice 110 and ranking of outcomes may depend on the 
therapeutic area being studied 30, 32, 111 and on prescriber-specific factors. 108, 111  
 
An alternative view is that prescribing involves a combination of cognitive and habitual 
behaviours depending on familiarity of the clinical problem or other factors. 21, 107 This view is 
supported by an observational study of GPs who verbalised their thought processes when 
prescribing for patients with urinary tract infections or stomach complaints.  Most prescribed 
habitually without any specific contemplation of treatment options. 112 Whilst this did not 
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necessarily result in suboptimal prescribing, important aspects, such as ensuring patient 
suitability (eg, asking about allergies) were sometimes overlooked.  
 
Prescribing has also been conceptualised as a problem-solving process, and schema theory has 
been used to examine how doctors problem-solve when prescribing.  According to the theory, if 
similar information is repeatedly encountered it is eventually incorporated into some form of 
schematic representation, which facilitates rapid and efficient decision making. 113  In a study 
comparing schemas used in prescribing by hospital doctors with different levels of experience, 
junior doctors were found to use simplistic schemas emphasising logical elements of prescribing, 
whereas consultants used sophisticated schemas emphasising the bigger picture and 
incorporating the patient’s view.113 
 
To sum up, appropriate prescribing is difficult to universally define, but concordance with locally 
accepted standards of treatment is the operational definition commonly applied.  Many and 
varied types of inappropriate prescribing behaviours have been identified.  Prescribing decisions 
are complex and may involve reasoned risk-benefit analysis of multiple outcomes.  Alternatively, 
as a way of dealing with complexity, prescribers may make some decisions without lengthy 
contemplation, which may be inferred as either habit or use of a schema developed through 
experience to shortcut cognitive processes.  Factors external to biomedical concerns, including 
social, personal and logistical, are integrated by prescribers into their decisions and may impact 
on the appropriateness of those decisions.  These factors are examined in greater detail in the 
next section.     
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1.2.5. INFLUENCES ON PRESCRIBING   
1.2.5.1. Biomedical perspective 
According to biomedical models, clinical, drug and cost factors should determine all prescribing 
decisions. 16, 90 Indeed, these factors are often cited by prescribers as the prime factors 
governing their decisions.  Efficacy, compliance, cost, tolerability, duration and adverse effects 
were nominated and ranked by doctors in two Australian teaching hospitals as the most 
important factors for determining prescribing choice in a clinical scenario32, which is consistent 
with findings from other countries. 30, 114, 115  Following this line of reasoning, problems with 
prescribing might be expected to be solved by concentrating on knowledge deficits of 
prescribers and honing of their clinical reasoning skills.  But unsuccessful educational efforts 
based upon this premise 116 and problems arising from lack of patient participation in decision-
making 100 have exposed flaws with this construct.  This is because the biomedical perspective 
does not represent reality.  It fails to take into account the social, cultural, environmental and 
commercial context in which prescribing takes place. 117  
1.2.5.2. Multifactorial perspective 
An alternative perspective is that prescribing is not just a test of knowledge utilisation and clinical 
reasoning skills alone, but a more complex challenge of acknowledging and dealing with a web 
of biomedical, historical, psychosocial and commercial influences.101   
 
Community and outpatient settings.  Abundant evidence from actual prescribing practice (as 
well as from analysis of decision-making 30) shows that a range of personal, social and 
environmental factors can and often do heavily influence prescribing decisions in primary care. 
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Several characteristics related to the individual and their professional contacts have been shown 
to affect the prescribing patterns of GPs.  Personal experience 31, 118 and the opinion of 
professional colleagues 119 , particularly hospital specialists 106, 118, 120, have been nominated as 
two of the most important influences on their prescribing decisions.  Age of the prescriber and 
training status has also been shown to account for variation in prescribing patterns.  Younger 
GPs have been found to prescribe in a more rational way than older GPs, partly through having 
more professional contacts with their colleagues and making more use of up-to-date 
resources.121 Older GPs have been found to have higher prescribing rates.122, 123 Higher training 
status of GPs has been associated with lower rates of prescribing of antibiotics.124, 125 
 
Factors affecting knowledge acquisition have also been identified as influential, such as 
continuing education120 and types of information sources used such as academic and 
professional literature.118, 126 Reliance on information provided by the pharmaceutical industry 
has been negatively correlated with rational prescribing 121, yet drug company representatives 
have been cited as one of the most important sources of information for GPs about new 
drugs.127 
 
Patient expectations 101 as well as doctors’ perceptions of their expectations104, 128 have been 
shown to affect the decision to prescribe.  Patient’s social circumstances have been proven to 
be important in drug selection decisions120 and patient requests have been shown to be 
influential in uptake of new drugs by prescribers.118   
 
Environmental factors such as practice location, training status of the practice, or whether a 
doctor works alone or in a group practice have also been identified as influential.  GPs in rural 
areas are more likely to avoid prescribing drugs that require a significant amount of monitoring 
than their urban counterparts.120  Lower prescribing rates of benzodiazepines 129 and 
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antibiotics125, 130 (and by implication, more appropriate prescribing of these drugs) have been 
reported in group practices and in training practices.    
 
Hospital settings.  Compared with general practice, far less is known about situational drivers 
that may predict prescribing patterns in hospitals.  Whilst similar types of factors to those cited in 
community-based studies have been nominated by surveyed hospital doctors 114, the nature and 
interrelationship of these factors within the hospital environment is less well understood.  A 
recent qualitative study examining the processes by which new drugs are prescribed by hospital 
doctors found that a configuration of varied influences affected drug adoption in this setting.  The 
study found that doctors drew on four forms of knowledge that were interconnected: scientific 
knowledge, social knowledge, patient knowledge and experiential knowledge.131 In particular, 
social processes, such as supervisory consultants’ prescribing practice, played a big role in 
grounding interpretations of ambiguous scientific research findings. 
 
Experiential knowledge and social influences have also been identified as major influences in 
other hospital studies.  In a survey of Australian doctors and clinical pharmacy staff at two 
teaching hospitals, drug familiarity was rated as a highly important influence on prescribing for a 
clinical scenario, with a mean weighted score of 8.5±1.5 (on a scale of 1 to 10), following drug 
efficacy (9.3±1.0) and illness severity (9.2±0.9).32 Based on a Likert scale (0= no influence and 
5=greatest influence), a US telephone survey of hospital-based doctors, pharmacists and 
formulary committee members, found that personal experience was the third most highly rated 
influence (mean rating 4.14±0.71) nominated by doctors, following drug effectiveness 
(4.73±0.45) and safety (4.73±0.49).114 In contrast, the pharmacists and committee members 
surveyed did not rate personal experience highly (3.44±1.01 and 2.72±0.93, respectively).  A 
Dutch study examining the expectancies and weightings (on a scale of 0-10) that hospital 
doctors placed on potential drug treatments for clinical scenarios found that efficacy (average 
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value of 9.7) was the most highly valued aspect of prescribing; however, personal experience 
(8.5) was valued similarly to some biomedical influences, such as serious side effects (8.2) and 
rate of onset of effect (7.8).xii 30  In this study, the opinion of medical colleagues was also highly 
regarded (6.4), and the opinion of pharmacists (4.7) and nurses (4.5) were rated more highly 
than pharmaceutical detailers (2.2).  A study involving interviews with Australian interns revealed 
that the opinion of senior medical colleagues (particularly registrars) was highly valued as was 
the opinion of nurses and pharmacists (particularly specialist practitioners).132 In the UK, a 
qualitative study with doctors of varying experience found that early on in their careers, senior 
colleagues were the major influence for hospital-based doctors.  However, as their career 
progressed, personal experience became the leading influence.133 The opinion of patients has 
been cited as influential, but considered less so than a doctor’s personal experience and 
opinions of their colleagues.30, 133  
 
Findings are conflicting regarding the impact of guidelines on prescribing in hospitals with some 
studies finding them influential 32 114, whilst others reporting a poor awareness of their 
existence 133 and low adherence.134  General prescribing references have been shown to be 
popular sources of prescribing information.133, 135  As in community settings, drug company 
promotion has been cited as less influential than other sources of information 114, but 
inconsistency between views and behaviours towards companies exists.  Whilst 70% of hospital-
based consultants in a UK study saw pharmaceutical representatives up to once a week, they 
rated independent sources of information as more important.136   
 
Environmental factors nominated as influential in hospitals include administrative interventions, 
such as prescriber-feedback and formulary restrictions.114   
 
                                               
xii
 The statistical significance of these relative values was not documented by the authors of this study. 
 43 
Drug cost.  Several studies in primary care have found that whilst some doctors believe costs 
should be taken into account when prescribing, this belief did not necessarily translate into 
action.137, 138 In one study, even when cost data was provided to doctors, there was great 
variation in the extent to which this information was applied.138  In some cases, espoused efforts 
to minimise cost have been associated with whether costs are directly borne by the patient or 
indirectly through insurance companies or the health care system.137, 139 In hospital-based 
research, drug cost has been rated more influential by pharmacists and formulary committee 
members than by hospital doctors 114, and when making prescribing decisions has been 
considered by some specialist doctors more than others.140   
 
Pharmaceutical industry.  Numerous studies have demonstrated that pharmaceutical industry 
has a major influence on prescribing patterns both in general practice and in hospitals, 
particularly on new drug adoption through advertising, information provision (via representatives 
or printed information) 118, 127, 141, seeding trials and samples, 118, 142 and indirect methods, such 
as gifts, food and sponsorship of education.114, 143 The impact of industry on prescribing 
behaviour is principally the result of its enormous expenditure on marketing – approximately one 
third of revenue.143 Nevertheless, despite overwhelming evidence, when surveyed, doctors 
typically believe that that they themselves are not influenced by marketing techniques of 
companies,144 145 although they think that their colleagues are.145 
 
Therefore, contrary to what some prescribers may feel and some educators may hope, evidence 
indicates that prescribers are influenced by multiple factors external to consideration of the 
patient’s physiology and the drug’s pharmacology.  As addressed previously (see 1.2.3.5), 
psychosocial and environmental factors can also contribute to error by affecting either decision-
making or prescription writing.  In primary care, the effect of various social influences on 
prescribing is well established - with opinion of colleagues, extent of professional contacts, 
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group practices, and training practices being important determinants of prescribing patterns.  In 
hospital environments, social influences also appear to be important determinants of prescribing, 
but their nature is less well understood.   
1.3. DEALING WITH CHALLENGES 
1.3.1. Strategies 
A wide range of interventions has been developed to help prescribers make appropriate 
decisions about medicines. 41, 91, 94 The main types of methods used include: (1) system-based 
interventions, such as, drug formularies, policies and restrictions; (2) educative interventions, 
such as, undergraduate curricula, postgraduate training in teaching hospitals, and continuing 
medical education; (3) persuasive strategies, such as educational outreach (academic detailing), 
and dissemination of information through opinion-leaders; (4) information provision and decision 
support tools, such as clinical practice and prescribing guidelines, drug bulletins, routine 
reminders, feedback, and computer-based decision-support; (5) and patient-directed strategies, 
such as promotion of medicine adherence or improving understanding of the role of antibiotics. 
 
How effective are they? The rigour of evaluation of these interventions has been variable 41, 146 
and therefore conclusions are not straightforward.  General lessons learnt are that the 
distribution of educational printed materials alone has little sustained effect on changing 
behaviours. 41, 94 Multifaceted interventions are more likely to be effective than single 
interventions.41, 147  
 
Specific findings are that restrictive system-based approaches are effective, but can be politically 
contentious.146  Patient-directed interventions, such as campaigns to reduce overuse of  
antibiotics have been effective in reducing prescription rates.148  Educational outreach and 
feedback to prescribers are considered generally effective.7, 41, 147 In hospitals, the fast and 
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specific feedback provided by pharmacists following chart review has been found to be effective 
in preventing potential adverse events from prescribing problems 35, 38, 66 as has pharmacist 
participation on medical rounds. 149 
 
There is convincing evidence that electronic prescribing decision support (EPDS) xiii systems are 
useful in reducing rates of certain types of medication errors.150, 151  These are rule based 
systems designed to present prescribers with patient specific information, such as allergies, and 
drug-specific information, such as drug interactions, in a format that prevents prescribers from 
writing incorrect or inappropriate prescriptions.  One study in the US showed a 55% reduction in 
serious medication errors following introduction of an EPDS system.150  However, these systems 
have limitations.  They do not eliminate all errors152 (eg, errors of omission153)  and can increase 
some forms of inappropriate prescribing 154 and also errors 155 through injudicious design.  They 
are also difficult to implement in complex hospital environments.154, 156   
 
Educative interventions involving medical undergraduates and postgraduate trainees are 
discussed in more detail under Prescribing Practice of Junior Doctors (see 1.5.3). 
1.3.2. Behavioural change and the importance of context 
An underlying assumption of early interventions aimed at changing prescribing behaviour was 
that improved knowledge results in improved behaviour 117, but as already discussed, 
dissemination of information alone has not been found to bring about lasting change.  Repeated 
failures of such interventions lead to examination of causes for success of interventions in other 
areas of healthcare (for example, lifestyle effects on health).  The basis for many of these has 
been the utilisation of behavioural change principles.  
 
                                               
xiii
 Known as Computerised Physician (or Prescriber) Order-Entry (CPOE) in the US. 
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Based on findings from professional behavioural change research, these principles can be 
summarised as 147  :  
• most interventions are effective under some circumstances but none is effective under all 
circumstances 
• interventions based on an assessment of potential barriers are more likely to be effective 
• multifaceted interventions targeting different barriers are more likely to be effective than 
single interventions 
• successful strategies need to be adequately resourced; and all strategies should include 
a plan to monitor and evaluate the change.  
 
Therefore, to effect behavioural change, an important starting point is to identify potential 
barriers to change.  Barriers may relate to the individual (eg, knowledge, skills, attitudes, habits), 
the social context (eg, patients, colleagues) or the organisational context of care provision (eg, 
organisational structure) 147, 157  For example, in order to optimise the design of an EPDS 
program for GPs,  Deveny surveyed, interviewed and observed GPs to improve understanding 
of how prescribing is actually done and how computerised decision support could best enhance 
prescribing practices. 29  
 
A further assumption of many interventions is that prescribing is part of a discrete episode of 
care involving one prescriber and one patient.  In other words, the doctor who writes the 
prescription is also (in collaboration with the patient) the decision-maker.   This assumption may 
be valid in community and outpatient settings, but is not valid for most prescribing in teaching 
hospitals, which involves not one doctor, but medical teams.   
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In summary, despite interventions such as EPDS being hailed by some as universal problem-
solvers, no single intervention has been shown to solve all prescribing problems.  Multifaceted 
interventions appear to have the greatest potential for success.  According to behavioural 
change principles, another important predictor of success is a good understanding of the local 
context in order to best identify potential barriers to change.  Assumptions about the prescribing 
practice of GPs may not be valid for the practice of hospital doctors.  Therefore, there is a need 
for greater understanding of the organisational and social dynamics of prescribing practice in 
hospital settings to guide the development of interventions.   
1.4. PRESCRIBING IN HOSPITALS  
In Australia, GPs write more prescriptions than hospital doctors xiv and in recent years, GPs have 
been the main focus of interventions to improve quality use of medicines.  The efforts of the 
National Prescribing Service, for instance, focus more on primary than on secondary 
healthcare.5   But hospitals are not only a further source of prescribing problems 44, arguably, 
they also legitimise and perpetuate them.  Prescribing problems in teaching hospitals have 
multiple and sustained consequences.   Not only can poor prescribing practices result in 
suboptimal patient care 97 and cost blow outs 158,  but they act as poor role models for medical 
trainees 94, and as an additional spin-off effect, may be copied by general practitioners.118  
 
So, what is known about prescribing practice in teaching hospitals? What is the scene, who are 
the players and how do they interrelate? 
1.4.1. Prescribing process 
Australian teaching hospitals are dynamic and challenging workplaces for prescribers.  These 
hospitals care for the most complex patients, who are often severely ill, have multiple co-
                                               
xiv
 There are no Australian data on medicine usage in hospitals, but it is widely accepted that general 
practitioners write more prescriptions than hospital doctors.  In the UK, based on cost, about 80% of 
prescribing takes place in general practice [Prosser H and Walley T. Soc Sci Med 2006; 62: 1565-1578]. 
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morbidities and require multiple drug therapies. 91  Drug regimens can be complicated and carry 
significant risks.  The choice of drugs is usually restricted by drug formularies, which are 
determined by local committees.  The use of drugs is governed by a bevy of institutional and 
ward-level drug use policies and protocols.  Historically, medication order forms vary between 
hospitals with local rules regarding their proper use.  However, the national implementation of 
the National In-patient Medication Chart in January 2007 is an attempt to streamline 
prescription-writing and reduce problems associated with unfamiliarity of process.159  
 
In Australian teaching hospitals, nearly all prescribing is done by medical teams.  Typically, 
doctors with different levels of expertise and experience undertake particular prescribing 
activities. The most junior members, interns, write most prescriptions 9, but they make few 
therapeutic decisions alone.116  They “prescribe” according to advice from registrars, who usually 
have several years of experience, and who may be undergoing specialist training (advanced 
trainees).  Registrars make most prescribing decisions operating within parameters defined by 
consultants 91,  the most experienced members of the team.   
1.4.2. Medicines management systems 
Prescribing activities form part of complex medicines management systems, which are 
comprised of numerous activities from diagnosis and prescription through to receipt of 
medication.44  Several different health professionals are involved, and the patient is also viewed 
as an active player.44, 160  In a simplified representation, doctors diagnose and prescribe, 
pharmacists review and dispense, nurses administer and monitor, 44 and ideally, the patient is 
involved in some or all of the steps.160 Empirically, however, the steps are not sequential or 
discrete, and overlap of some roles and responsibilities is necessary to ensure that the system 
works.  Indeed, the successful operation of the medicines management system is considered to 
depend on multidisciplinary teamwork 44, communication, and partnership with the patient.160   
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Providing consistency in delivery of quality use of medicines is an ongoing challenge for these 
systems.  This is because the health professionals responsible for managing the medication of 
any particular patient will change.  Some of this is due to logistics, such as change of shifts, but 
the organisational structure and the workplace environment of hospitals also bring about a lack 
of continuity in staffing, such as training rotations, and the rapid staff turnover of certain 
professional groups, such as nurses and pharmacists.   
 
Therefore, there are ideas about what is required to make the system work, but how does it 
actually work?  What actual processes and communication exchanges take place day to day? 
How do the pieces fit together in the real world?  
1.4.3. Social and cultural influences on medicines management 
The conceptual framework of organisational culture can be an effective and highly sensitive 
means of understanding how and why groups of people behave in certain ways in the 
workplace.   There are two major perspectives on organisational culture that have received 
recent attention in prescribing and medicines management research and it is important to 
distinguish between them and indicate which one is relevant to the aim of this study and hence 
our examination of the literature. 
   
“Desired attributes” perspective. Despite being long recognised in other high reliability 
organisations  10, 161, the importance of organisational culture to quality and safety in healthcare 
organisations has only recently been embraced.   A great deal of discussion in the medical 
literature and government policy papers has focused on “safety culture” or “reporting culture” 
and how it is cultivated.10, 80   In this context, organisational culture is depicted as a group of 
desired attitudes (such as openness when discussing errors162) and behaviours (such as 
teamwork162) that might be imposed through management interventions in order to achieve 
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specific goals.10, 163, 164 Permeation of these tenets has been measured using survey-based 
tools.164  
   
“Shared beliefs” perspective.  Anthropological definitions of culture, however, are based on 
the idea that certain things in groups are shared or held in common – such as values, ideas, 
concepts and rules of behaviour.163  These elements are held implicitly by the group and are 
typically resistant to change.  An often quoted distillation of this concept is, “the way we do 
things around here”165 (Figure 3).  In developing this idea, Schein 166 argues that there are three 
levels of culture: 1) visible artifacts;  2) espoused values, norms and rules of behaviour; and 3) 
underlying basic assumptions – unconscious, taken-for-granted beliefs, perceptions, thoughts 
and feelings.   
 
The concept of shared beliefs is useful for examining cultural phenomena in various 
organisational units.  In healthcare, this perspective has been used to explore the dynamics of 
the whole organisation and its structure 167, as well as the various subcultures of those involved 
in delivery of care.168  This is the perspective chosen for this study to aid exploration of everyday 
social and cultural dynamics affecting prescribing in hospitals. 
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Figure 3. Organisational Culture illustratedxv 
 
 
There are few studies that have examined the direct effect of organisational structure or 
professional subcultures on prescribing or medicines management.  A small number have 
explored the relationship between doctors and pharmacists.  In an Australian teaching hospital, 
doctors appreciated the role of pharmacists in reviewing prescribing, but did not know that 
pharmacists had specialist knowledge in patient counselling.169  In a UK study of junior doctors, 
pharmacists were well appreciated for their role in preventing errors, even to the extent that 
some doctors felt that they could be less diligent in their prescribing as they believed that 
pharmacists would detect any mistakes made.170 Evidence from studies in the US and the UK 
                                               
xv
 Cartoon by Neil Hardie (2004) and reproduced with his permission. 
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indicate that advice from pharmacists is well accepted by doctors with most suggested 
interventions being implemented. 35, 149   
 
A Belgian study examining processes leading to inappropriate prescribing in acute wards of five 
hospitals identified paternalistic decision making by doctors (for example, underestimation of 
patient’s ability to comprehend) as a problem as well as a reluctance of prescribers to interfere 
with treatment prescribed by a colleague.  Other flawed processes observed included reliance 
on short term treatment (tendency to overlook management of chronic conditions) and a passive 
attitude towards learning (reliance on supervisor’s advice rather than self-directed learning).171 
 
A Danish study examining implementation of drug prescribing sheets identified a number of 
cultural obstacles among doctors and nurses, including: unclear responsibilities of nurses and 
doctors, low community spirit among doctors, insufficient communication, and the view among 
doctors that prescribing was a low priority. 172  
 
Some of these findings accord with socio-cultural influences associated with prescribing error: 
the assumption among hospital doctors that prescribing is not important or has a low 
priority 9, 14, 34, 89, problems of communication of prescribing decisions and uncertainties about 
responsibilities.34   
1.4.4. Other potential cultural influences in hospitals 
In view of the paucity of qualitative analysis of prescribing and medicine management in 
hospitals, other qualitative studies were sought examining cultural phenomena or latent 
conditions in these organisations with arguable potential to affect medicine-related processes. 
The following represents the major factors that were identified: 
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• the vertical power structure of medical teams 34, 89, which places the person with least  
experience or influence (the intern or resident) in a key role in medicines management. 
• the so-called “culture of blame”, which is the expectation that those found at fault will be 
individually held accountable and responsible.173  
• the collegiality and professional autonomy of the medical profession, which was reported 
to impede error notification and sharing of errors data outside of their closed peer 
groups.10, 174 
• the professional identity of consultants, which was found to affect their collaboration with 
other health professionals within the organisation and with the consumer: older Visiting 
Medical Officers (VMOs) distinguished by having little association with the organisation 
and seldom involving other health professionals in decision making; younger VMOs and 
staff specialists who have a collaborative approach and close association with the 
organisation.168 
• acceptance of error by doctors as an inevitable part of complex medical systems173 
• resident doctors’ view of the hospital environment in the US, that “there is often little co-
ordination among medical staff, nurses, pharmacists, respiratory therapists, social 
workers and other team members, with no system of organized interaction.”175 
 
So, whilst formal analyses of the effect of local influences on prescribing decisions in hospitals 
are few and far between, cumulative evidence from a range of sources points to an environment 
with distinctive characteristics to shape how prescribing is done.  Examination of the medicines 
management process and the cultural landscape of teaching hospitals reveals a spectrum of 
organisational and social dynamics, which may affect how well medicines are managed and 
whether errors are avoided.   In particular, dynamics such as: communication, teamwork, 
recognition of responsibilities, and whether prescribing is seen as a priority. 
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1.5. PRESCRIBING PRACTICE OF JUNIOR DOCTORS xvi  
In Australia, after graduating from university, medical graduates are required to undertake at 
least two years pre-vocational training in hospitals.176  In NSW, the first year is known as 
internship and the second year as residency.177  This period of training consists of five term 
attachments each year of 10-12 weeks duration, and aims to provide experience in general 
medicine, general surgery, accident and emergency, as well as in subspecialties.178  This is an 
intense and formative time for medical graduates.  Behaviours, beliefs, values and norms they 
encounter may be powerful determinates of future practice. 8 As discussed previously, for junior 
doctors, training in prescribing occurs concurrently with performing a key role in hospital 
medication management.9  Therefore, in teaching hospitals, the training received and 
behaviours learnt have a bearing on the future prescribing practices of junior doctors as well as 
the day-to-day quality use of medicines in teaching hospitals. 
1.5.1. Evaluation of prescribing practice 
There are few detailed analyses of the prescribing practice of junior doctors in hospitals. Those 
located were categorised according to quantitative and qualitative measures.  
 
Quantity of prescriptions and types of drugs prescribed.  In quantitative evaluations, a US 
study found that first and second year postgraduate doctors wrote nearly 75% of all medication 
orders.71 In an Australian study, whilst interns wrote almost a fifth of all prescriptions, they made 
an independent prescribing decision in less than a fifth of these.179 The majority of this intern-
initiated prescribing was for symptom relief, such as prescribing simple analgesics.  A  survey of 
                                               
xvi
 Many terms are used throughout Australian hospitals to describe medical trainees in their first two years 
of postgraduate training: junior doctor, junior medical officer (JMO), postgraduate year 1 and 2 (PGY1 and 
PGY2), intern and resident, prevocational trainee, hospital medical officer, and junior house officer.  
[National Training and Assessment Guidelines for Junior Medical Doctors PGY1 and 2, July 2003: 
Resource 1: Prevocational and Vocational Training Post Definitions. [www.health.gov.au/internet/wcms 
/publishing.nsf/content/health-workforce-new-jmonatgui.htm. Accessed 01/07] 
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hospital doctors in the UK found that pre-registration house officers (interns) were responsible 
for prescribing nearly 90% of fluid orders.180 
 
Quality of prescribing practice. Of studies examining quality of prescribing, most focused on 
clinical skill acquisition using surrogate measures of performance (eg, tests or surveys) rather 
than on actual behaviour.  Many of these studies identified problems including: knowledge of a 
therapeutic area181; dosage knowledge182; and dose calculation skills (eg, paediatric doses 85, 183, 
adjustment for renal dysfunction184, narcotic dosage conversion185).  A UK survey found that 
routine use of safe prescribing practices, such as checking for potential drug interactions, was 
poor among interns and residents.186  
 
Of the small number of studies evaluating actual practice, a few found an association between 
the experience of junior doctors and quality of pharmacotherapy decision-making187, 188; for 
example, more patients were found to receive venous thromboembolism prophylaxis at the end 
of junior doctors’ surgical rotation compared with the start.188 Also, there was evidence to 
suggest that first year postgraduate medical trainees are more likely to make errors than more 
experienced staff 71, 74, 82, 87 and more likely to make them at the start of the academic year.87 
Conversely, two studies examining antibiotic prescribing found that junior doctors had arguably 
more appropriate prescribing practices than those of their experienced colleagues.189, 190  
 
Further to the issue of quality, two studies reported a positive correlation between 
appropriateness of prescribing and supervision of resident doctors.191, 192 
 
Confidence and perceived competency to prescribe.  A number of surveys examined 
perceived competence to prescribe.  Several reported low levels of confidence to write a correct 
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hospital prescription at the beginning of internship132, 193, 194, another found a significant increase 
in confidence and experience in prescribing between interns and first year residents. 195  
1.5.2. Influences on prescribing practice 
Senior colleagues.  Few studies have specifically examined influences on the prescribing 
practices of junior doctors. Nevertheless, findings consistently report that senior colleagues are a 
major if not the most important influence.  In one Australian study, interns identified registrars, 
subspecialty nurses and pharmacists as important positive influences on prescribing. In contrast, 
consultants were perceived as being physically and mentally remote and poor teachers. 132  A 
separate Australian study of resource use found that when unsure, junior doctors prescribed 
mainly according to advice from registrars.135  Two similar studies (one from the UK and one 
from Ireland) found that senior doctors were a major influence when junior doctors made 
prescribing decisions about antimicrobial therapy.133, 134  
 
Undergraduate training. Although the UK study cited above reported that medical school 
teaching was influential134, the Irish study, previously cited, found that recollection of formalised 
undergraduate teaching (and hospital guidelines) were a very minor influence compared with the 
immediate influence of senior colleagues.133  
 
Pharmaceutical Industry.  Based on surveys, resident doctors appear to have naïve views 
about the influence of interactions with pharmaceutical industry on their prescribing  
practice. 144, 145, 196 
 
Organisational influences.  In the Australian study cited previously, interns also nominated 
various organisational factors that had a detrimental effect on their prescribing practice 
including: theoretical, inconsistent and irrelevant teaching (such as grand rounds and didactic 
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education sessions), inconsistent and inaccessible resources, a confrontational and accusatory 
way of dealing with prescribing errors, and other pressures such as time and hospital 
hierarchies.132 
 
Pressures experienced by junior doctors.  Broadening the literature search to include 
influences on junior doctors generally and/or on their acquisition of clinical skills resulted in many 
more studies.  Long working hours and sleep deprivation have been shown to increase medical 
errors 197, 198, as well as potentially dilute the effectiveness of the intern training experience. 81  
Interruptions 199 , perceived mistreatment by colleagues200 and psychological stress 84 may also 
negatively impact on the learning experience of interns.  Workload may also be a problem.  
According to an Australian study that analysed the intern’s role, up to 80% of their time was 
spent in a service role (patient care, clerical, telephone)– much of it working alone –  leaving little 
time for formal or informal education and training.201 
1.5.3. Strategies to improve prescribing practice  
A number of strategies have been devised by universities, hospitals, and professional training 
bodies to improve the preparedness of students and the quality of prescribing of junior doctors.  
1.5.3.1. Undergraduate training 
Overall, the effort to improve prescribing competency of junior doctors has tended to be greater 
at the undergraduate rather than the prevocational stage of training.  This is probably because of 
the expectation that junior doctors will be able to prescribe, albeit under supervision, from day 
one of internship.202 
 
From facts to skills. Traditionally, medical undergraduate courses in clinical pharmacology and 
therapeutics concentrated on accumulation of facts.202, 203 Teaching students what to prescribe 
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was the focus.  In the 1990s, a greater appreciation of the clinical reasoning skills required, 
along with evidence suggesting that many medical graduates lacked confidence to prescribe193, 
204
 shifted the focus to teaching students how to prescribe.203 
 
As part of curricula development for universities in The Netherlands, an ideal model of 
prescribing was developed, based on medical problem solving and decision-making analysis.205  
The basic premise is to view prescribing in a similar way to solving a scientific problem, which 
has sequential steps or activities.  Emphasis is placed on learning the particular skills required to 
perform each activity – be it cognitive, motor or communication.  As acknowledged by its 
developers, the main criticism of the approach is that it “over-simplifies a highly complex 
reality.”205 Nevertheless, its perceived utility as an educational tool is illustrated by its 
endorsement, adoption, and wide distribution by WHO.16   
 
In collaboration with Australian medical schools, the NPS modified the WHO model of good 
prescribing for incorporation into local undergraduate curricula.  A web-based interactive 
prescribing program was developed based upon 12 therapeutic topics seen by interns as the 
most important to their daily practice: chronic obstructive pulmonary disease, peptic ulcer, 
hypertension, the confused patient, seizures, acute chest pain, otitis media in children, heart 
failure, anticoagulation, postoperative pain and vomiting, polypharmacy, and an intern 
orientation module.  As of 2004, the program was being used by 9 of 11 medical schools 
throughout the country. 206 Other countries have also utilised the WHO problem-based model as 
the basis for prescribing curricula.207 
 
Other innovations to curricula.  In the UK, various skill-based training programs have been 
devised at a local level for improving prescribing competencies of medical students.208, 209  In 
addition, one UK medical school also designed a program to improve students’ attitudes towards 
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concordance in medicine taking.210  However, of far wider potential impact is an integrated core 
curriculum in clinical pharmacology and therapeutics, which has recently been developed for 
national implementation across UK medical schools.202   The main innovations of this new 
curriculum are: the vertical integration of prescribing and therapeutics throughout all years of 
medical school, a core list of drugs or student formulary, and the formal assessment of 
prescribing competence. 
 
In addition to therapeutics-focused interventions, several other recently developed areas of 
learning would be expected to impact on the prescribing competency of medical students: 
patient safety education 211, 212 (which in Australia has been integrated into curricula of all 
traditional health professions211); interprofessional clinical education (for example, joint 
therapeutics sessions for pharmacists and doctors 213); and training in the principles of evidence-
based medicine (which has been integrated into pharmacist and nurse supplementary 
prescribing curricula in the UK 28, 214, but is also part of most undergraduate health professional 
curricula) 
 
How effective are they? The impact of specific undergraduate curricular in clinical 
pharmacology and therapeutics on subsequent prescribing behaviour has proven difficult to 
evaluate and is unknown. 202  Evaluation has generally consisted of testing students’ knowledge 
and skill in prescribing for simulated cases, 203 their confidence to prescribe,5, 209 and their uptake 
of an intervention.206  Whilst short and medium-term success in prescribing for simulated cases 
(up to 6 months 215) has been reported 203, 208, 209, 215, problems with ability to transfer skills to 
similar but different cases was identified as a problem in one study.203    
 60 
1.5.3.2. Prevocational training 
Currently in Australia, state-based Postgraduate Medical Councils or equivalent (in NSW, The 
NSW Institute of Medical Education & Training) are responsible for developing and supporting 
the training needs of prevocational trainees (medical postgraduate years 1 and 2).   The central 
aim of this training period is to ensure trainees gain appropriate knowledge, training and skills to 
equip them to proceed to general practice or specialist training.176 In NSW, this period of 
prevocational training is overseen by Directors of Clinical Training, who are usually active 
hospital-based specialists appointed at each accredited hospital.  Junior doctors are assessed 
formally and informally on various competencies (including clinical, professional, and procedural 
tasks) by term clinical supervisors.  Historically, there has been no specific assessment of 
prescribing skill 216; however, this may soon change as a draft Australian Curriculum Framework 
(ACF) for Junior Doctors 217  includes prescribing among explicitly stated competencies 
expected to be mastered by junior doctors during prevocational training.  
 
In relation to prescribing, the skills outlined in the ACF include: prescribing and monitoring 
anticoagulants, antibiotics and insulin.  Furthermore, there are specific information management 
skills related to prescribing, such as knowing how to communicate prescriptions and the 
accurate documentation of prescriptions; and specific competencies related to medication 
safety, such as knowing the medications most commonly involved in prescribing and 
administration errors, and routine reporting of medication errors and near misses. 217 
 
Despite calls for better training in prescribing during internship 9, 94, review of literature from 
around the world reveals a paucity of interventions specifically devised to improve the 
prescribing practice of junior doctors working in hospitals.  Of note, in the US, far greater effort 
has been devoted to improving prescribing of resident doctors in family medicine residency 
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programs. There are several possible explanations for this apparent bias in selection of research 
setting.  Firstly, because of their time-consuming service role, interns working in hospitals often 
lack the time or opportunity to participate fully in educational interventions. 218 Secondly, 
because interns rotate positions and move between urban and rural placements, post-
intervention follow-up can be logistically difficult.  Thirdly, because of variation in exposure to 
different therapeutic areas due to their rotations, confounding influences can be difficult to 
control for.  Lastly, if testing of all subjects is not conducted simultaneously, contamination is 
likely due to the social nature of the hospital environment. 116 
 
Due to the dearth of hospital-based strategies, interventions aimed at junior doctors working in 
family medicine residencies and outpatient care facilities were reviewed collectively along with 
interventions at inpatient care facilities.  In broad terms, interventions were either designed to 
improve appropriateness of prescribing or to minimise prescribing errors.   
 
Types of strategies aimed at improving appropriateness of prescribing have included: a 
web-based prescribing training program 206, problem-based tutorials 116, workshops on concepts 
of essential drugs and rational drug use 219, 220, feedback reports on prescribing patterns 221, 222 
on drug or prescription costs 223, 224 and on generic drug prescribing 225 , promotion of guidelines 
through “inservice” discussions and lectures 226, bi-monthly drug information sessions with a 
quiz 227, lectures and discussion on pharmaceutical promotion 228, 229, and variations in drug 
sampling policies.230  
 
Compared with the other interventions, the web-based training program for interns developed by 
the NPS is notable for its scope and comprehensiveness.  It is based on a similar but more 
sophisticated set of online prescribing modules to the program developed for medical students. 
The program has undergone pilot testing and is in the process of being implemented nationally. 5   
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Types of strategies aimed at reducing prescribing errors have included:  written tests of 
dosage calculation 231, a monthly quiz aimed at improving prescription writing skills 232, academic 
detailing to improve conformity with legal requirements of prescription writing 233, a medication 
error competition and intern orientation workshop234, evaluation and feedback of prescription 
writing errors 235, 236, and a tutorial and written test at orientation to an emergency department. 237 
 
How effective are they? Similar to undergraduate prescribing programs, there has been 
negligible evaluation of long term prescribing behaviours.  Furthermore, few studies have 
rigorously evaluated impact on short and medium term prescribing.  Of those interventions that 
have been evaluated, the overwhelming majority appear to have significantly improved 
prescribing with very few failures described. 116, 224, 226, 237  In light of the known poor success rate 
of single interventions on sustaining behavioural change, this raises the possibility of publication 
bias or may indicate the relative ease of improving some skills in the short term and not others, 
or improving behaviours in some settings (family medicine residencies) and not others 
(hospitals).   
 
One report of an unsuccessful intervention demonstrates the difficulties involved in effecting 
behavioural change of interns working in hospitals.116  Pearson designed an education program 
in antibiotic prescribing for interns consisting of three 45 minute problem-based tutorials lead by 
DCTs.   The program was evaluated against a control group of interns using Objective 
Structures Clinical Examination (OSCE) involving simulated patients.  Prescriptions written by 
the interns for the simulated patients were graded for appropriateness by two experts.  
Unanticipated problems were encountered during the study in attaining agreement on 
appropriateness of intern prescribing by the two experts.  Despite eventual resolution of these 
issues, overall, the program failed to effect change in prescribing quality.  Explanations proffered 
by the author included: the limited impact and intensity of the program, its focus on mainly 
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positive influences on practice, and its failure to address “the powerful negative forces’ that act 
on interns’ prescribing practice. 
 
In essence, the prescribing practice of junior doctors is difficult to characterise because there are 
few analyses and findings have been mixed.  It would appear however, that junior doctors are 
charged with responsibility for much of prescription writing in hospitals, but with narrow limits 
placed upon the quantity and types of independent prescribing decisions they can make – at 
least as interns.  A number of problems identified with prescribing quality of junior doctors have 
been identified, the main being: inadequate knowledge base (particularly regarding dosing and 
calculations) and a greater propensity to make errors than more experienced doctors.  
Supervision and advice from registrars and selected other hospital colleagues are positive 
influences on their practice, whilst long working hours, stress, and perceived mistreatment by 
colleagues are detrimental.  The need to improve the prescribing competency of medical 
graduates and to provide support for interns to further develop and extend their prescribing 
capabilities has become well recognised.  Broad-reaching innovations – such as in 
undergraduate curricula: the use of problem-based models, vertical integration of therapeutics, 
emphasis on patient safety and evidence-based medicine; and in prevocational training: the 
stipulation of specific prescribing competencies – are arguably the most important strategies 
developed in order to meet this need.  Whether these strategies will result in improved decision-
making and reduction in errors by novice prescribers is unknown.  Long-term evaluation of such 
strategies is difficult and the hospital environment presents many potential confounders.     
1.6. CONCLUSIONS 
Maximising the benefits of medicine use begins with prescribing, an inherently complex and high 
risk activity.  A thorough knowledge of the pathophysiology of disease and pharmacology of 
drugs may be appropriate foundations for prescribing, but multiple forms of evidence from a 
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diverse range of prescribing research show that in practice these are not the only resources 
used by prescribers.  Prescribers also integrate an array of individual, social, cultural, 
environmental and commercial factors into their decisions.  Furthermore, social and cultural 
characteristics of the prescriber’s workplace may influence how well prescribing decisions are 
carried out.  Although some of these non-biomedical factors may impact negatively on 
appropriateness or safety of prescribing, other factors, for example, certain social influences, 
may be important and legitimate determinants of prescribing decisions, particularly for 
supervised novice prescribers.    
1.7. AIM OF THIS RESEARCH 
Whilst numerous research efforts have helped to construct an in-depth understanding of non-
biomedical influences on GPs’ prescribing patterns, the characteristics of corresponding types of 
influences in teaching hospitals have not been well determined.  As outlined in our review of the 
literature, prescribing in teaching hospitals occurs in a highly dynamic social environment.  
Supervised medical trainees, registrars and consultants prescribe within the framework of 
complex medicines management systems involving nurses, pharmacists and patients.  
Currently, little is known about whether each of these groups has distinct beliefs, attitudes and 
values that may affect either prescribing behaviour or how prescribing skills of junior doctors are 
acquired.  Furthermore, the effect of intra and interprofessional relationships on the prescribing 
process is also poorly understood. 
 
The aim of this project was to explore social and cultural factors in two teaching hospitals that 
affect prescribing in general, and the way in which junior doctors learn to prescribe.  This study 
was conducted in two teaching hospitals.  The study sought to identify and characterise 
attitudes, beliefs about behaviours and perceived influences that may shape the practice of 
professionals typically involved in making and implementing decisions about drug therapy.  
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2. CHAPTER TWO: METHODS 
2.1. METHODOLOGY 
Since the underlying objective of this study was to improve understanding of naturalistic 
elements of prescribing (ie, how the social world of a workplace impacts on how prescribing is 
actually done in that setting), qualitative methods were chosen as the most appropriate means 
of exploring the research question.238  Qualitative methods place emphasis on participant’s own 
understanding of the meanings of their actions, interactions and experiences.239  This feature 
has been used effectively in health services research to help provide explanations for often 
complex social and cultural phenomena which shape the day to day provision of health care. 240  
This includes topics related to this research question, such as prescribing decisions 118, 241, 
interprofessional relationships168, 242, and organisational culture.167 
2.1.1. Philosophical approach 
The approach adopted in this study was essentially pragmatic, which means that the fit between 
the research instrument and research question was viewed as more important than the degree 
of adherence to a particular ontological or epistemological stance. 243  Pragmatism or methods-
based approaches are widely accepted as legitimate modes of qualitative enquiry 244, 245 and 
adopting prescribed methods according to a particular philosophical paradigm is considered 
unnecessary for demonstrating analytical quality and rigour 243, 244 Nonetheless, underpinning 
methods choices and analytical processes to broad philosophical perspectives on the nature of 
social reality (ontology) and the basis of knowledge (epistemology) is also argued to be of 
particular value when conveying qualitative findings in health care research. 246   
 
Although provision of health care is informed by both the natural and social sciences, the impact 
of the philosophies and traditions governing the natural sciences (such as those underlying 
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clinical and biomedical research) is debatably the more powerful and pervasive.240 This has lead 
to misunderstandings by healthcare decision-makers about the methodological goals of 
qualitative research (ie, the type of information being sought) and persistent doubts about it’s 
role and validity.240 247 In qualitative literature, it is widely accepted that quantitative and 
qualitative traditions are based on very different sets of assumptions about the nature of reality 
and how it is possible to know about it.244  Therefore, to ensure clear communication of our 
findings and to maximise their accessibility, we have outlined the philosophical beliefs to which 
our approach is most strongly aligned in order to help make transparent the methodological 
intent of the study, the basis for which certain design decisions were made, and the broad 
theoretical basis for interpretations we have made of the interview dialogues.   
 
Study of the natural sciences is underlined by a philosophy of recognising only observable data, 
separating facts from values (thus making it possible to conduct objective enquiry), and 
developing universal causal laws.243, 248 These principles constitute what is known as the 
positivism.  In contrast, most qualitative research is associated with a different set of beliefs 
known as interpretivisim.243  This stance is characterised by recognising that the researcher and 
the social world impact on one another, facts and values are not distinct, and the social world is 
governed not by laws but is mediated through meanings of human actions and experiences.243 
In short, qualitative research values “the subjective”, which is the approach adopted in this 
study. 
 
Since there is a wide spectrum of beliefs about the nature of social reality, which is at the core of 
qualitative enquiries, it is also important to define the form of reality that we are attempting to 
capture.  Aligned with the positivist philosophy, the realist perspective asserts that an external 
reality exists independent of our beliefs or understanding and that there is a clear distinction 
between beliefs about the world and the way the world is.243   A diametrically opposing position 
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is that of relativism, which puts forward that there is no external reality independent of human 
consciousness – there are only different sets of meanings and classifications, which people 
attach to the world.249  At the core of these divisions are the notions of objectivity and 
subjectivity248, but several “middle grounds” exist.   
 
Subtle realism acknowledges that an external reality exists independent of our beliefs and 
understanding, but that reality is only knowable through the human mind and socially 
constructed meanings. 243 The goal of this approach is to represent reality rather than attain 
truth. 246 This philosophy is therefore compatible with both quantitative and qualitative research 
methods because whilst acknowledging an underlying reality, the  philosophy allows that this 
reality maybe multifaceted and diverse 243, embracing selected features of a relativist or post-
structuralist approach.  Subtle realism has been adopted by researchers interested in 
maximising the accessibility and practical application of their findings whilst drawing on the 
methodological strengths of qualitative enquiry 243, 246, 249, namely capturing the diversity and 
range of participant’s own interpretations of the social phenomenon being studied.  Likewise, in 
this study we aim to capture the diversity of perspectives of how prescribing is done in order to 
build a comprehensive picture (but not a grand explanation) of what may actually be going on.    
2.2. STUDY POPULATION 
The study population consisted of health professionals working in teaching hospitals who were 
involved in making day-to-day decisions about prescribing.  Staff members from pre-determined 
groups were recruited: consultants; registrars; junior medical officers; pharmacists; and 
registered nurses.  These professional groups were chosen because they were involved in 
prescribing or they had potential to influence it due to their role in medicines management.44  In 
addition, they had been identified as having characteristic influences on the prescribing practices 
of interns.132   
 68 
A major potential benefit of using multiple data sources (ie, sampling from different professional 
groups) was that influences on prescribing practices could be explored from differing 
perspectives.  In theory, this so-called triangulation of data collection allows examination of 
patterns of convergence and divergence and so helps to build an overall interpretation of what 
may actually be occurring.246  Although there is much debate in qualitative research literature on 
the use of multiple perspectives as an absolute means of verifying findings 243, others view its 
strength as being less about forming a “single totally consistent picture”, and more about 
capturing different points of view and generating enquiry into why differences might exist. 250 The 
main benefit of triangulation, therefore, is in extending understanding and gaining a fuller picture 
of the phenomena rather than a more certain one  243, 246 (a view consistent with the 
philosophical approach of subtle realism).  In addition, incorporation of multiple views and voices 
is valued as a means of adding depth to the analysis of culture.163   
 
Although the need to acknowledge consumers as partners in medicines management was 
appreciated by the investigators of this study, hospital patients were not chosen to participate.  
As is, the study design concentrates analysis on professional behaviours, relationships and 
subcultures only.  Arguably, including patients’ views would have shifted analytical focus toward 
patient-professional interactions and away from interprofessional relationships, potentially 
weakening depth of analysis of the latter.  Furthermore, the scope of this study was already 
broad including both prescribing processes and training processes, extending the scope further 
may have made analysis unwieldy. 
2.3. STUDY SITES  
The sites were two large metropolitan teaching hospitals in Sydney, NSW: 1) St Vincent’s 
Hospital, Darlinghurst, Sydney; 2) Royal North Shore Hospital, St Leonards, Sydney.  These 
hospitals were chosen because they are both metropolitan teaching hospitals with large staff 
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numbers, are both publicly funded, are within close proximity of one another, and have broadly 
similar organisational characteristics.  This allowed convenience of sampling as well as 
maintaining the focus of this investigation on the cultural phenomena of those involved at the 
operational level of the prescribing process (ie, on those directly involved with the process) 
rather than on broader cultural differences at two hospitals.  The intent of sampling from two 
sites rather than one was largely to facilitate recruitment, but this design also provided additional 
confidentiality protection for participants’ responses.   
2.4. SAMPLING METHOD 
In the main, purposive sampling was used to locate appropriate data sources.  This method 
refers to the deliberate and strategic selection of participants based on a judgement that they will 
be informative about the questions under study.244  It is an accepted means of sampling in 
qualitative research and widely utilised 100, 118 241, the rationale being to target individuals who 
have particular features or characteristics which will enable detailed exploration of the 
topic 243 244, not necessarily individuals whose views are representative of a population.   
 
Therefore in this study, medical consultants were targeted rather than surgical consultants since 
the former were considered more likely to prescribe regularly and have views on prescribing.127  
Also there was deliberate selection within each group of health practitioners to ensure 
heterogeneity of clinical specialty and therefore breadth of opinion about the research topic.  
Nurses, pharmacists and registrars were selected in the main using snowball sampling (people 
who knew people who were likely to have views on the research topic244).  In the case of junior 
doctors, by necessity, sampling was based more on convenience (ie, interviewed those willing 
and available to participate) than strategy. 
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2.5. SAMPLE SIZE 
Originally, approximately 12 staff members from each group across both sites were anticipated 
to be required for adequate exploration of the topic. This number was selected based on 
qualitative studies with related research objectives 132,251 and on expected coverage of the 
phenomenon under investigation. 244  Recommendations for sampling in qualitative studies 
include selection to the point of theme redundancy. 244 Using this criterion, a total of 43 
interviews were conducted: seven nurses, eight registrars, nine junior doctors, eleven 
pharmacists, and eight consultants. 
2.6. ETHICS APPROVAL 
Ethics clearance was received from the Human Research Ethics Committees of: the University 
of Sydney, Northern Sydney Health (Royal North Shore Hospital), and St Vincent’s Hospital 
(Appendix A). 
2.7. RESEARCH TOOL DEVELOPMENT 
Semi-structured in-depth interviews served as the primary research tool and a brief 
questionnaire was used to collect demographic data.  In-depth interviews are considered to be 
an appropriate means of furthering understanding of complex processes and issues 243 and for 
this reason have been used widely in prescribing research.241  Although interviews result in 
“generated data” as opposed to observational methods, which collect “naturally occurring data”, 
interviews give participants a direct and explicit opportunity to convey their own meanings and 
interpretations 243 and so were deemed to be an appropriate means of exploring this research 
question.    
2.7.1. Steering Committee 
A Steering Committee was set up consisting of 11 experts in the fields of clinical pharmacology, 
medical education, and medicines management with the aims of: obtaining local opinion leader 
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support for the study, to aid recruitment of study participants, to help refine methods, and to 
assist with data interpretation.  All members of the committee were invited to participate by letter 
(Appendix B). 
2.7.2. Interview topic guide 
A preliminary interview topic guide was developed based upon a literature search and input from 
selected members of the Steering Committee.  Coverage of potential influences was 
underpinned by two bodies of literature: influences on appropriateness of prescribing decisions 
and contributors to prescribing errors.  There were three main reasons for this approach.  Firstly, 
the WHO normative model depicts prescribing as a series of decisions and actions16, which 
suggests that in order to best explore determinants on what medicine a patient actually receives, 
it is important to examine influences on prescribing activities as well as decisions.  Secondly, 
most studies examining influences on prescribing have been based on a model of one 
prescriber, one patient, and one decision (treatment or drug selection), and haven’t taken into 
account factors associated with the participation of multiple health professionals, which is the 
model in teaching hospitals.  So, in theory, by examining influences on failures in decision 
execution as well as prescribing decisions, a more complete picture might be formed of the 
social dynamics shaping prescribing in teaching hospitals.  Lastly, there are data suggesting that 
most prescribing errors in hospitals result from problems with prescribing decisions61; so by 
exploring perceived causes for error, fuller insights might be gained into why problematic 
decisions in this setting are made.   
 
Consistent with Schein’s theory of organisational culture, questions were devised with the 
underlying objective of eliciting perceptions, thoughts, feelings and unconscious beliefs of 
participants about prescribing and the training of new prescribers.  Schein argues that in order 
“to understand a group’s culture, one must get at [these] shared basic assumptions” 166 rather 
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than espoused values, which may not be congruent with what people actually do.  In order to 
achieve this, the interview schedule contained a question concerning  “a critical incident” related 
to a prescribing error, which was an attempt to produce a natural narrative and is an established 
method of accessing participant’s experiences, thoughts and views.118, 166, 252  Other questions 
designed to evoke participant’s beliefs covered topics such as: attitudes and values on 
prescribing, roles and responsibilities in prescribing, how prescribing decisions are 
communicated, influences on prescribing decisions, contributors to prescribing errors, attitudes 
on prescriber training, roles and responsibilities in training prescribers, and influences on training 
experiences of prescribers. 
 
Five pilot interviews were conducted by the author (MP) between May and August 2004 with a 
participant from each of five pre-determined groups: consultants; registrars; junior medical 
officers; pharmacists; and nurses.  The objectives of the pilot interviews were to: 1) identify any 
questions in the interview topic guide that were ambiguous or not easily understood; 2) assess 
richness and relevance of data collected to the research question; 3) ensure that questions 
elicited accounts tied to local experience rather than conjecture; 4) establish the schedule of 
interview questions; 5) refine the style of questioning; 6) and develop a preliminary coding 
scheme for emergent themes.  Whilst attempts were made during interviews to ask most of the 
questions (to ensure coverage of research objectives), ad lib probes were also used to explore 
particular insights in greater depth.  Thus the resultant format of interviews was semi-structured.  
Prior to these pilot interviews, MP practiced her interview technique by interviewing her co-
researcher (BB) using the guide. 
 
Using a computer program (NVivo 2 253) to organise the data, the text of the pilot transcripts was 
segmented according to interview questions and responses.  The content was systematically 
analysed for themes 244, and the themes were organised and categorised to create a provisional 
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coding scheme.  Responses to questions were compared across subjects.  Interview questions 
and, in some instances, the order of questions were modified following these interviews to try 
and optimise the richness of information elicited.  For example, the placement of the critical 
incident question on prescribing errors was changed when it appeared to be too confronting as 
the leading question in the first two interviews.   
 
To cater for the different roles of participant groups in medicines management, three versions of 
the topic guide were created for use in the main study: one for consultants and registrars; one 
for nurses and pharmacists, and one for junior doctors (Appendix C).  
2.7.3. Demographic questionnaire 
A questionnaire designed to collect demographic and background information was also tested 
by the pilot interviewees and refined for use in the main study (Appendix D).   
2.8. SUBJECT RECRUITMENT  
A range of strategies was used to recruit subjects at each hospital based upon differences in: 
communication networks of researchers at each hospital, advice and form of assistance from 
members of the Steering Committee, and types and frequency of various staff meetings.   
Subjects were recruited via means of: promotion through departmental, continuing education, or 
other regular meetings (pharmacists, registrars), direct assistance of members of the Steering 
Committee (email to consultants), and via formal education sessions and fliers (junior doctors) 
(Appendix E).  Ultimately, however, success with recruitment depended on direct invitation and 
endorsement from an influential staff member or face-to-face appeal from the researcher (MP).  
2.9. DATA COLLECTION   
Interviews were conducted by MP between August and December 2004.  All interviews took 
place in private consulting rooms, private offices, or hospital meeting rooms booked for the 
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exclusive purpose of conducting the interview.  Prior to interview, all volunteers were provided 
with written information about the study (Appendix F) and all consented in writing to take part 
(Appendix G).  The purpose of the study and conditions of consent were reiterated verbally as 
part of the interviewer’s introductory statements (Appendix H). Using the guides developed from 
the pilot interviews, each volunteer participated in a one-to-one interview of approximately 45 
minutes duration (range: 29 to 71 minutes).  The interviews were recorded using a digital voice 
recorder.  Each participant also completed the demographic questionnaire.  All collected data 
were de-identified and assigned a code.   
2.10. PRE-ANALYTICAL DATA HANDLING 
A flow chart for data handling (management, analysis and interpretation) illustrates the 
processes that were utilised based upon established methods 243, 244 (Appendix I). Each 
interview was transcribed verbatim.  Pilot interviews were transcribed by MP and remaining 
interviews were transcribed by an external transcription service.  Each transcript was proof-read 
for accuracy against sound recording (MP).  At this stage, the NVivo2 computer program 253 was 
used to organise the transcripts.   
2.11. DATA ANALYSIS 
2.11.1. Preliminary analysis 
 
Following each interview, field notes were compiled.  In addition to noting methodological 
factors, (eg, the number of interruptions and the interviewer’s perception of the participant’s state 
of ease), the interviewer documented her general sense of the interview including a list of 
themes, which she perceived at the time to be the most informative of the research objectives.   
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Since integrating or dovetailing systematic analysis with data collection was not logistically 
possible for the main part of the study (ie, it was only feasible for the interviews to be conducted 
in a block), the preliminary analysis of each transcript served as the means for determining the 
point of theme redundancy when no further interviews were required.   
2.11.2. Construction of a Coding Scheme  
The provisional coding scheme formed from the pilot interviews was further developed by 
thematic analysis of a further eight transcripts.  These transcripts were selected by strategic 
randomisation of the remaining 38 interviews to ensure a heterogeneous mix of health 
professionals.  The content of all thirteen transcripts (one third of all interviews) was examined 
systematically to identify themes (MP).  The approach to coding was consistent with the general 
principles of grounded theory 254, but with some modifications.  Transcripts were read 
reiteratively to identify categories or themes, which were determined by the researcher to 
represent the substantive meanings of the participant’s responses.243, 244  Most of these 
categories were then labeled (or coded) using terms devised by the researcher to capture the 
participant’s general sense (eg, “Influence of Pharmacists  – dose checker”), but some were 
labeled according to the language of the participants (eg,“ Intern attitude – willingness to learn”) 
and others influenced by terms used in the literature to describe similar types of phenomena 249 
(eg, “Prescribing errors – workload, busyness, time34”).  Whilst emphasis was placed on 
encapsulating participant’s own interpretations of the research issues, coding involved both 
deductive and inductive processes, as the effect of the researcher’s (ie, MP’s) knowledge 
(experiential and derived from literature) on forming a representation (ie, categorising 
participant’s views) was acknowledged. 
 
Related categories were clustered and then organised into an overall hierarchical structure.  This 
process involved the constant comparison of categories and rereading of text to ensure that 
 76 
categories were well defined and distinct from one another.243, 255  Also, the relevance of each 
category was constantly questioned in relation to the research objectives of the study.255  The 
NVivo2 computer program 253 facilitated comprehensive deconstruction of the text by allowing 
assignment of multiple categories to text segments. This helped to detect and characterise 
subtle differences in meanings of particular issues.  
 
Two lots of five different transcripts were selected by strategic randomisation for review by two 
co-analysts (supervisors, JB and BB).  Each co-analyst reviewed one transcript from each of the 
professional groups.  The primary aim of dual readings of transcripts was to seek concordance 
of the categorisations used (and therefore, basic themes inferred) by the primary coder (MP) to 
represent the participants’ accounts. 256 To this aim, the co-analysts read their allotted 
transcripts and critiqued: (1) the assignment of codes (ie, whether labels used were a 
reasonable categorisation of the situations and meanings expressed by participants), (2) 
consistency of coding 257, and (3) coverage of pertinent themes (ie, whether any pertinent 
themes were omitted).  Using multiple analysts (triangulation of analysts) for the express 
purpose of checking or establishing validity of analysis in qualitative research is widely 
contested239, 243, and furthermore, the rationale for comparing individual ways of “packaging” 
themes has also been questioned, as this is an inherently subjective process.256  Whilst some 
researchers persist in using numerical intercoder reliability ratings as a means of validating their 
interpretative findings258, the groundswell of opinion is that quantitative measures are ill-
equipped to verify whether an interpretation of reality is “true” as “we have no independent and 
completely reliable access to reality.” 243 The rationale for using multiple analysts in this study 
was therefore primarily to extend the breadth and depth of analysis, which some qualitative 
researchers believe may act as a check on selective perception and blind interpretative bias of 
the primary coder.250 
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2.11.3. Labelling or tagging data 
All remaining transcripts were labelled or tagged systematically according to the Coding Scheme 
(MP).243, 255 During this process, the scheme was further refined with some categories becoming 
more precisely defined and others being redefined into more conceptual terms.  
2.11.4. Cross-sectional analysis of data 
The computer program (NVivo2) facilitated retrieval of coded slices of text and cross-sectional 
analysis of data.  The program was used to compare differences in text fragments between 
different professional groupings assigned to a specific code.  This facility also assisted discovery 
of linkages in data or responses elicited from different questions.  
2.11.5. Analysis of questionnaire responses 
Data collected from the questionnaire were analysed using Microsoft Office Excel 2003.  
2.12. DATA INTERPRETATION 
 
Data generated from the interviews were interpreted at several conceptual levels.  Since the 
study was primarily about exploration of social and cultural phenomena, the chief level of 
interpretation involved identifying and characterising factors, determined by the analytical 
process to have a substantive influence xvii on prescribing and medicines management practices, 
to form a  descriptive map of the social landscape in which prescribing takes place.  At a further 
level of interpretation, explanatory accounts were developed by the researcher to help provide 
possible reasons for particular phenomena.243   This involved examining patterns in the data, 
particularly within the professional subgroups of the population, which was facilitated by 
                                               
xvii
 Patton uses the term “substantive significance” to describe important findings in qualitative research. 
He states that substantive significance can be determined by questioning the solidity, coherence and 
consistency of evidence in support of the findings, the extent to which the findings increase and deepen 
understanding of the phenomenon being studied, the consistency of findings with other knowledge, and 
the extent to which the findings are useful for some intended purpose. [Patton MQ. Qualitative Research & 
Evaluation Methods,3rd ed, 2002].    
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manually creating thematic frameworks or matrices.243  A third conceptual level of interpretation 
involved developing core concepts from the data and using theoretical frameworks from the 
literature to help deepen understanding of these concepts and to generate theory.  As part of 
these processes, the original transcripts were scrutinised for deviant cases (ie, cases that did not 
fit into categories or conceptual frameworks developed) in order to further strengthen and refine 
explanatory accounts and ensure that these accounts were grounded in the data.243 
2.12.1. Validation 
A number of established qualitative methods were used to optimise the accuracy of the 
interpretation of respondents accounts, most of which have been mentioned already.  In 
summary, these were: 
 
An iterative approach to analysis. 259  Categories that were developed at each stage of 
analysis were constantly compared with the original transcripts and also the audio files to ensure 
accuracy of fit.   
Deviant case testing. 243, 250 Explanatory accounts and core concepts were “tested” by 
searching the transcripts for deviant cases for reasons already specified.   
Use of multiple data sources 250 Five different data sources were used, although as mentioned 
previously, the use of triangulation to demonstrate certainty of findings has been debated.243   
Reflective account of researcher.  As presented below, an account of the researcher was 
provided to show how prior assumptions of the researcher may have influenced findings.260 
 
External forms of validation were not used in this study. Whilst the original intention of 
researchers was to present findings to the Steering Committee for peer review and to the 
participants for “member checking”, due to resource limitations, this was not possible.  The 
purported benefit of peer review is to challenge the researcher’s interpretation of data from a 
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variety of perspectives 260, but some qualitative researchers argue that this does not ensure 
credibility of interpretation as peers can never have the same engagement with the original data 
as the principal researcher. 261 Advocates of member checking see its value as ensuring the 
privilege of participants’ perspectives 239, but other researchers feel that it only adds to confusion 
since participants have a different role in the process 246 and may have changed their minds in 
light of the findings.261 Thus, the merits of these methods for demonstrating accuracy of 
interpretation are contentious anyway; and other qualitative studies involving prescribing have 
not used them.113    
2.12.2. Researcher characteristics 
Qualitative research aims to improve understanding of the social world of research participants 
and their subjective experiences.240, 243  In workplace environments, analysis and interpretation 
of a social situation is faciliated by appreciating, recognising, and empathising with humans 
involved.  Understanding the complexities of a situation may be enhanced by having 
experienced something of it, but this experience may limit the researcher’s ability to hear and 
represent all voices equally. 244  However, by not openly acknowledging the humanity of self and 
others, the qualitative analyst is effectively denying that she (or he) has any ability to fully identify 
with the attitudes, motivations or values espoused by those she is interviewing, when in all 
likelihood she may be recognising some better than others.  The conventional solution to deal 
with this spectre of bias is for the analyst to declare her biases up front, to acknowledge her 
vested interest, and her reasons for involving herself in the study.250 This allows inference of 
how much the researcher and her assumptions may have shaped collected data. 246  
 
Researcher’s account 
I am a pharmacist and have worked in several metropolitan teaching hospitals.  I have also worked for a 
pharmaceutical company in the field of medicines information.  Most recently I have worked in the public 
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health system as a drug information pharmacist and was involved in writing a component of an 
educational tool on prescribing for medical students and medical trainees.  It was my latter involvement 
coupled with reflection on my experience as a hospital pharmacist that lead to my interest in this area of 
research.   
 
When I first started working in a teaching hospital, I was surprised by the casual if not cavalier attitude of 
some junior doctors to prescribing.  Ordering medications seemed to require little contemplation and the 
consequences of this were clear.  I found that a large part of my working day (like that of other hospital 
pharmacists), involved clarifying, correcting, adjusting or modifying prescribing decisions, commonly to 
optimise therapy, but more often than not to avoid medication incidents.  This it seemed was a 
pharmacist’s job, which I grew to accept, but why were junior doctors so off-hand with prescribing? 
  
The association of risk with medication use was firmly instilled in me during my first year working as a 
hospital pharmacist, yet this did not seem to be the case for medical trainees.  Of course, most hospital 
pharmacists are intimately if not exclusively involved in medicines management and this no doubt 
heightens awareness of medication safety.  Yet, an appreciation of risk with medicine use was clearly also 
essential for prescribers.  Like my pharmacist colleagues, in carrying out my work, I provided feedback to 
junior doctors on medication orders that I felt were unsafe or suboptimal.  I was also aware during 
participation on medical ward rounds that the fundamental components of prescribing decisions – such as 
the dose, frequency, duration, patient acceptability, and so on – were seldom discussed in any detail 
within medical teams.  
 
Some years later, whilst I was assisting in the development of a problem-based educational tool on 
prescribing for medical students, a hospital pharmacist commented on the idealistic nature of the tool as a 
training device as she felt that it did not reflect everyday prescribing practices in teaching hospitals.  She 
felt that the value of such a tool would diminish as soon as an intern observed first-hand how prescribing 
was actually done by her or his influential senior colleagues.  This comment resonated with my 
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experiences and reflections.  What impact does workplace culture have on the prescribing behaviour of 
new doctors?  What factors in teaching hospitals reinforce and/or hinder good prescribing practices?   
 
The supervisors and co-researchers (JB and BB) for this study are academic pharmacists who 
have worked in hospitals during their careers.  The implications of potential professional bias on 
data interpretation are discussed later. 
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3. CHAPTER THREE: RESULTS 
A total of 43 health professionals participated in the study.  At the time of the interview, twenty-
five participants were working at St Vincent’s Hospital and eighteen at Royal North Shore 
Hospital. xviii The average duration of an interview was 45 minutes.  The longest interviews were 
with consultants (average of 52 minutes) and the shortest interviews were with junior doctors 
(average of 40 minutes). 
3.1. CHARACTERISTICS OF RESPONDENTS 
The sample consisted of eight consultants, eight registrars, seven junior doctors (PGY1-2) and 
two senior resident medical officers (PGY3), seven registered nurses, and 11 pharmacists.  For 
the purpose of analysing group characteristics, the two resident doctors were categorised as 
junior doctors.  The characteristics of the participants were compiled using responses to the 
questionnaires, with some data clarified at interviews.   
3.1.1. Age and experience 
The entire careers of nearly all participants had been spent working within hospitals with two 
major exceptions, a registrar (who had spent most of his career in general practice) and a 
pharmacist (who had worked predominately in the community).  Nevertheless, for each health 
professional category overall, the number of years since graduation was a reasonable indicator 
of the length of experience working in this environment.  As might be expected, the consultants 
were the oldest and most experienced group with half having graduated more than 20 years ago 
(Figures 4 and 5).   
 
                                               
xviii
 In the case of Visiting Medical Officers and the academic physician, meaning that they had admitting 
rights at the hospital.  
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There were four staff specialists, three of whom had academic affiliations, and three visiting 
medical officers, one of whom had an academic affiliation.  The remaining consultant was an 
academic physician.  There was a wide range of experience among the registrars; half were 
advanced trainees (ie accepted into specialist training programs). The junior doctors were the 
youngest and least experienced group; six were interns (PGY1) and had completed three to four 
rotations at the time of interview.  Of the remaining junior doctors, one was in the second year of 
postgraduate training (PGY2) and two were in their third year (PGY3).  Of the seven nurses, two 
were clinical nurse consultants and one was a clinical nurse educator.  There was a broad range 
in the age and experience of the pharmacists; four were specialist clinical pharmacists.   
 
Figure 4. Age bracket of respondents (n=43) 
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Figure 5. Number of years since graduating (n=43) 
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3.1.2. Gender 
The gender ratio differed among the health professional categories as shown in Figure 6.  
 
Figure 6. Gender of respondents (n=43) 
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3.1.3. Experience in medicine use activities 
The consultant and pharmacist cohorts had more experience in medicine-related activities 
outside of their practitioner roles than the other groups.  This may be associated with a greater 
awareness of issues concerning medicine use.  It was noted that more than half of the 
consultants had been on advisory committees set up by pharmaceutical companies (Table 1).  
3.1.4. Experience in training junior doctors 
In the last 12 months, most of the consultants had provided training in therapeutics or other 
medicine-related topics to both undergraduates and junior doctors, on a formal or informal basis.  
Most registrars had provided training to junior doctors in medicine-related topics, whilst fewer 
indicated involvement in the same for medical students.  A smaller proportion of pharmacists 
and nurses had provided therapeutics or prescribing training to students and junior doctors 
within the preceding year (Table 1). 
Table 1. Experience in medicine use activities and education (n=43) 
 
Consultants 
(n=8) 
Registrars 
(n=8) 
Junior 
Doctors 
(n=9) 
Nurses 
(n=7) 
Pharmacists 
(n=11) 
Any experience on drug-
advisory committees (excluding 
pharmaceutical industry) 
     
Yes  7 2 0 2 4 
Any experience on drug 
advisory committees set up by 
pharmaceutical industry 
     
Yes 5 0 0 0 0 
Any experience in conducting 
drug-related research 
     
Yes 8 3 4 2 3 
Any experience in developing 
drug-related protocols/ polices 
     
Yes 7 3 2 3 10 
Recent experience* in providing 
drug-related (eg,therapeutics) 
training (formal or informal) to: 
     
Medical students     Yes 7 4 0 2 3 
Junior doctors         Yes 7 7 0 1 4 
shaded boxes ≥ 50% of participants in that health professional category;  *  in the last 12 months 
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3.1.5. Therapeutic areas 
The participants had a range of therapeutics training and experience. The specialist training 
area of consultants, advanced trainee registrars, specialist nurses and pharmacists; and the 
rotation or ward description of other doctors, pharmacists and nurses are represented in Table 2.   
 
Table 2. Specialisations or current therapeutic area of rotation 
 
Consultants 
(n=8)* 
Registrars 
(n=8) 
Junior 
Doctors 
(n=9) 
Nurses 
(n=7) 
Pharmacists 
(n=11) 
Cardiology 1  2  1 
Cardiothoracic surgery 
    1 
Colorectal surgery 
  2   
Endocrinology 1 1    
Haematology 
 1  1 2 
HIV medicine 
    1 
Intensive care and burns 
    1 
Geriatrics 1 1 1 1  
Neurology 1   2 1 
Obstetrics 
 1    
Oncology 3  2 1  
Orthopaedics 
  1  1 
Pain management 1 1  1  
Palliative care 1     
Psychiatry 
   1  
Renal 
 2 1  1 
Respiratory 
 1   1 
Rheumatology and pain 1     
None 
    1 
* One consultant was a specialist in both rheumatology and pain management, and another was a 
specialist in both neurology and oncology 
 
3.1.6. University education of junior doctors 
Six of the junior doctors were graduates of the University of Sydney, two from the University of 
NSW, and one was an overseas graduate. 
3.1.7. Medical teams 
Most consultants that were interviewed had a medical team assigned to them consisting of at 
least one advanced trainee registrar and a junior medical officer (JMO).  However, two did not 
have an advanced trainee [Consultants 5 and 8] and their registrar was regarded by as having 
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similar expertise to other junior medical staff.  Another consultant did not currently have a JMO 
attached to his team [Consultant 3].  Because sampling took place at two sites over several 
months, to the best of our knowledge, none of the doctors interviewed were from the same 
medical team (e.g, none of the registrars were working with any of the consultants or any of the 
junior doctors), and no attempt was made during sampling to find direct working relationships 
between nursing, pharmacy, and medical staff.  Therefore, comments made by each respondent 
about their working relationships may be interpreted as unrelated to any other individual involved 
in this study. 
 
3.2. SITUATING RESPONDENTS’ ACCOUNTS 
Since interviews are a form of generated data and are used to construct a picture of how the 
social world surrounding a process is perceived, a map of the social and cultural factors under 
exploration was developed to help clarify the connections between these factors and the 
prescribing process (Figure 7).  The map was based upon the major descriptive themes derived 
from the analysis.  Because these themes have minimal abstraction from respondents’ 
meanings, their labels are closely tied to the broad lines of enquiry pursued in the interviews.   
Essentially, the map provides context and navigation for the main findings of the study, which 
are then described in detail.  
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Figure 7.  Map of social and cultural drivers influencing prescribing at the teaching hospitals 
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3.3. ROLES AND RELATIONSHIPS 
3.3.1. CONSULTANT 
3.3.1.1. Policy maker and reviewer of prescribing decisions  
The consultant cohort believed that their core role in prescribing at the teaching hospitals was a 
‘reviewer’ or appraiser of the prescribing practices of registrars and less directly, of that of JMOs.  
Working within a consultant’s predetermined approach or policy for patient management 
decisions, the registrar was viewed as making the pivotal day-to-day decisions affecting patient 
management.  A consultant’s role in prescribing involved review or modification of the registrar’s 
decisions using the clinical information provided to them or their own assessment of the patient: 
 
Depending on what is being treated, a policy decision - we will treat this patient's stroke 
in a certain way - there would be a policy for management, that's been laid down by the 
consultant. Often the registrar knows the consultant's patterns well enough for that 
illness, that the registrar will… initiate treatment that we can adjust later. [Consultant 7]  
 
Examples of prescribing policies preset by consultants varied widely from informal personal drug 
preferences to formal written protocols, sometimes comprising part of broader clinical 
management guidelines: 
 
…well I tend to prescribe according to what I think is the consultant’s drug of choice…. 
Like someone, like here, for example, for the geriatrics they tend to prescribe ampicillin 
instead of benzylpenicillin and things like that, and certain consultants in geriatrics give 
ceftriaxone in favour of penicillin ...[JMO 3 PGY1] 
 
…where I'm working at the moment because there's a certain set of medications that 
people get after they come in.  I mean our commonest presentations are quite standard.  
And they get their ACE inhibitor, beta blocker, statin, aspirin, and that's about it. And 
that’s almost like a guideline, but it's not actually written down as such… I guess the 
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bosses initiated it with their evidence-based pharmacology reading. There’s been a lot of 
studies around on the drugs that we prescribe, but they [consultants] don't control it day-
to-day necessarily, unless they’re known to have a specific preference for one drug or 
the other. [JMO 6 PGY2] 
 
In haematology, a lot of it’s protocolised, so most of the chemotherapy, the bosses, or 
consultants will say what they want and we follow that protocol for what they want - that 
treatment for whatever particular disease they’ve come in with.[Registrar 1] 
 
The consultant cohort used words such as “review”, “appraise”, “modify”, “adjust” to describe the 
way in which they responded to the prescribing practice of registrars.  Notably, none described 
their actions as supervisory or managerial, although clearly, some form of organisational 
hierarchy exists.  One possible explanation is the connotation of ‘dependence’ with ‘supervision’, 
as in “supervised training”, which is a term used to describe training received in internship before 
medical trainees are legally registered to practice.  Clearly, registrars’ prescribing practices were 
not perceived to depend upon the decisions of consultants, and this degree of control was not 
generally desired by the consultants.  Nevertheless, the registrars interviewed were in no doubt 
as to their relationship with their senior colleagues and many saw the relationship in managerial 
terms: 
 
That's the thing, I will make it and then discuss it with my boss, and then my boss will 
think about that…and then we'll just change it. [Registrar 3 advanced trainee] 
 
Accounts from both consultants and registrars revealed substantial variation in how closely 
consultants working at the teaching hospitals reviewed prescribing decisions and also the extent 
of their delegation of decision-making responsibilities.  A number of consultants stated that they 
altered their approach depending on the calibre of the registrar (or JMO) and their relationship 
with them, a theme corroborated by registrars’ accounts, with advanced trainees indicating a 
much higher level of prescribing autonomy than that expressed by basic trainees: 
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In most of the teaching hospitals, very little [on the role of consultants in prescribing], 
we’re responsible for the day to day management of the vast majority of care.  We get 
general guidelines and we may be responsible for initiating immediate therapy as a team 
member or given overtime as the senior doctor on the wards and probably 75% of that or 
three quarters of that would be under our own initiative based on our experience and we 
may, you know, we may then discuss any other problems with the relevant consultant. 
[Registrar 2 advanced trainee] 
 
Something really basic, pain relief, bowel care, those sorts of things I'll do.  At first with 
blood pressure I was asking the bosses but I guess now I'm more confident with starting 
that medication myself…If there’s certainly a new diagnosis that has come up in hospital, 
that’s brand new, I normally don't start prescribing until I've checked with the boss.  But if 
it's something that's ongoing, I will change the doses, chronic conditions I'm happier, on 
the whole. If it’s the exact reason why they came in or an acute thing, then I won't. 
[Registrar 5] 
  
Alternatively, the type of control on decision-making was sometimes related more to the 
personal preference or style of the consultant, their area of expertise, or even to their attendance 
at the bedside: 
 
 I think I do [make most prescribing decisions], but I think because I probably have a 
particular interest in it, because I’m not an interventionist. Whereas if you’re do a lot of 
interventions, let’s say you’re a surgeon for example, or even in cardiology, then 
therapeutics is of less importance…they delegate more responsibility to the resident 
staff. [Consultant 4]   
 
Sometimes-it's probably 50/50, but you would tend to, you would kind of understand 
whether your boss would be happy with you prescribing or whether you would know that 
particular boss would like to do - make the complete decision about what you're 
prescribing. [Registrar 7 advanced trainee] 
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I think in renal, the consultants have a high level of direct patient input, they make a lot of 
the decisions, perhaps more than in some other fields. [JMO 7 PGY1] 
 
…in different situations the influence of the boss changes because it depends on how 
much they’re around.  From [being] there every day to never there….Well you would still 
be communicating across the phone to the consultant what you’re doing, maybe in 
general rather than specific.  He won’t actually have his own validation of what I am 
saying is correct or what I am doing is necessarily working in a way, it’s just what my 
word is saying over the phone because he won’t actually necessarily see the patient 
before the patient goes home... [Registrar 2 advanced trainee] 
 
Some consultants implied that they had a greater direct input into day to day decisions about 
global treatment (whether to treat or not) than drug selection: 
 
Like last week I had someone who had a disseminated rash and I suppose that raises 
your awareness at the time, but also trying to look at the bigger picture of, well, is it 
actually appropriate to treat [them] for an infection?... So I suppose that’s looking at the 
indication on a… not just on the immediate ‘what’s the goal here for the short-term’, but 
also perhaps try and look at longer-term goals as well. [Consultant 2] 
 
…those are sort of more global dimension things that I have to think about more, but if I 
decide I need to treat something with medication then the decision to choose the 
medication is the easy part. It’s whether to treat or not to treat is the harder thing to 
overcome, or think about. [Consultant 1] 
 
Overall, however, the typical pattern described by both consultants and registrars was that 
registrars made the majority of prescribing decisions affecting the day-to-day care of patients 
admitted to the hospital; these decisions were discussed with consultants, whose role it was to 
appraise them, but who usually intervened minimally:   
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Probably the registrar, yes, because I guess they do most of the prescribing and I just 
‘okay’ what they do in the majority of times. [Consultant 1] 
 
Yeah, I talk to my consultant. So if I see someone - nine times out of ten- then I’ll start 
them on a therapy and then I’ll talk to my consultant and then say ‘I’ve seen this patient, 
and this is what I’ve done - and this is my plan.’ And usually they say, ‘That’s fine’. 
Occasionally they might say, ‘Well no, I want this medication instead,’ for whatever 
reason. But usually I’ll start them and my consultant will say yes or no - and yeah it goes 
like that.  [Registrar 4 advanced trainee] 
 
Processes. The ‘reviewer’ role of a consultant was acted out in two ways: via phone 
conversations with registrars about acute patient management needs; and more systematically, 
via regular ward rounds or patient management meetings.  Based on consultants’ perceptions, 
common elements of both interactions were a collaborative approach to decision-making, and a 
questioning style of discussion directed by the consultant.  In the case of discussions with 
registrars, this typically involved questions about alternative diagnoses, appropriateness of 
alternative management options, and the indications or goals for prescribing in that particular 
patient.  In the case of discussions involving a JMO, some consultants also spoke of questioning 
on drug dosage and administration:   
 
That for me is always I think one of the major roles that the consultant plays in asking 
questions that might identify whether there has been some error or omission in 
diagnosis. That’s one element. [Consultant 3] 
 
Usually with the junior medical officer’s I’d say, well, ‘What dose do you think they should 
be going on?’ You know, if they are going on gentamicin, I’d say, well, ‘What dose are 
you going to put them on?’, ‘How frequently are you going to give it?’ And then if we 
agree then that’s fine and if we disagree then we just sort of suggest something else. 
[Consultant 5] 
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Based on accounts from the other doctor cohorts, the degree to which consultants clarified the 
specifics of a prescribing decision for the benefit of the prescription writer was sometimes related 
to their perceived competence of the recipient or to the complexity of the clinical situation:   
 
But the boss and prescribing, if he or she wants something, it depends on the boss and 
the situation.  Sometimes, they’ll say just a class and sometimes they say exactly what 
they want…If it's complicated, definitely, they'll discuss a dosage plan.  Less 
complicated, it's more up to us. [Registrar 5] 
 
I think the consultants, particularly in surgery, do their quick rounds and don't have time 
to sit and explain doses. They usually speak to the registrar, there’s a chain of command.  
The consultants usually speak to registrars, and expect the registrars to know what to 
prescribe. [JMO 8 PGY1] 
 
Settings.  Ward rounds were described by consultants as the period during which most 
decisions affecting the primary management of their patients were made.  Ward rounds 
principally were recounted as involving the consultant leading his or her medical team on a 
methodical review of their patients.  During this time, as part of their joint patient assessment, 
medication charts would be reviewed, and if deemed necessary, prescribing decisions would be 
made, principally between the consultant and the registrar, and as will be discussed, sometimes 
involving the patient.  However, registrar-led rounds were also commonly described, and a few 
consultants described sometimes reviewing their patients alone, which gave them the 
opportunity to personally review and check on all aspects of patient management:   
 
You do see the patients sometimes when the registrar's not there, just to make sure 
because you're taking responsibility, just to make sure everything's going well.  
Sometimes you do it very quickly because the registrar's just going smoothly, and other 
times the more difficult the patient is, you have to take the story and look into it.  
[Consultant 7] 
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Nurses and pharmacists also attended rounds in some clinical areas; most examples given 
involved specialist nurse and pharmacists (eg, clinical nurse consultants or specialist clinical 
pharmacists), who described active participation.  But other data from a range of respondents 
revealed that their participation in ward rounds was not customary throughout the hospitals and 
was not seen by doctors as integral to prescribing decisions made at these times.  This may 
have related in part to the commonly reported difficulty of attending rounds, largely due to 
competing work priorities.  A recurrent theme from some consultants and registrars was that in 
the past, pharmacists played a very valuable role in aiding prescribing decisions at the time of 
treatment initiation, but this situation had changed.  Both nurses and pharmacists appeared to 
have a greater current profile with respect to prescribing decisions at other forums, such as 
regular multidisciplinary meetings and certainly a more active role in addressing prescribing 
issues, informally, as will be discussed under their respective roles.  
 
In summary, the salient depiction of ward rounds was that they were lead by doctors for the 
purpose of assessing their patients and determining among themselves what management 
decisions were required, such as decisions about pharmacological interventions. (Figure 8) 
 
The ward round also afforded consultants the opportunity to personally review their patients’ 
medication charts.  During this review, they would check on what had been prescribed by the 
registrar or JMO and also whether the drugs had been given as intended.  This formal review of 
charts was commonly cited by consultants as the way in which they exercised their professional 
responsibility for medication safety:  
 
It becomes such a routine that you look at the prescribing chart with the same care as 
you do the temperature chart.  And you can see drugs that are missed.  Also you can see 
where there's an inappropriate mix of drugs.  [Consultant 7] 
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…I see my responsibility as really reviewing their [JMO written] charts and making sure 
that the medications that we’ve discussed have actually been prescribed as we’ve talked 
about…[Consultant 5] 
 
Figure 8. Attendees during ward rounds 
 
Yes, senior registrar, junior registrar, resident, two senior medical students, and odd others, and 
so that team always does rounds together, and it follows a sort of chain of command. 
[Consultant 7] 
 
I have ward rounds and also multi-disciplinary meetings, which I attend, where patients will be 
discussed with nursing or with other allied health and then based on their reports I may modify 
the medications according to what they’ve reported to me. For example, if the nursing staff tell 
me that a patient can’t swallow any more, then I would direct the registrar that the patient’s 
routes of administration be changed to the subcutaneous route. [Consultant 1] 
 
The number of ward rounds that go on in the HIV unit are just quite large, in fact there’ll be a 
daily ward round with the registrar and the resident.  And often I’d get paged to say, ‘Are you 
coming?’ to see, to make sure. [Pharmacist 11 specialist clinical pharmacist] 
 
I try and sneak in the ward rounds where I can do at least in terms of hearing what’s going on if 
I’m about at the time. It’s difficult to actually tie in a ward round with your schedule because the 
times vary greatly. [Pharmacist 2] 
 
We do, there’s a formal ward round, well it’s more like a haemotology meeting on a Thursday 
morning and the nurses, it’s only the last few months really we’ve been invited to go, attend that 
and we do try, but it is difficult. [Registered Nurse 2] 
 
I like prescribing in a multidisciplinary setting so with a pharmacist there for oncology 
prescribing, which doesn’t happen here.  With the pharmacist and the nurses there.  That 
happens in a lot of oncology units, a chemo write-up. [Consultant 8]  
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However, close scrutiny of the medication chart was not systematically undertaken by all 
consultants for all patients who were admitted to the hospitals: 
 
You rely on trust a bit.  I might say, I suggest Oxycontin 10 mg twice a day for this 
patient, or maybe 8th hourly and tell the pharmacist not to worry about that.  And then I 
don’t go back and necessarily check that that’s been done because of time practicalities.  
Yes, it’s not, that’s why I think you really need to have close scrutiny by the pharmacists 
for hospital prescribing.  That’s the real safety net, that and an effective computer based 
organisation. [Consultant 6] 
 
I don't think consultants check the medication charts, or don’t thoroughly check the 
medication charts of their patients.  I'd say they probably look at them, but I don't think 
they go through and check the dosing or anything.  I'd say it's between the registrar and 
the intern because they should be looking at it each day. [JMO 8 PGY 1] 
 
Patient involvement.  Consultants’ perceptions about ward round discussions commonly 
emphasised the patient’s involvement in decision-making.  Patient ownership of decisions was 
seen as a vital step in ensuring patient adherence to treatment and maximising the probability of 
an effective outcome.   This theme was consistent over a range of specialties: 
 
Well, this it’s usually a three-way conversation between patient, myself and the junior 
hospital staff, the resident or registrar (or fellow)… if you just impose drug therapy on 
patients, you open the way to all kinds of problems.  Lack of understanding, resentment, 
greater increase in liability of non- adherence, so it’s got to be a joint decision. 
[Consultant 6] 
 
I think there’s risks and benefits and I often discuss that with the patients or their proxy-
decision makers and let them as much as anything make a decision, but without being, 
you know, wishy-washy and not giving them some advice, because people need advice 
as to what would be the best course of action.[Consultant 2] 
 
I think they’re equal partners.  So particularly with chemotherapy, you can have patients 
who say, “I’m not having anything, even to save my life, if I have to lose my hair”.  You 
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have other people who, you know, want treatment when you don’t think it’s appropriate. 
You have to - especially with cancer because it’s often a terminal disease with so much 
at stake - so the patient’s bear a huge part of that, a huge part. [Consultant 8] 
 
According to respondents who worked in the fields of oncology and palliative care, patient 
involvement in making global decisions about cancer treatment or palliative treatment was well 
established, and this was not specifically disputed by any other respondents interviewed.  
However, perceptions of patient involvement in prescribing decisions in the teaching hospitals, 
more generally, did differ from the active participation desired by the sample physicians.  In 
talking about how prescribing decisions for inpatients were made, with reasonable consistency 
(although there were a few exceptions), the other respondent groups described the discussions 
as being purely between staff members with no specific reference to the patient.  This inference 
was further substantiated by a registrar’s admission:  
 
I must admit, we're not always the greatest at telling the patient, [the] information, we 
probably should.  On the ward round with the boss, they're always so quick, that for a 
start, I may be back in touch with the patient later, but never with the boss.  It's just too 
quick.  I shouldn’t say never, but rarely with the boss. He's in too much of a hurry…. I 
think that's something we don't do very well, we tend to medicate in hospital.  
[Registrar 5] 
 
One of the exceptions articulated by a junior doctor was prescribing decisions about warfarin, 
where patient acceptance was more keenly recognised: 
 
I’m just trying to think of different sorts of things that they might be involved with and obviously 
things like anticoagulation require a big input from the patient, not [inaudible] on the ward, that's 
a huge decision, you need to do that very much in consultation with the patient.  [JMO 7 PGY1] 
 
There were also perceptions among nurses that patients were not routinely advised of newly 
initiated treatments:  
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[On patient involvement] Very little, I would say.  Usually, the patient gets told by the 
doctor that they are going to put them on a new drug, but not even always.  So they’ll just 
start something on the medication chart and then... Then you say, the first time you’re 
with the patient, “This is the dadadada, did the doctor tell you about it?” Probably, fifty 
percent of the time, it’s “No, no, no”. Now whether that’s because they’ve forgotten or 
what, but often it’s not something that the patient gets told.  [Registered Nurse 7] 
 
Recognition for the importance of patient education about prescribed medicines was more 
marked in these groups, with a number of registrars and JMOs indicating their awareness of 
patient adherence problems.  Nevertheless, the overall inference from the complete interview 
sample was that whilst the importance of patient ownership for decisions was espoused by the 
consultant cohort, this prominence was not realised by other medical respondents.   
 
An educative approach was also a common element of consultants’ recalled conversations 
about therapeutic management, directed at both the other members of the medical team and 
sometimes also to the patient.   
3.3.1.2. Educator of patients and doctors 
 
Patient education.  Patient education was illuminated as an essential part of prescribing by the 
consultants interviewed.  The two major educational topics included: the scientific evidence 
supporting various treatment options, which was explained to patients to assist them in making 
prescribing decisions; and information about administration or side effects of specific drugs for 
the purpose of maximising patient acceptance and ongoing adherence to treatment: 
 
For example, the adjuvant treatment for Dukes C, I go right through it… Twenty years 
ago we did studies to see whether any treatment after surgery would prevent the cancer 
form coming back and we took two groups of equal people, one we gave treatment to, 
and one we didn’t. And the people we gave the treatment to, less cancers came back.  
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But some people had no treatment and they didn’t get the cancer back and some people 
had treatment and the cancer still came backl…So I go through that whole thing. 
[Consultant 8] 
 
[In describing his role in prescribing] and also to check that people are taking things the 
way they should be. The sort of medications we use, for example the bisphosphonates 
group of drugs require taking in very, very specific ways and we still find sometimes, after 
years of when you’ve been talking to people that they’ve been taking it in some way 
which is very wrong, either because they’ve misunderstood something or someone else 
has told them something incorrect.[Consultant 4] 
 
Because they rated patient education highly, some consultants were keen to show their 
recognition of the role that pharmacists played in this area, particularly in regard to medication 
lists provided to patients on discharge, which is discussed in further detail under the role of the 
pharmacist (3.3.4.6). 
 
Prescriber education.  Consultants saw themselves as mentors for registrars and their 
contribution to their training was provided implicitly through discussions about prescribing 
decisions.  Registrars perceived consultants to have a very strong influence on their prescribing 
practices for inpatients at the hospital, and although not fully explored in this study, consultants’ 
practices were also cited as influential to registrar training in prescribing (ie, development of 
registrars’ personal prescribing behaviours).  This was because consultants’ experiences were 
considered to provide a form of experiential legitimacy.  
 
 I mean they [consultants] may use a particular evidence base, but then if 3 or 4 out of 5 
of them have had a terrible time with a particular medication, then you might steer well 
clear of it or you'd be thinking twice about using it, despite what the evidence says.  
[Registrar 7 advanced trainee]  
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… it’s not necessarily about getting the right therapy, it’s getting the acceptance, it’s 
getting the accepted therapy… Now I have learnt about CALxix and I have studied an 
exam, I have read the articles on CAL, but it is also fitting it to a local protocol in a sense, 
so… I don’t have to go back and change the thing because he wants… it for five days 
instead of four or doesn’t want it at all [Registrar 2 advanced trainee] 
 
Consultants also uniformly felt a sense of responsibility toward the education of junior doctors in 
therapeutics and prescribing.  However, some lacked the opportunity to do this in anything other 
than an opportunistic fashion as they did not interact with JMOs on a regular basis.  For the 
remainder, the educative aspects of their role were articulated as either giving formal tutorials or 
lectures to JMOs (or medical students) – two consultants in the group; or more commonly 
through informal discussion during ward rounds. The main topics cited as the focus for education 
were the evidence for various therapeutic choices, and aspects of drug knowledge. These were 
integrated into their review of the patient’s management and so took the form of further 
questions posed by the consultant to the junior medical staff: 
 
It's very much Socratic xx rather than didactic- this is the way I do it and therefore don't 
question it.  What is the evidence that this works?  A lot of it is questioning… what dose 
of dexamethasone should be used…? What is the half-life? - to the junior.  He did 
pharmacology only six months ago whereas I did it 30 years ago.  What's the half-line of 
dexamethasone? How many times a day do you have to prescribe it? [Consultant 7] 
 
 I think I always…we do discuss all the drugs and we always discuss why we are using 
those drugs and what the trials showed that affected or which was the basis for 
prescribing it. We try and discuss it, in terms of evidence-based medicine. [Consultant 4] 
 
                                               
xix
 Chronic Airways Limitation 
xx
 “The essential nature of Socrates’ art lay in the fact that he did not appear to want to instruct people… 
So instead of lecturing, like a traditional school master, he discussed.” Jostein Gaarder. Sophie’s World; 
London: Phoenix House;1995. 
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Junior doctors predominately cited registrars as their leading trainers in prescribing; but 
consultants were viewed by one as particularly influential in teaching them what to prescribe 
rather than how to prescribe:  
 
…but I suppose it would be the various specialists in terms of ‘what’ to prescribe 
[JMO 4 PGY1] 
 
Somewhat ironically, based on reflections of their own prescribing practices, a consistent theme 
from the consultant sample was a need for medical training focused purely on prescribing 
principles, specifically, “what is good prescribing” and “how to prescribe”, which some felt was 
gathered all too opportunistically over a long period of time:  
 
So I think just a knowledge of what is good prescribing and what is not, at JMO level, 
does help. [Consultant 7]   
 
I’d be inclined to reorientate undergraduate training to much more towards to what 
doctors actually do and that includes a lot of evaluation of therapeutic initiatives and 
regimens and pharmacological information… There’s a whole lot of stuff that they learn 
that is far less important than that. [Consultant 6] 
 
I mean I think it probably needs to be formalised. I just don’t think you can expect people 
to just passively pick it up. You know, I ‘m surprised at how much I still continue to learn 
about prescribing, having written scripts for probably nearly 20 years now, just because I 
didn’t really know that that existed or that you could do that or how you found out that 
information about a drug, the practicalities are pretty important but no-one tells you. 
[Consultant 5] 
 
3.3.1.3. Distance supervisor of junior doctors 
 
Some consultants spoke of their role in supervising the prescribing practices of junior doctors 
often in regard to specific issues or relating to the orientation stage of the JMOs’ learning cycle.  
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Registrars, however, were acknowledged to be primarily responsible for directing the daily work 
practices of junior staff.  The key discussion point of the consultants’ supervision of JMOs’ 
prescribing was the accuracy of their medication history taken from patients on admission.  
Consultants outlined general difficulties associated with this task, including problems with relying 
on GP records and a perceived lack of diligence of junior doctors, which necessitated their close 
scrutiny of JMO practices (Figure 9). 
Figure 9. Consultants' supervision of junior doctors 
 
I would, as part of my assessment of that JMO, maybe take charge of the management, even to 
the point of saying, ‘This is what I want.’ And maybe after a week or two when I have an 
understanding of the level of that JMO’s ability, then I will be giving that JMO more leeway to 
explain to me what he or she wants to do. [Consultant 1] 
 
Typically I would ask them [the JMO] what the patient has come in on, what medication they 
have come in, whether they’ve brought their medications with them. So whether the patient has 
actually brought along a plastic bag full of the pills that they reckon they are currently taking or 
whether they’ve got a written record of what they are taking. And then we just basically go 
through the medications that the patients thinks they’re taking, over the phone and decide 
whether those ones are really what they should be taking, yea or nea. [Consultant 5] 
 
They will, you know, when the patients are admitted, they will copy an out-of-date medication 
lists, rather than actually going through with the patient themselves as to what they are on at the 
time. [Consultant 1] 
 
3.3.1.4. Expert decision-maker and/or prescription writer 
Whilst the usual situation described by the consultants was that they modified prescribing 
decisions initiated by registrars, for highly specialised areas and/or prescription of medications 
with small margins for serious errors, prescribing decisions were considered the sole domain of 
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the expert consultants.  This informal system of prescribing according to level of expertise was 
widely accepted by all respondents:  
 
One of my roles as a neurologist is that people are referred specifically for a prescribing 
algorithm so patients with chronic pain or epilepsy or particularly areas like multiple 
sclerosis and brain tumours, the range of prescribing is somewhat limited and somewhat 
sophisticated, so part of my role is to actually outline a treatment program, prescribe into 
that, hopefully the GP will or whoever it is who is involved in the team of management will 
keep the prescribing going. [Consultant 7] 
 
…but I think if it came to a specialist and their entity, where with a particular specialty, 
things like the management for Cushings syndrome or things like that, then I would 
certainly not just start the medication without, it would come from the 
consultant.[Registrar 7 advanced trainee]  
 
Absolutely, the most difficult ones, just talking about my current term, those 
antiarrhythmic medications, they tend to be more risky and the consultant usually makes 
those decisions. [JMO 2 PGY3] 
 
In the case of chemotherapy, the oncologists interviewed stated that prescribing decisions were 
initiated by themselves based upon the mutual agreement with the patient (a collaboration, 
which was strongly emphasised in this particular context).  Some also voiced a preference for 
writing their own prescriptions.   Interestingly, although in other fields, cases of challenging 
prescribing were cited as being educational for junior medical staff, this was not the case with 
chemotherapy, where observational learning was considered potentially dangerous for those 
without a specialised knowledge base. 
 
It would be unusual for an experienced senior registrar to not pre-empt the consultant to 
some degree in starting appropriate treatment.  But, if for instance the decision is which 
chemotherapy we give for a malignant disorder, then I think the consultant lays down the 
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policy, the registrar writes up the doses and the more junior residents carry it out. 
[Consultant 7] 
 
I think that the principle should be that the oncologist writes up the chemotherapy. 
Because I don’t believe the junior residents or even the registrar staff know enough about 
particular chemotherapy - and neither should they - I mean really it’s a very specialised 
field and it’s changing rapidly, but they should understand the principles of it. 
[Consultant 8] 
 
I think there's been instances where it's been, where dangerous things have been 
charted and not understood by the residents, so it's a reason for us not having to do it.  
There's a sense of understanding, you don't have much involvement at all.  So your 
understandings not built up at all, so there is a downside. [JMO 5 PGY 3] 
 
3.3.1.5. External roles  
Unlike the other groups of health professionals interviewed, the main focus of each consultant’s 
clinical practice was not necessarily inpatient care at the teaching hospital.  On the contrary, due 
to the nature of the medical conditions that they managed, their employment relationships at the 
hospital and other factors, many (but not all) viewed the care of patients admitted to the teaching 
hospital as a small portion of their work.  Some also intimated a closer relationship and greater 
understanding of medicines management systems of other hospitals where they worked.  It was 
therefore not unexpected that a sense of distance was often conveyed about the specifics of the 
day-to-day activities at the teaching hospital and also on occasion, a remote relationship with 
their resident staff: 
 
Largely, my role is to be responsible for most of the prescribing that occurs with my 
patients, with the patients predominantly seen in an outpatient setting, where I am really 
the only person seeing them. It is the minority of patients that I see are actually seen by, 
or that I am responsible for, are seen by someone else, like a junior medical officer and 
their drugs are written up by them. [Consultant 5] 
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Oh, the hospital resident or registrar often does [make major prescribing decisions] and 
that’s an essential part of it because they’re the ones who may well know the patients a 
good deal better, and know their general medical status than I do as visiting physician.  
[Consultant 6] 
 
I mean I don’t think the pharmacy -  the pharmacists in a public hospital,  I’m not aware of 
the role they play. I mean they occasionally provide a list of drugs for the patients 
although I think they’re sometimes too busy for that, you know, for complicated cases or 
patients.  So I think…sometimes they do do that. I think that’s sort of arranged through 
the resident staff rather than myself. [Consultant 4] 
 
There were indications that this self-perceived remoteness of some consultants from day-to-day 
patient care at the teaching hospital was also felt by other staff members at the hospital and 
affected the way in which they queried prescribing decisions.  Some pharmacists associated a 
lack of approachability of some consultants to their accessibility.  The pharmacists felt that they 
were less likely to develop a rapport with VMOs or with consultants who they did not see during 
their working hours, and therefore less likely to directly discuss prescribing issues with them 
compared with staff specialists based at the hospital; a theme that was reiterated by some junior 
doctors: 
 
Yes there’s a bit of variety. Some in particular are very approachable, the ones that are 
sort of around a lot more, and that’s probably more the staff specialists as opposed to the 
VMOs. And some that are shared with other hospitals and so they’re just less obtainable, 
but I know the registrars contact them very easily and quickly.[Pharmacist 1 specialist 
clinical pharmacist]  
 
Oh yes, I'm fortunate in the area that I'm working in, in that, I've worked there for quite a 
while, and so I have quite a good relationship with the consultants. And they're very 
approachable and they do work very much as a team, more so than a lot of other teams 
within the hospital, whereas certain other teams you, they're either not around for a lot of 
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the time, just uncontactable or they’re very aloof or not really seeing pharmacy as really a 
part of that, that sort of team, that’s just the patient's medications.[Pharmacist 7 specialist 
clinical pharmacist] 
 
[On contacting consultants about prescribing concerns] Although that’s very consultant-
dependent, how much direct contact you have with them… Some consultants you don't 
always feel like, as the intern, you are in a position to be discussing things with… [JMO 7 
PGY 1]  
 
3.3.2. REGISTRAR 
3.3.2.1. Operational decision-maker 
Registrars were perceived to be the managers of inpatient medical care and were therefore 
seen to be charged with the responsibility for making the acute and key prescribing decisions for 
the management of the problem that brought the patient to hospital and for any problems arising 
during admission which could prolong the patient’s stay.  This role appeared particularly 
important at the time of admission, as registrars generally initiated the preliminary course of 
patient management, which they would, in most cases, subsequently discuss with the admitting 
consultant.  The main exception was for difficult or unusual cases, or as alluded to previously, 
instances where the registrar lacked experience and therefore confidence in prescribing within a 
highly specialised field.  In these cases, registrars contacted the specialist physicians to discuss 
management options and then implemented the decision: 
 
But, you know, let’s face it. They’re the ones that are there at the bedside at the 
beginning and they’re the ones that are prescribing. In general when people come in, and 
most of our patients come through emergency, they’re probably going to prescribe most 
of the things that they’re already on and then it’s actually the process of de-prescribing 
that I’m involved in when we review the patient [Consultant 2] 
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In the transplant population – the consultants [make most prescribing decisions].  In the 
non-transplant population, I think myself as a senior registrar, I play a fairly large role. 
The consultant then obviously has the over –  you know – they can over-rule anything 
you say.  But usually they’re agreeable, and there’s many ways to skin a cat, there’s not 
just one right drug – so you may not pick something the consultant may have initially 
chosen, but it’s still fine. [Registrar 4 advanced trainee] 
 
A further exception was when registrars were acting in a consultative capacity.  In this case, the 
primary team managing the patient had the choice of whether they would allow the consulting 
registrar take over the day-to-day management for that aspect of the patient’s care or whether 
they would integrate the treatment advice into their own management plan:   
 
[In relation to the role of registrars in decision-making] It sort of depends. I mean if you’re 
consulting to another medical team they’ll likely integrate what you say and make choices 
based on that. If they’re in intensive care they will integrate it and make choices 
depending on what they think is most important, and if it’s a surgical team they’re more 
likely to say, “Well, you know, you’re the drug lot. You make those decisions.” 
[Consultant 4 ] 
 
This situation sometimes created confusion among medical staff because of divergent views 
about responsibility for prescribing, which will be addressed in more detail under Responsibilities 
(Section 3.4).  
 
Some registrars emphasised the importance of their own regular critical review of medication 
charts as part of their patient assessment, and as will be discussed, was sometimes, but not 
invariably used as a check on the prescribing practices of JMOs:  
 
I will often do a medication review of the patient because 20% or so of geriatric 
admissions are due to medication problems, too much, too little, incorrect type, 
overdoses, side effects.  So often as part of my medical review of the patient, if I think 
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that it hasn’t been well explored or there is a lack of insight as to what is wrong with the 
patient then I will look into that. [Registrar 2 advanced trainee] 
 
3.3.2.2. Primary supervisor and educator of junior doctors 
Registrars were uniformly perceived to be the chief supervisors and trainers of junior doctors; 
and prescribing was seen by them as a component of their broader training of JMOs in patient 
management skills.  The registrar cohort commonly espoused open communication lines with 
their junior colleagues, who were repeatedly urged to ask if they were uncertain, an approach 
which was seen as beneficial to both patient safety and the training of JMOs.  This willingness of 
registrars to be accessible to the needs of junior doctors was widely corroborated by accounts 
from the JMOs.  However, some nurses and pharmacists felt that junior doctors did not always 
feel comfortable or were not given adequate time to question their senior colleagues, which 
sometimes compromised quality of patient care: 
 
I say, "you're more than free to ask me, before you make a decision". Obviously we can't 
teach them in one day...if you don't understand, you should ask us why this drug has 
been used and why this dose, and what are the side effects. [Registrar 3 advanced 
trainee] 
 
I don't think they actually expect too much of you and they are actually very happy if you 
just check if you are not sure because that makes you a safer practitioner, in medicine I 
think the most important thing is to be safe, that's very important.[JMO 2 PGY3] 
 
And I think they get - they come out thinking they’re not allowed to ring a senior doctor 
unless it’s life-threatening, and if they get over that then they’ve got a tool there that’s 
better than a MIMs or a senior nurse or anything… [RN 7] 
 
And sometimes they [the patients] have a lot of intravenous antibiotics going into the 
veins and at the end of the day they suffer from phlebitis in their vein, they get really hard 
and knotty.  And the young doctors will prescribe it [intravenous antibiotic] on the 
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medication sheet, without even thinking whether the patient needs to have it all, without 
asking the consultant, how many weeks are we doing this for?  I always feel there is a 
lack of care towards the patient.  [RN 6] 
  
The closeness of their supervision (such as, how explicitly they provided prescribing instructions 
to the junior doctors), and the degree of educational emphasis they gave, depended on the 
junior doctor’s experience and their assessment of the JMO’s competency.  The rationale or the 
evidence supporting a prescribing decision, details of the dose, frequency and duration of a drug 
treatment were more likely to be specified in detail at the start of a junior doctor’s term; but as 
the junior doctor was perceived to gain knowledge of standard types of drug regimens within a 
therapeutic field and confidence in prescribing them, then less specific information would be 
provided.  Less specific information might also be provided due to time constraints, but a 
widespread understanding of both registrars and JMOs was that if dosage instructions were not 
given, the onus of locating this information was on the junior doctors.  So, whilst registrars 
provided dosage details to new interns and to junior doctors at the start of terms, the 
presumption was that correct dosing of patients was the responsibility of junior doctors.  As one 
junior doctor commented, “ I guess, there’s a balance between being condescending and 
teaching”.  However, there were indications that the assumption that junior doctors could locate 
and interpret dosage information was not always sound.  For example, circumstances where 
junior doctors’ knowledge was inadequate to cater for exceptions in general dosing rules, such 
as prescribing morphine in the elderly (Figure 10).   
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Figure 10.  Closeness of registrars’ supervision of junior doctors’ prescribing practices  
 
…it depends on their level, if they’re interns usually it’s fairly specific, for example, the name of 
the drug, the dose, how you give the drug, and for what period of time that will be required. If 
they’re more senior, and I know them and I know that they already have that sort of… 
knowledge, then I will just say, ‘Start them on such and such’ and assume that they will know 
those other details, and if they don’t, then they can ask or look it up or whatever. [Registrar 4 
advanced trainee] 
 
Initially my registrar didn't expect me to know the Imodium dosing for colorectal surgery patients 
so he'd usually explain it whereas now he's usually happy to say, “Just start them on Imodiumxxi.”  
[JMO8  PGY 1] 
 
I guess probably that initially it was inadequate and that perhaps supervision should have been 
greater for things like that, where there is potential for harm. And even things where you’re 
inexperienced with prescribing your S8s, you know you're not quite sure initially how much 
morphine you start someone on or how much Endonexxii you use and how much is safe for a 99 
year old compared to a 55 year old. You don't know those things and while there's reasonable 
supervision by the registrars, and certainly you would get picked up if it was a very inappropriate 
dose, it leaves particularly the very elderly quite vulnerable to overdosing, because they get 
overdosed quite easily.[JMO 6 PGY2 ] 
 
The registrar should be responsible of making sure the new doctor, the relatively new doctor 
under supervision, are doing the right thing… [but] they assume that he's been through the 
schools; he or she should know what they're doing.  I work on one day over the weekend, 
Saturday, and there's no young doctors around, just the registrar, and they go on a round and 
they usually get me on the round.  So that's when I say to them, “OK, do you think this is the 
right prescription?  And they say, “No, I want more than that.”  And I say, “Did you specify?   It's 
not written anywhere in the notes how much a patient should be getting”, especially when 
they’ve been in a febrile state for so long. [RN6] 
 
 
                                               
xxi
 Tradename for loperamide 
xxii
 Tradename for oxycodone 
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In addition, accounts from various respondents suggested that prescribing difficulties 
experienced by JMOs may also emanate from a lack of self-awareness of knowledge deficits 
and a consequent misjudgement of when to seek advice about prescribing decisions.  In other 
words, a problem of “not knowing what they don’t know” or not being able to identify likely 
exceptions to how knowledge is usually applied and therefore not knowing what questions to ask 
at the time a verbal medication order is given.  Collectively, these factors implied a gap between 
undergraduate training and workplace responsibilities, which, based on examples of prescribing 
errors described in the interviews, were not always met by the supervision provided by their 
registrars, particularly at the start of their internship (Figure 11). 
 
Figure 11. Presumptions about asking 
 
 
It’s presumed that they will ask.  It’s presumed by your registrar that they will be asked if there’s 
a problem. So if they - if the resident does not perceive that they’re having a problem, then it will 
be done by the resident. [RN 7] 
 
Well, I mean.  I’m sure nobody would have thought that I wouldn’t know how to prescribe 
morphine as a doctor. But I’m sure patients are not aware of...patients are not aware of how 
inexperienced interns are when they first begin...I say to my family, “Don’t go near a hospital in 
January” [JMO 9 PGY1] 
 
Especially dosages I think in the first term, we’re just not sure at all. We know sort of from 
knowledge, like basic knowledge, like pharmacology, but whether, how to apply it, so nothing, 
like as I say, “Do we use 20mg now or 40mg of frusemide?”, things like that.[JMO 3 PGY 1] 
 
I prescribed pethidine at way too high a dose once and the order was seen by two nurses and 
they saw the number and went , “Do you really mean that? And then I saw the number and 
thought “No, that isn’t what I really meant.”[The error was due to] probably a degree of 
unfamiliarity with pethidine, it's not a drug that I use a whole lot… [JMO 7 PGY1] 
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Irrespective of the perceived adequacy of registrars’ guidance, the relationship between 
registrars and JMOs was understood unambiguously by all groups as being supervisory.  Most 
of the registrars expressed an awareness of the steep learning curve that interns experienced 
when they started prescribing and that in addition to issuing directives, junior doctors needed 
checks on their practices:   
 
The check would come when you see them on a daily basis and I certainly always check 
the medication chart every day and I guess that would be my check.[ Registrar 7 
advanced trainee] 
 
I guess from the obstetric point of view we're always keeping a pretty close eye on 
whether the medications are compatible with pregnancy anyway, so initially the 
consultants when doing their rounds will have a look at the med charts, and each day 
one of the registrars will usually have a look at a medication chart with a resident as well. 
[Registrar 6 advanced trainee] 
 
However, descriptions of interactions between registrars and junior doctors revealed that 
because the priority for registrars was acute management of their patients, this necessarily took 
precedence over systematic checks on how accurately junior doctors prescribed.  Registrars, 
therefore, did not always personally review medication charts or conduct a detailed check on 
whether intended medications had been prescribed and administered.  According to one 
account, to facilitate making timely decisions about patient care, registrars relied on junior 
doctors to provide them with “filtered” patient information, including information about the 
patient’s medications.  The needs of the patient at the time were addressed and according to the 
respondent, the JMO worked “synergistically” with the registrar; however the implication of this 
practice was that inexperienced prescribers were likely reviewing their own prescribing practice: 
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But often on a ward round I will be examining the patient and it will be the RMOxxiii, the 
intern or resident’s responsibility to flip through the observation charts…and then flip 
through the medication chart and have a look and see what the medications are going 
and where we are up to and I might say “How many days have we had them on 
ceftriaxone?”, “Are they afebrile now?”  “Well they’re looking better and the chest is 
starting to clear, so let’s put them onto oral therapy and see how they go”.  So it’s a 
synergistic role.  Often the resident’s are just an extra eye to see as to what’s going 
on…The things are all filtered in just the bare minimum of information …I’ve just got to 
accept that, unless, if specifically I have a reason I might look.[ Registrar 2 advanced 
trainee] 
 
In general, the registrar cohort fully accepted that training of JMOs was one of their core 
responsibilities.  However, there was one notable exception; a registrar who had worked for a 
number of years as a GP, who thought that there was too much hand-holding in the training of 
JMOs and that they needed to be taught to take responsibility for their own learning.  His views 
of responsibility were possibly influenced by his own experience as an intern being “sent to the 
bush” in his first term with little registrar support, which forced him to become assertive and 
resourceful in the way in which he sought information and advice. (Figure 12). 
 
Whilst the junior doctor group was in agreement that registrars were largely responsible for 
teaching them how to prescribe, a few JMOs also expressed the need to accept responsibility for 
their own training: 
 
I really see myself as responsible for that. I mean the registrars aren’t really, I mean 
they’re influencing me, but ultimately, it’s my responsibility to make sure I know the side 
effects of all of them, you know, the interactions and the doses of the drugs that I’m 
prescribing.[JMO 9 PGY 1] 
 
                                               
xxiii
 Resident Medical Officer 
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A recurring theme from the registrars’ accounts of training in prescribing was that prescribing 
was a skill which was best acquired through experience.  Whilst some thought that their own 
undergraduate training, usually described as pharmacology or therapeutics lectures, was 
inadequate preparation for their internship, at the same time they saw it as appropriate that the 
strongest influence on their prescribing practice came during their hospital apprenticeship.  
Influences such as registrars, pharmacists, peers, and their own observations of medication 
charts and prescribing practices were cited as being the formative factors that shaped their 
prescribing practices (Figure 13). 
Figure 12. Responsibilities of registrars to train JMOs 
 
If they are there, then I will direct them…far more to write them up and that’s part of, I think, any 
physician should review medication charts daily when they’re seeing patients.  I do think that’s 
an important part of you learning review because it’s how you treat patients… we should be 
doing daily reviews. [Registrar 8 registrar] 
 
[On whether he felt a responsibility in training JMOs to prescribe] Yes, because we have to 
make sure that the patients are on their appropriate treatment, for their condition and everything. 
They are not over-treating them or under-treating them…[Registrar 1 registrar] 
 
You know, you’ve graduated with a degree, you now have a practicing registration in New South 
Wales, you've got to be held professionally responsible for learning about what you're 
prescribing and so forth.  I know there's a very hold-your-hand attitude here in public hospitals, 
some of these people have been stuck in public hospitals forever.  It's a different world out there.  
When you're admitting patients in individual rooms, then you're the one who's responsible.  
We’re often very poor in teaching that to registrars here, and residents here, because everyone 
gets their hand held so much, and if anything goes wrong, then it's always, why wasn't the 
consultant informed and all this sort of thing, the teaching of responsibility to people could be 
improved.  That's what happens in the real world. [Registrar 6 advanced trainee ] 
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Figure 13. How registrars learnt to prescribe 
 
Well, in terms of the actual writing of the prescriptions, it's usually from how you see things done 
on the chart.  If you particularly, I guess, thinking back to my intern days, you'd be transcribing 
across and you’d see different ways people did things...  But also influence from pharmacy, we 
had a couple of sessions on the proper abbreviations for things. [Registrar 7 advanced trainee] 
 
We did get a, in fifth year we got some lectures on therapeutics, what to prescribe for certain 
conditions, side effects and so forth… I guess when you're an intern it comes down to the nuts 
and bolts, you've got a person in pain, you've got to write something up.  It doesn't come down 
to, oh, there's a GABA pathway in a spinal cord.  You've just got to give them something.  
Oxycodone, what the hell's that?  Oh that's right.  A lot of it too is informal too when you ask 
around your mates… what do you do?  What do you give?  Because we'd all been through med 
school together so we'd bounce things off each other.  Learn that way [Registrar 6 advanced 
trainee] 
 
You don’t get taught it well. I didn’t get taught at University how to prescribe and the week before 
you started work, you did an orientation and they showed you the basics of how you fill it out and 
how you fill out the medication chart… And in the beginning you shouldn’t expect them to have 
anything. You should teach them how to do it, because it’s very much a learn-as-you-do skill. 
[Registrar 4 advanced trainee] 
 
3.3.2.3. Prescription writer 
Variations in registrars’ assignment of prescription writing activities were described by the 
respondents.  Sometimes, this related to the organisational structure of their medical team.  For 
example, one advanced trainee worked with another registrar and had no JMO assigned.  He 
described how they made joint prescribing decisions at the bedside and either one of them 
would write the medication order.  In other instances, it related to workflow.  For example, one 
registrar felt that the reason she wrote most medication orders for her patients was because she 
made prescribing decisions whilst looking at the medication chart, so it was easier to write it 
there and then.  Alternatively, some registrars were perceived by other respondents to have a 
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preference for tighter control on medication ordering and so wrote their own orders, even though 
they had a JMO.   More typically however, registrars were perceived to delegate medication 
ordering or writing to junior medical officers:   
 
…it depends, some of the registrars do like to take quite a lot of control ... to be hands on, but 
others don’t, they like their resident to do most of it for them, and that just depends on the 
individual. Some of the registrars are very active and their signature you’ll see all through the 
ward and other times you just see the junior’s signature through the ward which is quite 
interesting.[Pharmacist 5] 
 
I think a lot of other registrars, I can't speak, I can speak for other registrars, but I think that a lot 
of others would probably just let the JMO do it. I think, fifty fifty…most people feel fairly relaxed if 
you’ve given a good verbal order to them over the bedside, then they’ll understand and write, 
write the drug. [Registrar 7 advanced trainee] 
 
3.3.2.4. Patient educator 
In general, the inference from registrars’ accounts was that patient education about medicines 
was not one of their core responsibilities, although they did recognise that it was important to 
patient adherence.  A number of registrars provided examples of problems with patients’ 
understanding of medications leading to poor adherence, but often these were proffered and 
interpreted by them as cases whereby patients had exercised their free will despite best efforts, 
rather than opportunities to reflect upon the quality of their own communication and education of 
the patient: 
 
Well you know, they’ll often go home and they’ll say, ’Oh when I started taking that drug, 
it really made me feel this or that’ and they’ll just stop taking it. Or they won’t see the 
necessity of taking aspirin after their heart attack - someone hasn’t explained it to them, 
so they’ll just stop taking it. Well, one woman went home after a transplant and stopped 
taking her prednisone because she ran out and she didn’t know that she was meant to 
keep taking it!  So, we have in the transplant department, we have a lot of education - as 
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you can imagine - so I don’t know how that one slipped through!.[ Registrar 4 advanced 
trainee] 
 
An exception to this was a registrar with an interest in clinical pharmacology whose role it was to 
review the pain management of patients in the Emergency Department, who appeared keenly 
sensitised to the importance of patient education about medicines, as well as patient 
involvement in making decisions about drug therapy: 
 
I have to look at things like, you know, an individual, whether their, you know, social 
circumstances are appropriate for them to have a lot of opiates on them so if they’re 
living on the street, if they have small children at home, you know, giving them advice 
on… storage, you know, ensuring that they understand why they’re getting the medicine, 
like the side effects they’re going to have and I guess empowering them to be involved in 
the prescribing decision-making process as well, not as a sort of legal cop out but as a 
sort of enhancing efficacy and compliance. [Registrar 8] 
 
3.3.3. JUNIOR DOCTOR 
3.3.3.1. Medication history taker 
A fundamental role of junior doctors in prescribing was perceived to be obtaining a medication 
history when patients were admitted.  As outlined earlier, consultants identified inherent 
difficulties associated with the task, as well as levelling some criticism at the diligence of JMOs 
in carrying it out.  Furthermore, there was divergence of perceptions from JMOs and 
pharmacists as to the typical methods junior doctors used to take a medication history: 
 
I guess on initial admission, I’d usually check and make sure that the patient's actually on 
the drugs they think they are.  I often call in the GP if the patient is confused, demented, 
things like that, check or look at their boxes.  Occasionally call the local pharmacist 
particularly if they’ve got a webster pack [JMO 6 PGY3 ] 
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So if I’m admitting a patient, I’m transcribing whatever drugs they are taking.  I’m 
ensuring that I am getting the correct dosages, the correct drugs and all that, so that 
often requires me to I check the packaging that they bring it in with, to call nursing homes 
to call GPs to make sure that all that's correct [JMO 4  PGY1] 
. 
Well, first of all, I think when a patient gets admitted through emergency, it would appear 
to me that the medication history taken by the admitting officer is taken from the previous 
discharge medication.  So, it may not necessarily reflect the patient’s true medications.  
So, very often I notice that they go in the notes and write it down from the discharge 
medication [Pharmacist 9 specialist clinical pharmacist] 
 
Some doctors will treat it as a very mundane task, writing up regular medications, and 
they don’t actually think about what they’re writing and why the patient came into 
hospital. They just write up, you know, duplications and so on. It’s not considered a high-
priority task I think.  [Pharmacist 1 specialist clinical pharmacist] 
 
As will be discussed later, there was a strong belief among the pharmacist cohort that they were 
more proficient in carrying out this activity than junior doctors, which may have some bearing on 
their opinion of JMOs’ practices.  
 
3.3.3.2. Prescription writer 
Junior doctors were universally perceived to be the principal writers of medication orders and 
discharge prescriptions within the hospitals.  Few of these written orders emanated from their 
own prescribing decisions, but involved transcribing prescribing instructions provided verbally by 
a senior colleague onto medication charts, or copying written medication orders from an old 
chart to a new one.  Transcribing was a contentious activity among junior doctors and some 
recent JMOs (registrars) for several reasons:   
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Responsibility.  There was confusion over the extent of responsibility attached to the activity.  
Did transcribing carry the same responsibility as making a prescribing decision for a patient or 
was it a lesser form of prescribing?  Was it the responsibility of the junior doctors to write down 
exactly what their registrar told them to prescribe, or was it their responsibility to check on the 
appropriateness of what they had been told before they put pen to paper? 
 
Well our role isn't to initiate medications, it's more often to rechart medications or it's to 
actually chart whatever my registrar or consultant or consulting team, registrar consultant 
has requested [JMO 8 PGY1] 
 
I feel quite secure knowing that someone who is more qualified than I am is making the 
decisions, and all I need to do is make sure that I’ve heard it correctly and carry it out 
appropriately…I don’t have that same risk as someone who is actually making the 
decision to start the medication I think [JMO 1 PGY1] 
 
I think the way is that whoever makes the decision is responsible for the prescribing.  So 
if I decide that this person is going to have 1.2, like I say to the resident 1.2 grams of 
penicillin qid okay IVI.  And [if] I am wrong, then I am wrong and then I am responsible if 
they write it down that way. [Registrar 2 advanced trainee] 
 
I think in terms of transcript, because often that's what the JMOs are doing, I think that's 
their responsibility, if writing something that they're not sure what it is, they should ask.  I 
think that it's the responsibility of whoever's writing the order [Registrar 7 advanced 
trainee] 
 
On the question of whether JMOs felt responsibility to check verbal orders, consistently the 
junior doctor cohort emphasised that their usual practice was to check with their registrar when 
they were uncertain of an order.  In addition, all mentioned using MIMS (an Australian drug 
compendium) and many also the Therapeutic Guidelines (an Australian series of guidelines on 
therapeutics) on their PDAs (personal digital assistants) to locate drug information when 
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needed.  All felt that they had good access to information about drugs through use of their PDAs 
or computers on the wards and none identified any problems with locating information at the 
teaching hospitals when they felt they needed it: 
 
I don’t like prescribing something - and I mean especially in this hospital -  I don’t like 
prescribing or writing something that I don’t... that I’m not very familiar with. I mean we’ve 
got very good access to computer-based MIMS and so it’s very easy to look up 
something and verify the dose.[JMO 9 PGY1] 
 
…most commonly I refer to my own medical knowledge, in terms of what medications are 
appropriate in what situations and I back that up with expert advice from registrars and 
consultants.  I also cross check that with MIMs in terms of two drugs that need to be 
prescribed and they might have an interaction I will always check that with the MIMs and 
make sure that there is nothing. I will look at what the contraindications are to prescribing 
the particular drug.  So, it’s kind of a combination of all three things. [JMO 4 PGY1] 
 
Therefore, in general, the cohort of junior doctors recognised the importance of verifying unclear 
medication orders and they were aware of ways to do this efficiently.  However, accounts from 
nurses and pharmacists suggest that in their experience, junior doctors encountered difficulties 
in routinely verifying orders: 
 
It’s no good saying “Well you should go and look that up”, they won’t, they can’t.  
Because while they’re going to look something up there’s about four other things being 
held up for them to do, and they’re constantly being interrupted.  So they don’t get a 
chance to sit down and absorb something properly.  [RN 1 Clinical Nurse Educator] 
 
Sometimes they [junior doctors] don't use the MIMS appropriately to check the dose, but 
you know, Flagyl TDS 400mg when they mean it to be intravenous, you know, it's 
500 mg.  So young doctors have a bit of problem initially at the beginning of the year, but 
after that, they improve.[RN 6] 
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Importance. The commonly used terms “transcribing” and “charting” (as opposed to prescription 
writing or prescribing) appeared to underscore an unspoken but widely held belief that it was 
essentially an administrative task.  At the same time, there was also a pervasive suggestion that 
it was menial and of little consequence in the big scheme of patient management: 
   
Well in cardiology, I don’t think the junior medical officers determine any prescribing.  It’s 
all determined per team….So basically they’re seen as if they’re the scribes. 
[Pharmacist 9 Specialist Clinical Pharmacist] 
 
I don’t think JMOs prescribe on day shifts other than transcribing medications particularly 
other than…I suppose on ward rounds I might say, ‘Would you write up this?’ and I’d tell 
them what the drug is and usually tell them the dose. [Consultant 2] 
 
Uhh, I guess I’m pretty important if I write out the med charts every week, but I guess I’m 
not really. I mean a lot of the time what’s written up doesn’t depend on what I...when I’m 
following instructions from the registrar or consultant [JMO 9 PGY1] 
 
According to the pharmacist cohort, the perception of transcribing being unimportant or a low 
workload priority was a contributing cause for transcribing errors made by junior doctors.  This 
was surmised from instances where verbal orders given by senior colleagues were not clearly 
understood by JMOs, who, according to the pharmacists, did not seek to verify the orders.  
Within these examples also lies the implicit suggestion that the senior colleagues did not 
routinely check to see whether their orders had been understood: 
 
…but some of the JMOs… they mis-hear the direction from the consultant or the registrar 
and, depending on their personality, they don’t want to keep asking and they think they 
should know, and they’re too busy to look it up and so they just think, “Oh I’ll just write 
that down. I’m sure they said that” and I’ll check later or something.[Pharmacist 1 
specialist clinical pharmacist] 
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Prescribing-wise,  I mean we’ve had, and this has occurred actually a few times… is 
when the patient was started on cyclosporin and they meant to be on cyclophosphamide 
And it is just…it’s clearly written as the wrong drug…I think when it did happen the last 
time, it was again written by a junior medical officer who heard, like been verbally given 
the order from someone senior to write the person up and I think probably in the 
busyness of it all they would be more familiar with cyclosporin and so they just wrote that 
up because it sounded like it and it was sort of hours later and they had done 15 things in 
between.[Pharmacist 5] 
 
Well they were anti-retrovirals and it was more to do with the dosing of someone who 
had never been on them before and they [the JMO] were told - as far as I was aware - 
they were told by the consultant to start them on a certain combination of treatment and 
they just wrote up the names of the drugs. But the doses weren’t particularly correct in 
any way shape or form and that’s where the uncertainty was admitted to later on, but it 
wasn’t actually seen to, actually confirmed what they really were meant to write. 
[Pharmacist 11 specialist clinical pharmacist] 
 
Weekly rewrite of medication charts. For the junior doctor cohort, the weekly re-prescription of 
medicines onto a new chart was often cited as the time most likely for them to make errors.  At 
one hospital, this was related, by a junior doctor, to recharting on overtime for patients he didn’t 
know.  At the other hospital, it was related by several JMOs to the onerousness of recharting all 
patients’ medications on the same day, which was the system in place at that hospital.  Because 
of these factors, several junior doctors cited problems with loosing concentration when 
transcribing:  
 
Even if the handwriting's alright, you're running from this choking person to that vomiting 
person and doing a med chart in between, you can spill something up pretty quickly … 
it's easy to put the wrong number in the wrong place, or a decimal point…I find it a 
problem.  Recharting on overtime can get dangerous, it's a dangerous way to do things 
generally. [JMO 8 PGY1] 
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Look errors happen even when you're sitting down and recharting, sitting down, nothing 
else to do, you can still sometimes do it.  I don't think you can eliminate errors entirely, 
but it's reduced by sitting down and not rushing round while you're doing it - doing five 
things at once. [JMO 6 PGY2] 
 
Several of the junior doctors described methods that they used for minimising the risk of errors, 
such as matching the number of medicines or aligning new and old charts.  In the accounts 
provided by JMOs, the aim of the weekly rechart was purely to transcribe the patient’s existing 
medicines as accurately as possible; none specifically mentioned using this time to critically 
review the patients’ medicines.  Although several pharmacists espoused what appeared to be an 
informal institutional creed that commencing a new medication chart was an opportunity for 
review of medications, the limited role of junior doctors in making independent prescribing 
decisions as reported in this study, would suggest that few would have felt that it was their role 
to do so.  This was corroborated by a pharmacist’s observation:  
 
I think they just re-write them.  I’ve probably met one or two, maybe two, residents who 
make changes on the re-write… how the patient is going so far… But on a whole, [for] 
most people it’s just an automatic rewrite, sometimes it’s not even re-written right. 
[Pharmacist 6] 
 
Discharge prescriptions. Junior doctors were perceived to have a pivotal role in ensuring that 
patients were discharged from the hospitals with an appropriate supply of medicines.  By all 
accounts, junior doctors were often placed under pressure to prescribe discharge medications 
within a short time frame:   
 
Time is another important thing, that the doctors are not given enough time to do things 
like writing medications, writing discharge prescriptions. I mean if you can’t do discharge 
prescriptions. They’re so often done so badly that the doctors are so pressurised, you 
know, to get the patients out that sometimes they write the discharge way too early and 
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then it’s not fixed before they change it and at other times they just write it way too late 
because they’re on ward round or doing theatre or whatever, and it is a major 
problem.[Pharmacist 1 specialist clinical pharmacist] 
 
Prescribing for patients being discharged from the hospital was seen by the pharmacist cohort to 
require not only accurate transcribing of medications from an inpatient chart to a discharge 
prescription and summary sheet, but also a systematic review to work out which medicines were 
needed following discharge.  This review of medications appeared to be one of the main 
opportunities for junior doctors to make prescribing decisions independently, yet this particular 
role was cited by only one of the junior doctors interviewed:  
 
Well, I’m an intern so basically… I’m the one who writes down in the hospital on the 
charts and then on discharge, I prescribe the discharge medications. I guess in a way my 
role too, because at discharge, would be just a review of the medications to make sure 
they those that need to be ceased are ceased and those that they need…sufficient 
supply for the next few days, so they’re provided what they need.[JMO 1 PGY1] 
 
The general lack of prominence placed by the junior doctors on this role may be associated with 
an attitude described by one registrar that many junior doctors don’t rate writing discharge 
medication summaries as a responsibility, and by implication discharge prescriptions (since they 
are written simultaneously or in tandem with the summary).  However, revealingly, she acquired 
greater respect for the process when asked as an intern to ring the GP for each patient being 
discharged and provide them with a verbal summary of medication changes: 
 
And I think the interns and residents don’t take responsibility for it [discharge summaries], 
when it’s just something they write down and then it gets put away somewhere in a file. 
You take responsibility for what you’re saying and doing, when you’re actually talking to 
someone [phoning the patient’s GP at time of discharge]. So it does actually make you 
learn. It makes you listen and take notice about what you’re doing for the patients. 
[Registrar 4 advanced trainee] 
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Consequences. Despite some ambiguity over responsibilities associated with the task, all the 
junior doctors interviewed expressed an awareness of the consequences to patients of making a 
mistake whilst charting medicines.  Some reflected that the challenge in transcribing was being 
able to sustain that awareness of risk.  Because transcribing was often done away from the 
bedside and because execution of the task was effortless, “writing down on the slip of paper”, 
then it was easy not to give much thought to the action.  For some, awareness of the dangers 
associated with making mistakes was so great that they devoted time at the beginning or the 
end of their working day, whilst their pager was turned off, to transcribe their patients’ charts for 
the week.  For others, the risks were rationalised by their reliance on nurses and pharmacists to 
detect any errors that they might make: 
 
I think a one-off because I tend to, because we have to write the medication on Tuesday, 
so I always take my time on medications. I always leave it to the end of the day, so 
nobody will page me or anything like that. I just do all my medications on Tuesday 
afternoon, at the end of the day because...I know when I, when we do it during the 
daytime you rush; you always tend to miss out things. I think when writing the 
medication, when we write it we should actually sit down and think, and so that’s the way 
I try to do it. [JMO 3 PGY1] 
 
I've mentioned before about the service [pharmacy] we have here, and it's a very good 
service, particularly because they pick up when you do do transcribing errors, which 
happens not infrequently. [JMO 6 PGY 2] 
 
This sense of assurance among doctors that prescribing errors will be picked up was a common 
thread in accounts from pharmacists and nurses: 
 
Well I often feel that the doctors don’t really appreciate the sort of power that they’ve got 
with prescribing, because there are a lot of circumstances where you see things that are 
prescribed inappropriately or incorrect dosages. They’re usually fairly blasé about it in 
that they probably think that it will be picked up somewhere along the line if it’s…you 
know, when you mention it to them it’s a case of, “Oh okay that’s fine. I’ll change it.” It 
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doesn’t seem to always come across as the amount of power they’ve got actually in their 
prescribing. [Pharmacist 2] 
 
I don’t really think that much about them [dosage omissions on medication orders] cause 
they are routine I think, yeah, and I sort of think, “ Oh, everyone’s busy”, “Slack and 
hopeless, but everyone’s busy”.  So, yeah, you can’t - and I think they’re not as 
dangerous I don’t think because none of them is going to - oh - no nurse is going to say, 
“Oh, I’m going to make that QID” and “Oh, I’m going to make that eighty milligrams.” 
They will ask, so I suppose it’s a less sort of an evil than if the frequency is incorrect or 
the dose is incorrect because that may be many days before it’s picked up.[RN 7] 
 
Pressures.  There was also the issue of being asked to “chart” medications for patients they 
didn’t know and hadn’t assessed, which in some instances was related to the weekly rewrite of 
charts and at other times related to pressure placed by other medical and also nursing staff.  
This practice was widely understood by all respondents as being undesirable and dangerous, 
yet anecdotes revealed that it was not an uncommon event within hospitals where they had 
worked.  Examples provided by doctors conveyed the suggestion that the staff placing pressure 
on the JMO did not feel they were requesting any great burden of responsibility, again harking 
back to an underlying assumption that rewriting charts was an administrative task: 
 
Because often times the drugs will be written up by people who don’t have as much 
knowledge as we would like. The interns are often re-writing drug charts and they’re 
writing up medications that they’ve never heard of, you know, copying from writing that 
they can’t read and they’ll put the wrong spelling or the wrong name or the wrong dose.. 
[Registrar 4 advanced trainee] 
 
For example as I remember as a junior doctor I got into trouble because the nurse said 
“Oh the patient is on atenolol not metoprolol” and they showed me the tablet and 
obviously it was atenolol and I saw it was metoprolol on the chart so I crossed out 
metoprolol and wrote atenolol.  And the next minute I got myself in a whole lot of trouble, 
because the cardiology registrar wanted them on metoprolol. I really didn’t understand 
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the situation… but often we don’t think, I’m actually doing anything in that situation, I am 
not actually prescribing I am just actually charting, you know, but in fact that medication 
is active and the situation may not be appropriate for that patient to go back on that 
medication [Registrar 2 advanced trainee]  
 
While I was an intern, I was an intern in [country town] and initially I had to write some 
chemotherapy drug for a patient coming in for chemotherapy and I didn't know anything 
about the drug, I just felt very uncomfortable about that and finally we actually got the 
consultant to do it, the registrar made the decision. [JMO 2 PGY3] 
 
3.3.3.3. Communicator of prescribing decisions 
The role of junior doctors in verbally communicating prescribing decisions to nursing staff was 
inferred from general comments by a number of respondents about patterns of communication: 
 
…if we start a new medication we normally let them [the nurses] know because if you let 
them know… it will get to the patient faster.  Otherwise, if you wait until they find it on the 
drug chart, there might be quite a bit of delay… if it's a stat dose order you need to let 
them know otherwise it probably won't be given. [JMO 2 PGY 3] 
 
However, a number of nurses felt that verbal communication from junior doctors was sometimes 
inadequate:   
…often we don’t get told and then it’s after hours, you notice the medication is ordered 
and you can’t get it.  Oh, it’s very poor and it can be adverse because if the patient 
misses out on the medication when they should get it.  So, in that way, it’s not good for 
the health of the patient.  I have to say doctors are just as busy as nurses though and it’s 
hard to find someone to tell, but it’s probably something that needs to have someone 
found and said, “New drug here”. You know? [RN 7] 
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3.3.3.4. Decision-maker for symptom control and minor complaints  
Junior doctors and particularly interns were perceived by all as making few independent 
prescribing decisions.  The circumstances where they were called upon to prescribe using their 
own initiative were described by respondents as:  
 
• management of pain, nausea, and bowel dysfunction 
• management of intravenous fluids 
• the treatment of minor complaints; eg, itchy skin, insomnia 
• treatment of electrolyte imbalances or mineral deficiencies; eg, potassium, iron 
• empiric treatment of some infections; ie, antibiotic prescribing for urinary tract infection 
• treatment of infections based on culture sensitivity reports 
 
This level of prescribing responsibility was widely accepted by all the doctor groups interviewed 
as being part of the medical apprenticeship and was an appropriate starting point for a steady 
progression in prescribing responsibility; although, as indicated previously, some concern was 
voiced by a number of junior doctors about their competency to prescribe opioid analgesics from 
the first day of internship:     
 
I suppose the things that interns get in their first few months, have to face is, is the 
prescribing of opium analgesics, antiemetics, intravenous fluids, sedation, maybe 
antibiotics.[Consultant 2]  
 
If the patient's constipated, then the junior doctor will take care of that and the consultant 
may never hear about it… If there is some intercurrent problem, the patient gets an 
infection, it’s urinary tract, it’s simple and straightforward then the intern may well be 
taking responsibility for that prescribing.  I think the system works in that way reasonably 
well, the doctors prescribe according to their level of experience or expertise.  
[Consultant 7] 
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I might suggest something or ask about something, but not so much decide. The only 
thing I would decide about would be probably on overtime shifts - little decisions about, 
you know, I don’t know, starting antibiotics for someone, but even then I’d really talk to a 
registrar.  Maybe aperients or something like Coloxyl and Sennaxxiv or something like 
that.  Pain medications, morphine and sleeping tablets…. Yeah, I think it’s appropriate 
the consultant should be making most of the decisions or the registrar, and I shouldn’t be 
making too many treatment-related decisions. [JMO 9 PGY1]  
 
Junior doctors were also perceived to initiate a greater range and make more consequential 
prescribing decisions when they were on after-hours shifts or when they were on surgical or 
obstetric and gynaecology rotations.  This was because in these situations, they received less 
on-hand registrar support than during work-day medical shifts: 
 
[On who makes the majority of prescribing decisions in his surgical team] In a lot of ways 
me, I think it is hard to say because it is quite varied, um there's certain things that each 
consultants wants for every patients.  Each patient gets a certain type of procedure done 
and they get a certain type of therapeutic regimen after their procedure. [JMO 4 PGY1] 
 
I think most of the medical chart issues that come up, once they're [the patients] 
postnatal, goes with the resident.  If there's a medication, they need something for break 
through pain, they'll speak to the resident on the ward, usually, rather than us. [Registrar 
6 advanced trainee] 
 
Furthermore, it was apparent that junior doctors in their second and third years of residency 
prescribed a greater range of medicines than interns and were more directly involved in 
prescribing decisions: 
 
If it's something very simple - if it's just, say, Slow-K xxv or just an electrolyte thing, you 
know, probably the resident would make the decision because if the potassium is low 
they need to have more.  That's the resident's decision and then for some anti-
                                               
xxiv
 Tradename for docusate sodium and senna 
xxv
 Tradename for potassium chloride 
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hypertensives, you need to change those if … their blood pressure is going up and 
increase the dose.  If they have hypotension you need to decrease the dose.  So it's 
pretty much - sometimes you know it happens between the resident and the registrar and 
during the ward round…[JMO 2 PGY 3] 
 
3.3.3.5. Trainee prescriber 
Consistent with observation that junior doctors made a limited range of prescribing decisions, 
was the belief that their role was essentially about learning.  Junior doctors were posted at the 
teaching hospitals for the purpose of developing and honing core clinical skills, one of which was 
prescribing:  
 
They do know when someone should have a drug in general, but - and that is their role - 
but I suppose their role is to learn as well.  If they have something that they’re a little bit 
unsure about or someone, a senior nurse or anyone is saying, “This isn’t right”, their role 
is to find out. [Registered Nurse 7] 
 
So, what prescribing skills did they arrive with and what did they learn about prescribing during 
their apprenticeship? 
 
Undergraduate training. There was a range of opinion among the junior doctor cohort as to 
whether their undergraduate training in prescribing prepared them for internship.  Most thought 
that they had sufficient orientation to the legal requirements and practicalities of prescription 
writing.  Graduates from both University of Sydney and University of NSW cited experience in 
writing medication orders on hospital charts prior to internship.  Also, most of the JMOs 
mentioned orientation sessions on prescription writing that they had received from pharmacists 
at the start of their intern year.   
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Divergence of opinion existed on the issue of drug and therapeutics knowledge.  Whilst there 
was general consensus that a sound knowledge base was essential for good prescribing 
practice, there were three broad categories of opinion on the adequacy of knowledge acquired 
from university training.  One group believed that their knowledge was sufficient for the type of 
limited prescribing required of interns.  Another group thought that their knowledge was 
inadequate, but was as good as could be expected.  They based this belief on the difficulty they 
perceived in retaining a useful level of detail from university training and their perception that this 
knowledge was best gained on the job. The third group were more critical of their undergraduate 
training and identified specific gaps, such as applying knowledge to complex cases and 
knowledge of the most clinically relevant drugs within a class.  Four of the interns interviewed 
were graduates of the same university (University of Sydney), and this range of opinion was 
evident even in this subgroup, all of whom underwent an 8 week pre-internship at the end of 
their final year of university (Figure 14).   
 
One of the graduates from UNSW commented on his use of the educational prescribing modules 
developed by the NPS during his last year of medical school.  He felt that the patient scenarios 
were too simple and not typical of the clinical situations he encountered at the teaching hospital, 
where patients tended to be on more complex drug regimens.  Although the modules provided 
alerts on drug interactions, he found that in practice, decisions were commonly made to keep 
patients on potentially interacting drugs because the overall benefits of the drug combinations 
were perceived to outweigh the risks.   
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Figure 14. Preparedness for intern prescribing responsibilities 
 
As a student, you learn in the textbooks, that's the thing, and then we do lots of practice while 
we were students in the last year in the hospital… we would write it and then the doctor would 
actually sign it so we co signed it… I think that was very helpful. In the last year were basically 
working as an intern so you just don't have the prescribing right , you need a co signature but I 
think it is very, very useful, so that when you actually work, you have more confidence because 
you’ve done it before. [JMO 2 PGY 3] 
 
I mean we were taught the general things about prescribing, how you consider the dose, 
consider the renal function, consider the liver function, the weight, and you know. But things like 
gentamicin prescribing, when you start out as an intern, you've got no idea and it's not 
something that's ever mentioned at uni… I don't know if it necessarily would improve matters if 
you were taught at uni that sort of thing.  I don't know if you'd remember. [JMO 6 PGY 2] 
 
To write in the boxes, that was fine. I could do that without any problems. To choose what drug 
to give, not very good at all.  I knew I had gone through the drugs and I knew what classes of 
drugs there were.  I guess the other big difference between university pharmacology and real 
prescribing pharmacology is that you’re taught every single drug in every class, or... well you’re 
taught a lot of drugs in every class, but when you get to hospital, they only use one or two of 
them in every class for whatever reason… So you don't actually need to know all of them…so 
you find yourself swimming in all these drugs you vaguely remember, not being able to get 
focussed. [JMO 8 PGY 1] 
 
Probably in terms of knowledge, not particularly prepared, I mean I enjoyed medical school, but I 
really found the learning curve once we started working was really extremely steep… It almost 
seemed that what we learned in medical school didn't seem to apply in the practical world, the 
real world.  That people never present as textbook problems and so there aren't really textbook 
solutions to what patients are presenting with, so I just think that when you really started working 
things seemed to change a lot.  We just stepped out of medical school and we were sorely 
deluded once we got into it.[JMO 4 PGY 1] 
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Despite differences in satisfaction with undergraduate training, the junior doctor cohort broadly 
agreed that their internship was when they actually learnt to prescribe, when they signed 
medication orders for real patients, and when they were active participants in prescribing. 
 
These views generally accorded with the perceptions of experienced prescribers in the other 
doctor cohorts who, like the nurse and pharmacist cohorts, did not have particularly high 
expectations of interns’ prescribing competency at the start of internship.  Some of the 
pharmacists had a variance in opinion to that of the junior doctor cohort regarding familiarity with 
the practical aspects of prescribing, and did not think that new interns had a good understanding 
of medication ordering skills.  Their expectations of new interns in this respect were therefore 
also low:   
 
I know they have none. So I wouldn’t expect them to have more than they do. I guess 
because I have done a lot of the intern education and things and what we do in those 
sessions we give them a whole load of scripts and line up scenarios and ask them to you 
know what would you prescribe, what would you do? And the first few times I did it I was 
absolutely aghast… because they really… have no idea of even the legal aspects of 
writing S8 scripts, let alone the selection of drugs, just the very how you write up a drug 
on a drug chart and that you have to sign your prescription. Little things like that, they 
really don’t know. [Pharmacist 5] 
 
[On expectations of prescribing skills of new interns]…well one small thing that they write 
clearly on the chart. That they actually put their name and their pager number, so that’s 
somewhere on the chart, so they’re contactable [Pharmacist 4] 
 
Nevertheless, respondents from the various cohorts cited a range of skills, which they 
considered were desirable for interns to have from day one of work.  A collation of these is 
presented in Figure 15: 
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Figure 15. Important knowledge, skills and attitudes for interns starting to prescribe 
• Basic drug knowledge of major drug groups, common side effects and common 
interactions 
• Basic therapeutics knowledge, such as treatment options for common clinical conditions 
• How to apply patient knowledge, such as why drug doses require modification in certain 
populations, what other drugs the patient is taking, allergies 
• Prescription writing skills, particularly legible handwriting, familiarity with legal 
requirements of prescribing, familiarity of medication charts, use of generic drug names. 
• Understanding of professional responsibility, such as communicating the purpose of the 
medicine to a patient. 
• Safe prescribing practices, such as not prescribing a drug if you don’t know how it works, 
being careful 
• Self-criticism and awareness of knowledge limitations 
• Readiness to ask if uncertain 
• Knowledge of how and where to access drug information 
• Willingness to work as part of a multidisciplinary team 
• Competency in taking a medication history 
• Knowledge of medicines management systems 
• Communication skills 
 
Of these skills, the salient piece of advice to new interns was to ask, ask, ask!  This mantra was 
widely acknowledged as the most useful and safest attitude for junior doctors to adopt. 
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3.3.4. PHARMACIST 
3.3.4.1. Checker of prescribing decisions and written orders  
The primary responsibility of the pharmacist in prescribing at the teaching hospitals was widely 
seen as “picking up” errors and potential drug interactions by reviewing medication charts.   
However, there were differences in understanding of how far this role extended.  In general, 
doctors and most nurses viewed this role purely in terms of preventing adverse effects, a safety 
net; whereas pharmacists also saw their role as a review on appropriateness (or suitability) of 
prescribing (Figure 16).  In this regard (and also for the purpose of detecting drug interactions), 
pharmacists perceived that their unique responsibility was to review the entire medication list for 
each patient, contrasting their practice with that of doctors, whom they felt focused only on 
medications related to the patient’s admission:    
 
I think it comes down to, I suppose, the pharmacist who directs it all, because we put it all 
together. Cause very often we find that the consultants come along three days later and 
they'll say "I didn't know that so and so was on this" or “They don’t need to be on that, 
stop that.”… [or] “How come they're not having it now?” I think it's really the pharmacist 
who has a handle on all those changes.  [Pharmacist 7 specialist clinical pharmacist] 
 
The pharmacists’ review of appropriateness also incorporated a check on compliance of 
prescribing decisions with hospital policies, such as the hospital formulary and antibiotic policies.  
This role was perceived negatively by some pharmacists, who felt they were policing the actions 
of doctors:  
 
I had a case yesterday of someone with pneumonia and…they’d prescribed ciproxxvi, 
Keflexxxvii and Rulidexxviii  and I was like, “Why the three or why the Ciproxin?xxix” to the 
                                               
xxvi
 Colloquial for ciprofloxacain 
xxvii
 Tradename for cephalexin 
xxviii
 Tradename for roxithromycin 
xxix
 Tradename for ciprofloxacin 
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registrar, “My consultant said so”, and I thought well with cipro you need to get micro 
approval and all this.  And the consultant came round and I wrote [had written] in the 
notes [about needing micro approval].  And he’d ceased the Keflex and kept the cipro 
because he thought it was better and then you have to explain to him that it’s micro and 
sometimes you feel that you’re just policing them the whole time.  You comment about 
the antibiotics and they all raise their eyebrows [Pharmacist 10] 
 
Malcontent with this regulatory role was also expressed by one of the registrars, whose only 
knowledge of pharmacy activities was related to notifications about drug use policies: 
 
All I know is that we've got nasty letters from pharmacists saying that we're writing up 
PRN medications, don't put a range in the box, as opposed to say 10 or 20 mgs of 
temazepam.  You've got to write either 10 or 20 and that's the only feedback I think we've 
had.  And signing the nurse-initiated medications.  And that’s about the only feedback 
we've had on our medical charts. [Registrar 6 advanced trainee] 
 
This view of the pharmacist’s role, however, was the exception and overall medical and nursing 
respondents expressed appreciation for the chart reviewer role of pharmacists: 
 
I've been pleasantly impressed by the high level of input that you get from the pharmacy, 
from the ward department pharmacist, and also the renal pharmacist also has a lot of 
input, you know I’ll frequently be charting things and he’ll then approach me and say, “Do 
you realise the dose that you've prescribed is for a patient with renal impairment, who 
therefor needs dose adjustment or do you realise that these two drugs interact?  High 
level checks and balances in place. [JMO 7 PGY 1] 
 
However, there were important resource limitations to the role of pharmacists as “catch alls”: 
 
Well I think they [doctors] are quite reliant and I think that’s okay, so long as, you know, 
there’s a pharmacist always around.  And in terms of staffing and… lack of staffing, it’s 
not always the case… I mean we only work Monday to Friday and a tiny bit on Saturday 
and then you come in on Monday and the things that have gone over the weekend, it’s 
just horrendous. I mean it really is. [Pharmacist 1 specialist clinical pharmacist] 
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Figure 16. Perspectives on pharmacists as checkers  
Well first of all…of course that they’re getting the right medication that’s been ordered in the first 
place, so a supply role basically.  And that obviously it’s safe for the patient that’s getting it, so 
various concerns there regarding dosage and interactions and general safety for that particular 
patient, you know, renal function or liver function for example. But then I suppose there’s the 
other side of whether it’s actually appropriate for the condition that it’s being used for. 
[Pharmacist 2] 
 
So you read the chart, make sure that all the orders are all legal, all appropriate to the patient in 
the terms of what their current diagnosis is, their diseases or conditions, make sure that the 
doses are all appropriate, and then annotate the chart so that to help ensure that nursing staff or 
any other staff involved with the medications to help ensure that the patient receives the right 
drug at the right time, in the right form. [Pharmacist 6] 
 
The pharmacist does a regular review of patients’ medications, and identified three drugs with 
anti-cholinergic action and predicted that if this wasn’t critically reviewed the patient was at risk 
of certain problems, urinary dysfunction and before I had a chance to put into effect the 
changes, that person had urinary dysfunction and required catherisation… so it just illustrates 
the potentially very important role of the critical appraisal, especially the multiple drug that so 
many of the patients are on, so I’m a huge believer of that. [Consultant 6] 
 
Pharmacists are certainly influential but not in terms of what should be initiated I don’t think, as 
much as just reviewing the medications…the interactions or the problems or ‘Is it actually 
necessary?’ You know, I have a good relationship with our ward pharmacist. We both believe in 
stopping medication so if she asks for that, I tend to scratch things out…[Consultant 5] 
 
I see them as…  a catch-fall…. I guess they’ve got time to look at the chart in a lot more detail, 
and they'd probably remember a few more interactions and they’re able to plug things into the 
computer...I think that they're a safety net. [Registrar 7 advanced trainee] 
 
If the pharmacy did have an influence, I don't think it would be to commence a drug as maybe to 
change one, so the side effect wouldn't be as severe as what they might be on now.[RN 5 
Clinical Nurse Consultant] 
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3.3.4.2. Medication history taker 
The pharmacist cohort also viewed obtaining a medication history from patients as one of their 
most important roles in effecting prescribing decisions.  This contribution of pharmacists was 
acknowledged by a few registrars (one a former pharmacist) and one nurse; however, 
recognition of this role was not widespread and was not evoked by any junior doctors or 
consultants who were interviewed: 
 
Well basically I see my role as really doing a medication history and essentially checking 
what history has been obtained by often a variety of prescribers. Sometimes it’s just 
the… accident and emergency doctor, and sometimes it’s the haematology RMO, who, 
you know, admits the patient and frequently they just miss things or get it wrong and the 
patient forgets to tell them things. So, you know, I would want to basically do a 
medication history on every patient, when I first see them preferably.[Pharmacist 1 
specialist clinical pharmacist] 
 
There’s been a couple of cases recently, in one of the geriatrics and the drug was always 
“BD xxx” and I couldn’t find any evidence.  I spoke to the registrar and they don’t know 
why they’ve got it, just because their GP is doing it, so now I’m going to contact the drug 
company and say “Well have you got any information on it?” and things like that. 
[Pharmacist 10] 
 
If I see the patient in emergency, checking thoroughly that their drugs are the right ones 
that their on.  To be honest, I probably get a bit slack sometimes, if they’re on the ward 
and it’s already been done and that's with [name of pharmacist] checking - I rely on the 
pharmacist a bit for that, because I know that they do it. [Registrar 5] 
 
As mentioned previously, pharmacists felt that they had a particular expertise in performing this 
function and that they performed it more competently than junior doctors.  One pharmacist 
described how she was involved in developing a tool to assist pharmacists in taking accurate 
histories; however, she admitted that she had not attempted to share this resource with junior 
                                               
xxx
 BD abbreviation for “bis in die” (Latin) meaning twice daily 
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doctors.  Her belief, and that of some other pharmacists, was that this activity was peripheral to 
junior doctor’s responsibilities, and therefore pharmacists were better placed to perform it: 
 
I don’t think medication history taking is top of the list of priorities.  I don’t think it’s a 
major priority for them.  I suspect they’ve got time restraints.  I mean, and the time 
restraints are getting the bloods done, making sure that the physiology is okay, 
potassium levels, sodium levels, whatever they are.  Seem very good at monitoring 
things like that... And prescribing what they think they [patient] need then, not what 
they’ve been having. [Pharmacist 9 specialist clinical pharmacist]  
 
3.3.4.3. Drug Information/ Knowledge source 
 
Respondents’ accounts highlighted four core areas in which pharmacists’ knowledge about 
medicines was sought or proffered to shape prescribing decisions: dosage adjustments in 
special populations (eg, in renal impairment, and the elderly); drug interactions; drug 
administration (eg, compatibility of intravenous fluids); and drug availability.  As indicated 
previously, there appeared to be limited opportunity for pharmacists to provide this information in 
a collaborative way at the time when prescribing decisions were made.  According to 
respondents’, this largely related to logistical difficulty for them to attend ward rounds as well as 
fulfil their other responsibilities.  Pharmacists saw that their main chance to be proactively 
involved in prescribing decisions was at ward meetings, which a number mentioned attending.  
However, there were indications that whilst attendance at these meetings involved multiple 
disciplines, decisions were lead by the medical attendees.  Furthermore, the focus of the 
meetings was more about explaining treatment plans and reviewing treatment decisions, rather 
than initiating treatment: 
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When - after the initial management plan then we have - I have ward rounds and also 
multi-discipline meetings, which I attend, where patients will be discussed with nursing or 
with other allied health and then based on their reports I may modify the medications 
according to what they’ve reported to me. [Consultant 1] 
 
… we have a meeting once every week … we might get the registrar coming in or the 
RMO and they will speak about each patient so you’ve got a clear understanding of 
background with that patient, then also because they’re there at that time you can check 
and say, “Well, what were you thinking about doing this?” or [something] about the 
medication, you don’t go into too much detail because there’s other people there as 
well…[Pharmacist 10] 
 
Otherwise, input of pharmacists into primary decisions relied on whether doctors chose to 
contact them.  This was felt to depend upon the level of rapport established by the pharmacist.  
The overall impression from both doctors and pharmacists was that more typically, pharmacists 
provided drug information as part of their medication review, and so their influence was more to 
modify or revise prescribing decisions than to be involved in core decisions (Figure 17). 
3.3.4.4. Treatment advisor 
The pharmacist cohort felt that they had a minor role in providing treatment advice or 
suggestions.  The circumstances where this was most common were when: they identified 
potential drug interactions and would provide alternatives; were familiar with particular protocols 
or treatment guidelines for a therapeutic area; or were asked for advice on treatments for minor 
ailments.  This role was evoked by some of the medical respondents as well: 
 
Sometimes in haematology, [the pharmacist], she was great at saying or often a patient 
with this picture is normally on this, have you considered that?  So she’d often suggest or 
say why isn’t this patient on this or she'd pick up interactions and saying, they shouldn't 
be on that.  I think from that there is a role there.  Probably more so any interactions 
they'd missed.[JMO 5 PGY3 ] 
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Figure 17. Drug information provided by pharmacists  
The other thing that I would talk to the doctors about is availability. If they say, “I want to switch 
Mr Bloggs from cyclosporin to tacrolimus” well then I’m immediately thinking, “Well hang on you 
can’t because it’s not on Section 100 and you have to get permission from the committee and 
how am I going to get an ongoing supply?”[Pharmacist 1 specialist clinical pharmacist] 
 
And then on one of the wards I am on at the moment I tend to link up with their ward rounds so 
that I am actually there when they are prescribing which is always useful. So that you can 
actually be there at the point of prescribing and that I guess you have a little bit more influence in 
being able to steer them towards something that we have rather than a drug that we don’t have 
… things like that. [Pharmacist 5] 
 
I mean pharmacists sometimes they say, ‘Oh look, this has a reaction with the other one.  Are 
you sure you want to do this?’  Sometimes we change it. You might forget that they're on 
sertraline and you give them tramadol, and they'll sort of say, ‘Hang on a minute’, and so you 
change it and that's, that can be quite useful. [JMO 6 PGY 2] 
 
And often times, especially in the transplant population, they’ll have renal impairment and so 
we’ll write down a dose and then [the pharmacist] will call up and say ‘Actually I figured out the 
creatinine clearance and they should be on this dose.’ So often times, not so much what 
medication you put them on, but the dosage, or those sorts of things - the pharmacist has a 
large role to play.[Registrar 4 advanced trainee] 
 
I don’t know that they make a prescribing decision in saying, ‘Use this drug’, like up front when 
the person’s in A and E or something, but you ‘re relying on them to come around and look at 
the charts after they’re written up and ring and say, ‘You used that drug, maybe you should have 
used this one’ or ‘Did you know that this one’s interacting with that one?’[Consultant 5] 
 
 
3.3.4.5. Educator and trainer of new prescribers 
The prevailing view among the pharmacist cohort was that they had a strong influence on the 
way in which junior doctors learnt to prescribe.  Whilst a few of the pharmacists had run formal 
 143 
education sessions on prescribing skills for interns, their greater impact was perceived to be 
from the individual feedback they provided to junior doctors on their prescribing practices.  This 
feedback was inherent to the advice pharmacists gave to junior doctors to modify medication 
orders due to errors or inappropriate prescribing.  Some pharmacists therefore saw their 
responsibility to train junior doctors as a side benefit of their responsibility to ensure safe 
prescribing and quality of patient care.  Others perceived the responsibility to be part of working 
in a teaching hospital or part of sharing knowledge and expertise within a healthcare team.  
There was general consensus among the pharmacists that their greatest influence was in the 
legal aspects of prescribing, but several other influences were cited, such as raising awareness 
of guidelines and policies, drug interactions, and the value of comprehensively reviewing a 
patient’s medication: 
 
…the responsibility [to train junior doctors in prescribing] is there for me but it’s usually 
triggered by an incident or something that, where the prescribing is inappropriate and 
then you have to intervene.  And when that happens, we’re all, we’re all human. And I 
guess that’s more where the trigger is, but it’s definitely a responsibility [Pharmacist 11 
specialist clinical pharmacist] 
 
I think you [pharmacists] have a big influence actually. In terms of probably, I mean their 
drug selection coming from often their medical team…, but in terms of legalities of 
prescribing, and like even getting them to be a bit more aware of interactions and things 
like that, rather than just looking at what they’re prescribing. I think your feedback to them 
as they’re learning to prescribe can be pretty valuable. You know, and I think that’s 
something that we do relatively well now, but that’s more the reason for feeding back the 
errors, which you know interacted with something that was up here on another chart and 
just getting them into the habit of looking at everything, like the patient as a whole, rather 
than looking at each drug prescription as a separate identity that doesn’t impact anything 
else. So I think, yeah, you do, you can sort of develop good habits in them particularly in 
the first year. [Pharmacist 5] 
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The junior doctor cohort predominately believed that pharmacists had a role in teaching them 
the practicalities of prescribing, such as legalities and prescription writing.  Some viewed this as 
an indirect role of pharmacists.  They did not perceive a role for pharmacists in teaching them 
what to prescribe or how to select drugs, which they felt were the responsibilities of their 
registrars and consultants: 
 
…in terms of prescribing as in actually what to fill out on the chart, [pharmacist’s name], 
the pharmacist …she was the first one that I worked with in the ward and I just found that 
she was really the person that hammered into us how, even just the little things like what 
different symbols mean and you sort of don't pay attention to that…Yeah I think she 
made a big difference in knowing how to prescribe and knowing the little tricks almost to 
prescribing. [JMO 4 PGY 1] 
 
3.3.4.6. Educator of patients 
Education of patients was not a role in prescribing that was strongly evoked by pharmacists 
themselves.  However, accounts from other respondents suggested that this was an important 
and valued role of pharmacists.  The reason why it was not strongly conveyed by the pharmacist 
cohort may have been because it was viewed as a separate medicines management 
responsibility; ie, patient education was not part of prescribing: 
 
…if there are lots of changes to the patient’s normal medications then they need some 
counselling to go through that, you don't want to just send them home with all these new 
meds without knowing what the hell they’re using them for. [Pharmacist 8] 
 
I have a superb relationship with the ward pharmacist at [a smaller public hospital], 
where she is part of the medical team.  Every patient gets a pharmacy review on 
admission and the discharge.  They do a pharmacy discharge summary, which looks at 
which medications were discontinued and why, which ones were initiated and why and 
this is then fed back to the GP or the team. [Consutant 7] 
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3.3.5. NURSES 
3.3.5.1. Medication chart reviewer 
Nurses felt that one of their main roles in prescribing was checking the legality of medication 
orders through their scrutiny of medication charts.  In particular, they described reviewing the 
legibility of the order, dosing, allergy history relevant to what was prescribed, availability of the 
drug, and in some cases, the appropriateness of treatment selection or whether what they heard 
on ward rounds was correctly prescribed.  Their primary focus in performing this task was on 
patient safety, and they liked to review the chart well before medications were due to be 
administered so that any unclear orders could be amended: 
 
I do a lot of medications for patients on the afternoon shift…and before five o'clock, we 
have to check all our medication charts: one, to see all the prescriptions are followed 
through, our doctors do walk in and order medications without telling anyone else, so we 
pick it up as we check the charts and then order it from pharmacy.  Because I've worked 
in nursing for a long time, I pick up whether the dosage is right or wrong, much quicker 
than the new nurses. [RN 6] 
 
3.3.5.2. Treatment advisor 
Many of the nurse respondents felt they had an influential role in making treatment suggestions 
most typically based upon their assessment of the patient’s symptoms.  Their most common 
suggestions were perceived to be for analgesics, bowel preparations, antiemetics, and 
intravenous fluids.  However, in some specialised areas, their suggestions related to standard or 
common regimens of medicines given for a particular condition, where was described as 
“pointing them in the right direction” or “drawing their attention to it”.   For example, a nurse 
working in a neurology ward prompted doctors to prescribe statins and ACE inhibitors for stroke 
patients; and the nurse working in the psychiatric unit provided doctors with suggestions for “prn” 
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antipsychotics. There was variation in how the nurses obtained the information to support their 
suggestion: some based their advice on established protocols or guidelines, whereas others 
based it on their experience of working in the area: 
 
Because well, there was one, like Bactrim xxxi, I said, ‘Well I’ve seen say like, two 
ampoules given or three ampoules’ and the doctor said, ‘Well I’d better look to see,’ you 
know, so he looked it up - he was making an assessment on the infection and the degree 
[severity of infection], so it wasn’t really my call, but I just put him in the right position to 
be able to make that decision… [RN 2] 
 
I believe my role is very much advice to, particularly to junior medical staff and also 
consultation with senior medical staff as in discussion on, for example, what do you think 
would be the best pain management strategy for this person. I’ll give you an example… a 
junior anaesthetic registrar on an acute pain round was going to prescribe a patient's 
PRN MS Contin and I said perhaps you might like to use an immediate release 
preparation rather than a sustained release preparation.  So advising on what would be 
the best course of action.  [RN 4 Clinical Nurse Consultant] 
3.3.5.3. Patient knowledge source 
Several of the nurses also mentioned their role in providing doctors with information on the 
patient’s condition, which acted as a trigger for doctors to assess patients and therefore, 
commonly make prescribing decisions. 
 
I mean I can only as a nurse, it’s not for me to diagnose, I feel.  If I’ve identified - if I’m not 
happy - I have made an assessment of the patient,  who is not nursing well, I’m not 
happy and they have all those signs that make me feel unhappy with them… I just feel 
it’s my role to at least alert the doctors and it’s up to them. [RN 2] 
 
Nurses were not generally viewed by any of the doctors as having a major role in prescribing 
(although nurses working in private hospitals were seen to have a greater role because they 
                                               
xxxi
 Tradename for sulphamethoxazole and trimethoprim 
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assumed some of the duties taken on by JMOs in the public hospital).  However, the role of 
providing intimate knowledge of the patient’s condition was acknowledged: 
 
For example, if the nursing staff tell me that a patient can’t swallow any more, then I 
would direct the registrar… that the patient’s routes of administration be changed to the 
subcutaneous route. [Consultant 1] 
 
And the nurse in the bedside to tell us how, what the patient’s like.  Part of - makes part 
of that clinical picture…So I always ask the nurse before I go, “How are they going?” 
Yeah I do take their comments onboard. [Consultant 8] 
 
3.3.5.4. Trainer of new prescribers 
In general, the nurse cohort did not perceive that they had an official role in teaching junior 
doctors to prescribe, but recognised that they had a responsibility to ensure safe prescribing 
practices and therefore provide advice when appropriate and feedback when doctors made 
errors.  The type of influence they felt they had varied from offering advice on how to write up 
medicines correctly to giving assistance with prescribing fluids and PRN medications: 
 
They ask us more about intravenous fluids for example, what should I prescribe 
someone that needs IV therapy?  What do you think I should prescribe, over how long?  
They're not used to that for example PRN medications, we often, they might not know 
which is the better antiemetic or the best pain relief for a person and they'll often ask for 
a nurse's opinion [RN 5 Clinical Nurse Consultant] 
 
Nurses were not mentioned by the junior doctor cohort as having an influence on how they 
learnt to prescribe, but a number of senior doctor respondents felt nurses had an influence at the 
beginning of their internship: 
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Well the nurses are a very important part of JMO learning because often on the overtime 
shifts it’s just you and the nursing staff against the world and 30 patients on a ward and 
lot of things to do and they actually hold your hand and take you through it and they’re 
pretty good. There can be sometimes errors because of their influence but mostly it’s 
actually pretty safe. They’re very experienced clinicians. [Consultant 2] 
 
I mean when you physically first came to write a chart or write up something, they [the 
nurses] were the only ones that told you what to do.  They would say, ‘Give this dose’ 
and ‘You would write that there’ and ‘This goes in this box’ [Consultant 5] 
 
3.4. RESPONSIBILITIES 
3.4.1. Notion of shared responsibility 
The central opinion of the entire study sample was that the medical team along with pharmacists 
had the chief responsibility for safe and appropriate prescribing for patients at the hospitals.  
Whilst some doctors implied that pharmacists had a lesser professional responsibility than the 
medical teams, generally, both professions were considered to shoulder the bulk of 
responsibility.  Nurses were generally perceived to have a lesser responsibility for this particular 
element of medicines management.  Responsibility was conceptualised by many as a “team”, 
“collective”, “group” or “shared” notion, but with differing levels of responsibility associated with 
professional categories, particular processes, or organisational units (Figure 18). 
3.4.2. Individual responsibilities 
 Consultants. A recurrent theme of the consultant cohort was that the ultimate responsibility for 
safe and appropriate prescribing for patients admitted under their name lay with them. This view 
was also reiterated by several members of the other cohorts.  As alluded to earlier, this 
responsibility was exercised in their review of the medication chart and also underlined their 
“constant” questioning of their medical team:   
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The senior physician, surgeon or consultant under who’s care the patient is nominally 
admitted and that’s the way it is in Law.  There’s absolutely no doubt that the buck stops 
there. [Consultant 6] 
 
I suppose, the ultimate responsibility must lie with the VMO really. The doctor that the 
patient comes in on.  They must have overall responsibility for patient’s care.  
[Pharmacist 4] 
 
Figure 18. Shared responsibilities for prescribing 
 
I think that it’s a collaborative thing… I think a lot of people have to be vigilant about it.  
Obviously prescribers themselves, the medical officers, whether they’re interns or consultants 
should make sure that what they’re prescribing is appropriate and correct and obviously the 
pharmacists - we’re there to check the orders and make sure that it’s all appropriate that’s one of 
our main roles.  And the nursing staff who are following those orders that are on the medical 
charts have to make sure that the drugs are signed correct and, you know, have been written up 
in an appropriate way…[Pharmacist 6] 
 
Yes, I think it is really a collective responsibility for really most of the people here [Consultant 5] 
 
The doctors are the primary responsible person. And the pharmacist makes sure that the person 
prescribed properly. Nurses make sure that it's been charted and that it's in the appropriate 
place, and whether it's legible enough for them to dispense the medication. [Registrar 3 
advanced trainee] 
 
It is, like I think it’s teamwork.  You can’t do it all by yourself.  It would be unrealistic to expect me 
to take on the role of a pharmacist because I’m not qualified to be a pharmacist.  And vice versa 
for a pharmacist to take on my role, or a doctor.  We have each other, you know, we still have 
our distinct roles I think, but we still complement each other as well. [RN 2] 
 
The doctors, who are actually charting it in terms of overseeing patients, combination of the 
medical team and pharmacists. [JMO 5 PGY 3]  
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There were limits on how far consultants considered their responsibility to extend.  As the 
tangible tool of communication, the written medication order appeared to represent a line (but 
not a cut off point) between responsibility for prescribing and responsibilities for dispensing and 
administration.  If a medication order was considered to be written correctly and based on an 
appropriate prescribing decision, then the responsibility for communicating the decision was 
considered to have been met.  There was an assumption or trust that the recipient of that 
information would not implement the instruction unless they understood it, in which case they 
would contact a member of the medical team for clarification: 
 
So I guess there are a number of steps after me although I don’t see myself as being 
responsible for their jobs [pharmacists and nurses], in a sense - only that what we’ve 
decided is going to be prescribed is being prescribed. [Consultant 5] 
 
So the team is wider than just a few doctors hovering around the end of a bed, and we 
acknowledge that, just writing in the treatment orders book what new treatment implies 
that part of the team will implement that. Pharmacy will look at the interactions and if the 
patient’s on that prescription then the nurse will give it.[Consultant 7] 
 
Although, there was no suggestion that communication lines were closed between professionals 
involved in managing medicines, these views do reveal conceptualisation of prescribing more as 
a sequence of individual responsibilities than as a shared singular responsibility of professions 
working within the one system.   The great trust that was placed on the medication chart as the 
primary tool for communication represented this underlying assumption. 
 
Prescription writer.  Many respondents from a range of the cohorts thought that whoever puts 
pen to paper must accept responsibility:   
 
I mean the junior medical people - under the registrars - I would see as probably being 
more responsible for ensuring that it's written correctly and transcribed correctly and that 
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we look, and if there's something anomalous that we're worried about, talk to the registrar 
about it.  [JMO 6 PGY 2] 
 
Furthermore, one consultant felt that a team responsibility did not preclude the personal 
accountability of the prescription writer, who could not use the defence of “I was told to do it.” 
 
Decision-maker. Other opinions focused more on those who made the prescribing decision and 
some felt that the decision-maker was more accountable than the transcriber.  One registrar 
gave an example of prescribing a dose of cyclosporin for a patient with renal impairment.  She 
stated that although she would feel concern for transcribing the order correctly, she would not 
feel a hundred per cent responsible, because her consultant was advising her.  However, as 
alluded to previously (under the role of junior doctors in prescribing), there was uncertainty 
expressed as to the respective levels of responsibility associated with making a prescribing 
decision versus transcribing that decision: 
 
Well, I think the person who’s writing the script is responsible but I know that my actions 
as an intern - I’m under supervision of a registrar who’s under the supervision of a 
consultant - so I mean if there is a prescribing error, then ultimately the consultant is 
responsible.  However, I’m sure that… I would have to accept partial blame for 
something like that [JMO 9 PGY 1] 
 
… as junior doctors we are not really responsible for much prescribing, in fact, we are 
often, or we often think that charting, we often don’t see charting as prescribing. So we 
will write whatever the registrar says.  You know, whether it’s understood or not 
understood, you know, often we won’t query what the registrar because he knows and I 
don’t really know either, so I write, so while my name might be on the medication chart, 
you know, I am taking it from what the boss said on the round or, you know, what the 
registrar said on the round. [reflecting on his experience as an intern, Registrar 2 
advanced trainee] 
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I mean I think they [doctors who make a prescribing decision] do have a big responsibility 
for it, but from a legal point of view and every other point of view when push comes to 
shove it looks like they’re not involved. I mean in my opinion yes, they do have a very big 
role, but they pass that on and I guess than the responsibility then does go onto the 
person who is going to write it because they are finalising and making that decision 
concrete and in doing so they can be the one who ends up making an error that is going 
to affect the patient [Pharmacist 5] 
 
There were also uncertainties about responsibilities for prescribing when two or more medical 
teams were involved in patient care.  Several accountability issues were identified by 
respondents regarding prescribing decisions made by the primary (or managing) team versus 
the consulting team.  Primary teams, who allowed the consulting team to manage all aspects of 
management for which the consultation had been sought, were perceived to absolve themselves 
of responsibility.  Primary teams, who chose to reject some or all of the consulting team’s inputs, 
were perceived to shoulder full responsibility themselves.  Lastly, primary teams who worked 
more collaboratively with the consulting team were perceived to share responsibilities: 
 
Sometimes we've had some difficulty in the past… for example, sometimes the pain 
consultants will be a little bit cross when they've made a recommendation and 
commence some analgesic at the request of the parent team, who will then come in and 
say, “No we don't want them to have that and cancel it all”.  So for example, the boys 
have often said, “Why are they asking us to come and see a patient if they cancel or 
delete what we actually prescribe?”  So I think sometimes there's a bit of a, pardon the 
expression, a bit of a turf war.  I believe the managing doctor is what I call parent team, is 
overall responsible for the patient, but from an analgesia referral prospective, I believe if 
[the pain management team has] been asked to consult in regards to pain management, 
then [that]… recommendation should be fine. [RN 4 Clinical Nurse Consultant] 
 
Pharmacists were consistently viewed as having a specific responsibility for detecting errors, 
checking doses and vetting potential drug interactions.  In this regard, pharmacists were 
perceived by some respondents as having a very great responsibility to the extent that some 
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prescribers felt diminution of responsibility knowing that pharmacists would detect any errors 
they had made: 
 
And obviously as the prescriber you have the greatest responsibility because you’ve put 
your name against that drug. So, I think obviously the prescriber has the greatest 
responsibility, but I think in practice, I think the pharmacists play the greater role in 
picking up mistakes that have been made. [Registrar 4 advanced trainee] 
 
I think there’s systemic, how can I put it, there are things in place that often catch a lot of 
the things that go wrong with prescribing.  And I think that often we as doctors rely on 
that. [Registrar 2 advanced trainee] 
 
I mean the actual prescriber, the person putting pen to paper should be but unfortunately, 
you know, it’s not often the case. I think a lot of the doctors write out something and 
expect that it’s going to be checked, you know? I think a pharmacist has a large degree 
of that responsibility, to check that it is the right stuff, but it’s a shared responsibility I 
guess.[Pharmacist 1 specialist clinical pharmacist] 
 
One junior doctor, however, was unclear about the responsibilities that pharmacists had for 
prescribing and therefore did not display the same level of trust: 
 
And I'm not sure about the obligation of the pharmacists is in terms of checking 
medication.  I know they do check them but I don't know if they're obliged to check them, 
or if they're obliged to highlight problems with them.  I know they often do, and I 
appreciate that because they're more expert at it, it’s their field and as I said, part of their 
job's, often doctors get busy doing other things… I don't know if it's actually their 
responsibility.  I don't know if that's their job description or not. [JMO 8 PGY 1] 
 
The dominant view among the medical cohort was that pharmacists were not responsible for 
what was prescribed.  Therefore, other than checking for interactions, they were not seen to 
have responsibility for the appropriateness of prescribing:   
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…how medications are used correctly is what I see the pharmacist’s role as.  I’m not sure 
but I don’t think most pharmacists get a chance to read too many histories.  They’d have 
to go out to the main notes. Certainly not in our area because the pharmacist is just flat 
out.   So they don’t have intimate knowledge of that patient’s history. [RN1 Clinical Nurse 
Consultant] 
 
I think that they're a safety net.  But they're not the ones who are ultimately responsible 
for prescription of the drugs. [Registrar 7 advanced trainee] 
 
These views were substantiated by an example of a medication incident provided by a 
pharmacist involving a patient who inadvertently received a dose of enoxaparin whilst awaiting a 
lumbar puncture.  The pharmacist explained that without knowledge of the planned procedure, 
which was not documented in the notes, she did not have any reason to question the order, 
which was written correctly with the correct dose.  The case illustrates a type of error that the 
system was not able to readily detect because of reliance on the medication chart as the primary 
tool of communication. 
 
However, as indicated previously, pharmacists themselves generally did perceive that they had 
a role in verifying appropriateness where possible.  For example, several pharmacists described 
their practice of matching drugs to a patient’s medical conditions as part of taking a medication 
history.  However, it was obvious from both nurses’ and pharmacists’ accounts that pharmacist 
appraisal of a patient’s changing clinical state was not possible for every medication that was 
ordered: 
 
I look at all the medications that they're on and try and piece it together as to why they're 
on every single medication that they're on. And check as to the suitability, that there is an 
indication for everything that they're on, that the doses are suitable.  I also check with the 
patient just to make sure what they're on corresponds to what's been ordered. And 
 155 
basically explain to them if there are any differences, try and find out why there are any 
differences. [Pharmacist 7 specialist clinical pharmacist] 
 
We’re seeing a decline in that in the hospital in a big way and they [pharmacists] do not 
have time to check every chart every day, but they often write little messages when they 
feel the prescription is incorrect or when they’ve have the chance to check up the drug 
history of the patient, you know, “This patient is usually on this, you haven’t put them on 
it”. All that sort of thing.  They have that role but they don’t get a chance to follow through 
because they’re too busy. [RN 7] 
 
Nurses were generally considered to have a lesser responsibility for what was prescribed, but 
were responsible for knowing what they were administering, picking up errors, and seeking 
medical review if there was a change in the patient’s condition.   There was some debate about 
whether nurses were responsible for verifying doses and several respondents felt that nurses 
lacked the necessary training to do so: 
 
Yes it is our responsibility, but I can’t know all the medications, so I tend to find myself  -  
if I obviously saw something and it was incorrect or I was worried about it, well then yes I 
would query it. [RN 2] 
 
I think the nurses less so, look at what the actual drugs are, unless there’s some simple 
errors, but they don’t tend to review what has been prescribed as much, except with the 
exception of when they check the observations and someone’s bradycardic, they’ll 
withhold the digoxin or question should they be on it?[ Consultant 2] 
 
I don't think they have an obligation to do it.  The feeling I get from nursing staff is their 
role is to put it into the mouth whatever is written.  I appreciate, I think they are generally 
quite good at picking up mistakes and things, and I think that's something they do 
beyond what is actually expected of them. [JMO 8 PGY 1] 
 
I'm not… convinced they have enough training in that area to say that they should be 
responsible for prescribing. I think that in the area, in which they're working, they should 
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have some idea of what the appropriate doses are and I guess they should have a 
certain training in the way they approach reading a prescription, that'll hopefully trigger 
something if it's not quite right…it's more the process I think that they should be 
responsible for, rather than the prescribing itself. [Pharmacist 7 specialist clinical 
pharmacist] 
 
One pharmacist also felt that because enrolled nurses (unregistered nurses with 1 year of 
training) were now able to administer medicines, the responsibility of nursing staff to verify the 
safety of medication order had probably been reduced. 
 
An alternative view expressed by one nurse was that nurses should be auditing medication 
charts for safe and appropriate prescribing as they are the ones administering the medications: 
 
I think normally a ward should have a nurse who audits these things, the charts, pick up 
the chart and see if they’re prescribing...  But then you see the school [medical school, 
University] says to us, it's not your job so where do we go from there? [RN 6] 
 
3.4.3. Organisational responsibility.  
Predominately, medical respondents conceptualised responsibility for their patients as a 
professional rather than an organisational responsibility.  This interpretation was based upon the 
fact that respondents rarely mentioned the responsibility of the hospital or its organisational units 
without the question of organisational responsibility being posed.  This was also illuminated by 
one consultant.   
 
But if you’re asking, ‘Do they [the Drug Committee and other bodies] have a 
responsibility for what is prescribed?’ No, I think I do. I believe people are my patients 
and my name at the end of the beds and therefore I’m responsible. Therefore if 
something goes wrong, I’m not going to sort of say, ‘Well they let me prescribe it’… So I 
don’t see that they have a role in checking that I’m doing the right thing. [Consultant 2] 
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Another consultant indicated concern for over-reliance on organisational responsibility stating 
that the more people there are involved (in prescribing), the less personal responsibility 
individuals take.  For this reason, he did not think that prescribing in hospitals “worked all that 
well.” 
 
When prompted, consultants cited the hospital’s Drug Committee, the pharmacy department, 
and the microbiology department as responsible for determining the availability of medicines in 
the hospital (via the formulary), developing policies on appropriate use, and containing the cost 
of medicines.  Medication Incident Committees and Patient Safety Committees were mentioned 
as being responsible for reporting errors, although few expanded on how these reports improved 
prescribing safety for their patients: 
 
Well I mean there are choices that are made within the hospital as to what drugs are 
available within the hospital pharmacy and we sometimes communicate with that 
committee if we feel that there are things that should be available or should be changed  
and sometimes they even listen to us, but not always. [Consultant 3] 
 
In general, registrars and junior doctors were less aware of the functions and responsibilities of 
organisational bodies within the hospital concerned with medications.  Awareness was greater 
for the incident reporting committees than for the Drug Committee; and none of the junior 
doctors cited the Drug Committee by name. 
 
Overall, pharmacists and nurses expressed a far greater awareness of organisational 
responsibility than the medical cohorts.  Nurses, in general, focused on incident reporting 
systems; whereas pharmacists cast the widest net on organisational bodies which they felt 
shared some responsibility for prescribing in the hospital:   
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…you’ve got things like Medication Incident Committees… where they pick up on 
incidents in the hospital and can…put together strategies and ways of minimising 
medication incidents through prescribing errors, so they’re also like a body, like an official 
body involved for the hospital to promote rational prescribing… the Drug Committee for 
appropriate prescribing, you know, in terms of protocols and what drugs are on 
formulary, first line, second line and that sort of thing. And then that would also come 
down to I think the clinical teams and I guess each department developing their own 
protocols for prescribing for certain conditions like the clinical pathways…[Pharmacist 6] 
 
3.5. VALUES 
A series of questions were used to explore respondents’ beliefs about what prescribing involves 
and what they felt they were trying to achieve when prescribing.  The foundation questions were 
definitions of prescribing, goals of prescribing, and skills required for good prescribing.  The main 
findings were that prescribing was commonly conceptualised in simple schemas, but 
paradoxically, was widely acknowledged to require a complex variety of skills to perform it well.   
Whilst a similar spectrum of skills was evoked by each respondent cohort, there were indications 
that some groups placed greater value on some skills than others.  Few of the respondents 
demonstrated awareness or full engagement with literature on prescribing principles; for most, 
the goals of prescribing were seen purely in terms of desired efficacy or outcome.  Some 
respondents included side effect minimisation as a goal, and fewer respondents again, 
incorporated cost considerations.  Very few combined patients’ choices into their goals of 
prescribing.  A detailed description of the main themes, which lead to these interpretations, is 
presented below. 
3.5.1. Definition of prescribing.  
Most respondents took this question at face value and attempted to encapsulate their meaning 
in a concise phrase.  Predominately, this was done in one of two ways: by defining prescribing 
as a risks/benefits analysis or as an act of writing or communicating the content of a prescription. 
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There were a couple of notable exceptions.  A few respondents provided a more global 
definition, encompassing both decision-making and prescription communication activities, such 
as stating that prescribing was instituting a therapeutic intervention.  Some saw prescribing as a 
derivative of treatment planning, and therefore saw it as implementation of a decision than 
involving decision-making itself.  A very small number provided comprehensive definitions; two 
examples are shown below: 
 
Certainly means more than just the filling out of the prescription.  It's the institution of the 
management program that involves more than drugs.  It's how to treat this condition and 
it covers the education of how to use the treatment modalities, how to take the drugs, 
how to avoid problems with the drugs and having fallbacks - so if problems arise, this is 
what we do, and that’s part of the education.  An education of the patient, an education of 
the person who has to do the next prescription.  [Consultant 7] 
 
Oh, it’s so incredibly complex process isn’t it from making appropriate diagnosis, 
identifying appropriate therapeutic interventions in, you know, what class of therapeutic 
agent or medicine you want to use, looking a co-morbidities, looking at side effect profile 
of the medicines that you want to use, looking at interactions with other medicines, 
looking at likely compliance issues,... ensuring that they understand why they’re getting 
the medicine, like the side effects they’re going to have and I guess empowering them to 
be involved in the prescribing decision-making process as well, not as a sort of legal cop 
out but as a sort of enhancing efficacy and compliance. So I think that’s all part of the 
prescribing process.  [Registrar 8] 
 
These more considered definitions may have emanated from reflection of actual practices, or 
alternatively, from experiences in teaching prescribing, which would have sensitised the 
respondents to established principles of the activity.  Nevertheless, these definitions were 
meaningful in that they shared an appreciation for the complexity of prescribing and the need for 
patient engagement or education (as opposed to “advising the patient”); facets of prescribing 
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which were seldom incorporated into the bulk of respondents’ definitions or seen as goals of 
prescribing.     
3.5.2. Skills required for good prescribing   
The various respondent groups tended to evoke similar sorts of skills, which they felt were 
required to prescribe appropriately and safely.  Differences lay in the recurrence or emphasis 
placed on some of these skills by the various cohorts.  The types of skills (which also included 
knowledge and attitudes) cited by the entire sample are categorised in Figure 19. 
 
The main differences noted across the cohorts were: the strong emphasis on drug and patient 
knowledge evoked by registrars; the emphasis on communication to staff as well as patients 
evoked by both pharmacists and nurses; the complete failure of any of the junior doctors to 
mention communication skills (although a few mentioned that these as important in response to 
other questions); and the emphasis on adopting appropriate attitudes evoked by nurses. 
 
The lack of prominence placed on communication skills by junior doctors was particularly 
meaningful, because in earlier questioning, they did not cite education or communication to 
patients as one of their roles.  
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Figure 19. Knowledge, skills and attitudes required for good prescribing 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Knowledge 
• drug:  dose; metabolism; drug interactions; side effects; administration; availability 
• patient: medical history; patient’s “wavelength” to enable engagement 
• awareness of resources and how to access them 
• knowledge of prescribing principles 
Skills 
• diagnostic and clinical assessment skills 
• clear writing 
• communication skills (to others involved and to the patient) 
• skills in education 
• frequent medication review 
• medication history taking 
• monitoring and follow up 
• generic use of drug names 
• time management skills 
• cost minimisation 
Attitudes 
• awareness of limitations and not fearful of asking for advice 
• awareness that you can make mistakes 
• awareness of the implications of what you are doing and why you are prescribing 
• flexibility if strategies don’t work 
• being meticulous, checking your work, checking resources 
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3.5.3. Goals of prescribing 
Overwhelmingly, the goals of prescribing were described in terms of improving health outcomes 
or maximising efficacy.  For many, this aim was enough; others also considered the unintended 
effects of medicine use and spoke of minimising side effects.  A few respondents also included a 
goal of containing costs (although on prompting, many more thought that cost was an important 
influence on prescribing.)  As noted previously, very few evoked patient involvement or patient 
acceptance of treatment as a goal:  
 
You try to treat their condition, whatever they’re condition is, with the least possible side 
effects or complications from them, if possible, because sometimes there’s going to be 
complications and you can’t avoid them, so you have to allow for them. [Registrar 1] 
 
Well the goal is to be able to communicate about that particular tablet or medication, a 
particular dose, a particular frequency for duration of time and to have that legibly written. 
[Registrar 7] 
 
That you're choosing a medication that's appropriate, that's the best available medication 
for that condition, it's not going to interact with other things, it's unlikely to cause side 
effects, have a good side effect profile, and I guess convenience for the patient.  How 
many times a day they need to take it, administration cost. [JMO 7 PGY 1] 
 
One respondent had a more pragmatic perspective:  
 
To try and get the patient out of hospital basically. To treat condition that brought them 
into hospital in the first place, to try improve, or to treat that condition. And also to prevent 
complications, secondary to whatever disease they've got. [Pharmacist 7specialist 
clinical pharmacist] 
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3.6. ATTITUDES ABOUT PRESCRIBING  
3.6.1. Attitudes explored 
Attitudes surrounding several facets of prescribing were explored in this study, such as roles, 
relationships, responsibilities, influences, errors, and communication.  The primary means of 
exploration was through implicit questioning about these facets of prescribing at the hospitals, 
which revealed a number of commonly held attitudes. These have been described under the 
themes that they shape.  However, in order to gain a clear understanding of respondents’ 
association of risk with prescribing, a direct question was put to the participants, which was 
analysed along with responses to other questions.   
3.6.2. Perceptions of risk 
 
Range of attitudes. In each of the five respondent cohorts, there was a diversity of attitudes 
about risk associated with prescribing.  At one end of the spectrum, respondents used terms 
such as “small risk”, “not being fearful”, “not particularly stressful”, “being careful rather than 
anxious” to the other end of the spectrum, “high risk”, “huge risk”, “fear”, ”scared” and 
“frightened”.   
 
These views were fairly evenly distributed among the consultant and registrar groups; but in the 
junior doctor cohort, there was less of a spectrum of views and more of a dichotomy.  One group 
perceived a low risk, which they consistently attributed to their sense of security in the system of 
checks on their practice:   
 
Because we’ve got like the consultant, the pharmacist, there’s all this communication 
before we actually write pen on paper on prescriptions, so I think, what I’m trying to say is 
the safety net - it’s pretty safe - I mean relatively. [JMO 3  PGY1] 
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Because of my position I guess, I don't feel any responsibility really.  On overtime I do, … 
but I guess the way the system is set up, a junior medical officer doesn't have that much 
responsibility in their day-to-day job.  We sort of do and we sort of don’t.  But on overtime 
particularly, you know you worry more about what you're prescribing, and check more 
that they’re not going to interact, because normally [during the day] you think, ‘Oh the 
registrar will know.’[JMO 6 PGY2] 
 
The other smaller group of junior doctors were keen to express their awareness of drugs as 
poisons and respect for the risks involved: 
 
Well yeah it is inherently risky, cause it doesn't take much, a fairly small error can be 
potentially lethal.  When you are dealing in numbers it is not hard to misplace a decimal 
point or to write something that the person actually giving out the medication doesn't 
understand and gives out the wrong dose in milligrams instead of micrograms.  Or gives 
the wrong drug cause the writing isn't legible.  No it is very, very easy to make lethal 
mistakes.[JMO 4 PGY1] 
 
In the nurse and pharmacist cohorts, the dominant view was that prescribing carried great 
responsibility and was risky; furthermore, a recurrent belief of pharmacists was that junior 
doctors did not have a full appreciation of this risk.  However, there were also divergent opinions 
in these groups: 
 
[On whether prescribing was a risky activity] I think so.  You prescribe the wrong dose it 
could kill someone.[RN 6] 
 
I mean I often think like for the junior doctors that it is very risky because I feel like they 
often prescribe things that they have no idea what they are and I guess that comes 
across when they phonetically spell the drug that they are meant to be prescribing and it 
is nothing like the actual. [Pharmacist 5] 
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Probably, I don’t even think about it which is very bad, even if it’s an intravenous drug, 
probably don’t even think about it. [I don’t think about it] because hospitals are so drug 
oriented.  I mean people come here to have medications or surgery or both, in a way, 
and that’s what we do.[RN 7] 
 
Concepts.  Although seldom differentiated explicitly by respondents, there appeared to be two 
ways of conceptualising risk with prescribing: as the potential for adverse drug reactions (ie, 
intrinsic risks of drug) or as the potential for errors that might be made by the prescriber or those 
involved in carrying out the prescription.   Whilst many expressed an awareness of both, some 
respondents focused on one of these risks.   For example, many doctors mentioned how they 
rationalised fear in the same way that they would for any intervention, by weighing up the risks 
and benefits of the drug therapy, but it was unclear as to whether this analysis incorporated the 
risk of error:   
 
I think you always feel that something could go wrong with the prescription or that it 
doesn't get taken correctly [Registrar 7 advanced trainee] 
 
I’d have to say that it’s a risk. I’d consider it a risk just like any other intervention so, you 
know, if you’re thinking about doing an angiogram or surgery on a patient, you have to 
look at the risks versus the benefits if you’re considering an investigation. An X-ray, you 
have to weigh up the risks and benefits and I guess to an extent probably try and be as 
scientifically rigorous as you possible can in terms of looking at risks and benefits of any 
intervention. [Registrar 8]  
 
Arguably, risk of error was a more dominant theme in pharmacist and nurse accounts; however, 
the way in which each respondent expressed risk appeared to also relate to the types of drugs 
within their therapeutic area.  Chemotherapy prescribing in particular was strongly connected to 
fear of error: 
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Yes, I think it is a high risk procedure - the bottom line. I think it is. Yes, that is how I feel 
when I prescribe things. Do I still feel nervous when I’m writing out scripts for 
chemotherapy drugs? Often is the answer! Yes, I’m often triple checking noughts and 
ones, because the difference is…I mean I’m much more nervous prescribing 
chemotherapy drugs than I am prescribing normal drugs because there is less margin for 
a big mistake to be causing a big problem. So yes, I am, I feel generally, yes, cautious 
when I’m prescribing. I hate being rushed to write up chemotherapy drugs and, you 
know, thousands of people talking to me and that’s usually what’s happening. So, yes, I 
feel like I’m in a very vulnerable ‘highly-likely- to- make- a- mistake’ position when I am 
writing up chemotherapy drugs.[ Consultant 5] 
 
Circumstances.  A number of doctors felt that familiarity and clinical practice lessened their 
sense of risk, and consequently risk was more acutely felt for less routine prescribing.  One 
consultant felt greater risk and responsibility for prescribing decisions that fell outside the 
manufacturer’s recommendations.  Some doctors apportioned greater risk with making global 
patient management decisions, such as whether to treat or not rather than with drug selection; 
others felt increased risk when prescribing for patients with complex medical histories.   One 
registrar felt greatest risk when prescribing for patients who were being discharged from hospital 
because the immediate effects of the drug were not being monitored:  
 
So sometimes I’m more scared of new antibiotics that I haven’t heard of than old 
chemotherapy drugs that I’ve prescribed many times. But we’ve got a huge learning 
curve as new drugs come in [Consultant 8] 
 
Anticoagulants in the elderly are the things I think that I would worry the most about.  
Both for and against, you know, the issue of well should I actually use the anticoagulant 
prophylaxis or should I not? [Consultant 2] 
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3.7. CONTRIBUTORS TO ERROR 
Respondents were asked to describe a prescribing error from their experience of working in the 
hospital (not necessarily a mistake they had made personally) and then to bring to mind possible 
contributors to that error.  Examples could also include instances where they considered the 
order to be correct, but for some reason, it was misunderstood. 
3.7.1. Perceptions of frequency 
Few respondents provided an example of an error they had made, yet there was widespread 
acceptance that errors occurred frequently at the hospitals and that “everyone makes errors”: 
 
I mean I think it happens all the time. You mean the patient gets the wrong drug? I mean 
it happens. [Consultant 4] 
 
I sure have - everybody does, most of the time you just mis-write something accidentally. 
I haven’t done anything that hasn’t been pointed out that I know of, but I have mis-written 
things they couldn’t understand whether it was micrograms or milligrams or something 
like that. [Registrar 1] 
 
Part of the acceptance of errors as being commonplace appeared to arise from the view that 
most errors are intercepted by the checking system: 
 
Prescribing errors happen all the time, which is unfortunate, but mostly they're picked up 
before they actually happen. [JMO 7 PGY 1] 
 
Well, in every occasion that I can remember, the nurse or the pharmacy has kind of, sort 
of done their normal job, and been coming around fixing up my mistakes. So fortunately 
they have always picked those things up as far as I can recall and it’s never been 
executed. [Consultant 5] 
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This sense of security in the system, particularly among the junior doctors, may possibly have 
been enhanced by lack of awareness of errors that go undetected.  Of interest, three junior 
doctors stated that they had never seen a report on incidents at their hospital, but others working 
at the same hospitals stated that they knew about incidents reported from various meetings and 
through bulletins. 
3.7.2. Examples of prescribing errors 
Various types of errors were identified in respondents’ accounts.  Errors associated with: illegible 
handwriting (eg, transcribing Aropaxxxxii instead of Aurorixxxxiii); omission or unclear decimal 
points in doses (eg, diazepam 25 mg prescribed instead of 2.5mg); drug interactions (eg, 
tramadol and an selective serotonin reuptake inhibitor [SSRI]); incorrect choice of dose (eg, 
chemotherapy dose not adjusted for ideal body weight in a patient with obesity); incorrect route 
of administration (eg, intramuscular instead of subcutaneous administration charted for 
Aranespxxxiv); duplicate orders; plus others. 
3.7.3. Individual factors 
Lack of skills and knowledge were commonly evoked contributors to error.  Dominant themes 
were: poor skills in taking medication histories, illegible handwriting, and poor knowledge of 
doses.  As well as problems with prescriber knowledge, deficits in nurses’ knowledge were 
identified, in particular ability to check and interpret complex medication orders (eg, insulin): 
  
I think the ones [errors] most commonly [seen] are patients who come in on SSRI and 
tramadol …it might be written and charted in an emergency because that's just what 
they've been on and no-one’ sort of reviewed it actively down in emergency.  And so you 
see them on the ward and change it to something else. [JMO 5 PGY 3] 
 
                                               
xxxii
 Tradename for paroxetine 
xxxiii
 Tradename for moclobemide 
xxxiv
 Tradename for darbepoetin 
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I have had problems before where you have made an order in the notes about a certain 
medication and it is not heeded or they [nurses] don't pay attention.  Or you tick the box 
with the trough level and the trough level is just not taken and the medication is just 
given.  So I mean again maybe more nurse training as well. [JMO 4 PGY 1] 
 
Experience of working in a particular therapeutic area and familiarity with systems were also 
indicated in a number of responses: 
 
I know we all hate changeover time [when JMOs begin their 10 week rotation into an area] 
because there are so many errors. [Pharmacist 5] 
 
A large number of factors specifically relating to the workplace environment and practices of the 
teaching hospitals were cited:   
 
Physical Health. Tiredness was the main physical health factor mentioned, which tended to be 
given as an all purpose explanation for errors on overtime.  Of interest, stress was rarely 
mentioned by any of the doctors interviewed, although some pharmacists attributed some errors 
to junior doctors’ stress: 
 
And also, a level of tiredness, trying to work out the maths, obviously my brain wasn't 
working at the time.  Overtime shift and I was tired at the time.[JMO 7 PGY 1] 
 
And I think they know it too [know that they are not devoting enough time to prescribing] 
because they seem very, very stressed out, junior medical officers on the wards. And I 
think part of that stress is associated with the fact that they’re going a million miles an 
hour and they will often say I didn’t have time to look it up [Pharmacist 5] 
 
Attitudes. Several attitudinal factors were identified, the dominant ones being “laziness” and 
lack of care.  According to the respondents, these attitudes were either associated with the 
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failure of an individual to understand the consequences of their actions or more generally with 
an underlying workplace sentiment that placed prescribing as a low priority.  As previously 
mentioned, several pharmacists associated this attitude with transcribing errors made by junior 
doctors; also, in one pharmacist’s opinion, less care was taken by doctors when prescribing 
medicines unrelated to the reason for admission:   
 
Because there - to me - there didn’t seem to be any care behind it. The fact that they 
really honestly weren’t a hundred percent sure of what they should be prescribing. 
[Pharmacist 11 specialist clinical pharmacist] 
 
I think maybe because she’s not in for that condition, she’s probably been prescribed it 
for ages by the renal team and it’s just a drug that actually has nothing to do with what 
they’re treating at the moment.  [Pharmacist 10] 
 
 
Communication.  Communication between doctors and nurses was commonly evoked as a 
contributor to errors involving non-routine or complicated medication orders.  Several doctors 
thought that the transience of some nursing staff contributed to these errors, whilst others 
(nurses and doctors) put these problems down to poor planning, documentation and/or 
communication by the medical team: 
 
You know, in a morning and an afternoon, you will see two different nurses that you’ll 
never see again in your entire life, so you might make it clear about how the dose should 
be given, even if you’re correct, it might be executed by the first person and not the 
second person, ditto with the medical workforce who are moving around. But the nursing 
workforce in particular are incredibly transient, there’s a lot of part-time people. 
[Consultant 5] 
 
… the team responsible for the patient, I think, has to have ownership for appropriate 
communication with after hours staff.  It’s part of ownership of the patient, you know, part 
of the strategic direction we have. [Registrar 8] 
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[Referring to treatment plans documented in a patient’s notes] I felt that didn’t make - that 
isn’t a kind of statement, that’s just educated guesswork.  I mean I could have written 
that.  You need something clearer. [RN 2] 
 
One nurse perceived a particular communication problem associated with doctors who walked 
away before checking to see that their instruction was understood:   
 
That’s another big problem too is that the doctors will rush up to nurses and tell them…   
see we’ve got a lot of new grads, you know, the first year out from uni.  They’re a bit 
frightened of questioning doctors, even the JMO’s so they’ll just pretend that they know 
what they’re talking about and come and get me, then I’ll have to go and re transcribe…  
or find the JMO and ask him exactly what he meant… and if I wasn’t there, I often worry 
what would happen. [RN 1 Clinical Nurse Educator] 
3.7.4. Environmental factors.   
Interruptions, distractions, and multi-tasking were recurrent themes associated with prescribing 
errors and particularly transcribing errors.  For example, one registrar commented about the 
need to “find headspace” when prescribing and found the constant paging from nursing staff she 
experienced as a junior doctor intrusive.  As commented previously, a consultant felt that 
interruptions whilst prescribing chemotherapy substantially increased her risk of error: 
 
Similarly, workload (especially on overtime shifts), hurried workflow patterns (for example, 
rushed ward rounds and sudden decisions to discharge patients), and general busyness were 
repeatedly cited.  Several pharmacists believed that a common source of errors was the lack of 
time given to junior doctors during ward rounds to transcribe verbal orders:  
 
…you have to come in at six o’clock to do the med charts on a Tuesday before seven o’clock 
- because at seven o’clock you’ve got a ward round, at eight o’clock you’re going to theatres 
and you know, the whole day’s going to go by and it’s going to be seven o’clock again and 
the med charts won’t be rewritten. So there’s a limited amount of time to write the med charts 
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and a limited amount of time for checking. So -  and also you might get distracted during - 
while -  you’re writing and just leave off the last signature or whatever or the last number. It’s 
just being really, really busy. [JMO 9 PGY 1] 
 
I think probably the main one which I mean I think a lot of it gets down to the timing for the 
junior doctors…in that they will often go on a round and there will be so many things 
happening and they will be being told to write up this and write up that, and some of them do 
write it up on the ward rounds, but some of them come back and do a second round later, to 
sort of do all the things that they have been told to do and I do think that timing gap is quite a 
problem. [Pharmacist 5] 
 
Insufficient time for accurate transcription and critical review of discharge prescriptions by junior 
doctors was also reported as a contributor to error by a range of respondents: 
 
I guess the most common thing is to ‘drop the drug’ when you rechart the chart, like drop 
them out, or put the wrong dose.  They're the most common things I've seen, and they're 
usually picked up by the ward pharmacist, sometimes by the nurses.  And particularly up 
on the discharge chart, you know, you forget to write them in the summary or something, 
and the pharmacist picks it up when they do it.  I think they're the most common things, 
wrong dose or drop it out. [JMO 6 PGY 2] 
 
A patient was prescribed olanzapine on discharge and she was supposed to be on 
diazepam…It was only when we were discharging we asked them to send along the 
medication chart [because we saw that] the patient was on risperidone and so it was very 
unusual to have two antipsychotics, We looked at the chart and saw that it was diazepam 
and not olanzapine, and it had been written up by a relatively junior doctor on the 
discharge…Well the handwriting was one[factor], the other one was I think, there was 
rush, rush, rush and the other one was just her experience.. I think it was a combination 
of rushing, just the handwriting and, you know, her inexperience…[Pharmacist 4] 
 
A further contributing factor specific to the hospital environment was the diminution of patient 
responsibility.  Although some patients with chronic conditions were seen to be knowledgeable 
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about their medicines, this knowledge source did not appear to be proffered or tapped as a 
means of error prevention: 
 
They come into hospital, and normally they'll do insulin well themselves, they come to 
hospital; they lose all responsibility for everything.  I find they're very happy to sit back.  They 
know that they're supposed to check their blood sugar, take their insulin and eat and 
somehow when they come to hospital, that whole routine, that whole thinking goes out the 
window. [Registrar 7] 
 
3.8. INFLUENCES ON PRESCRIBING (DECISIONS) 
3.8.1. Consultants 
The strongest influences on the prescribing practices of the consultant cohort were considered 
to be scientific evidence and peer review.   
3.8.1.1. Scientific evidence 
Various terms were used by the cohort to describe this form of influence: “meta-analyses”, 
”randomised studies”, “controlled studies”, ”evidence-based medicine”, ”systematic review” or 
most commonly just “the evidence.”  Scientific evidence was sourced by the consultant cohort in 
several ways.  Predominately, it was identified through their own reading of medical literature: 
from subscribed journals, conference proceedings posted on the internet and literature 
searches.  Many also utilised articles provided by drug representatives.  In addition, the cohort 
also acquired knowledge about scientific evidence at scientific meetings or via referral to 
established protocols and guidelines.  Whilst it was viewed as a dominant influence, limitations 
to its influence were widely acknowledged.  Problems with extrapolating clinical trial outcomes 
(benefits and risks) to patients falling outside the trials inclusion criteria were cited; in particular, 
patients with other significant medical conditions.   
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Cardiologists are fantastic at doing evidence-based trials and putting people on five 
different medications, but they may not necessarily be reviewing the fact that it’s making 
the person confused or falling, and so it’s a balance between looking at the evidence for 
a medication, and in my patient population looking at the side effects that they may 
actually be causing. [Consultant 2] 
 
Consider the evidence as to what works best in the context. It’s not always the answer to 
prescribe the evidence-based best product, because it doesn’t always suit all patients. 
[Consultant 6] 
3.8.1.2. Peer review 
Peer review of prescribing decisions occurred as part of medical team discussion or during 
patient management meetings.   In the former sense, registrars were classed as peers.  Peer 
review was highly valued by some as a means of improving the experiential rigour of particular 
prescribing decisions.  To this end, it was used in various ways: to appraise management 
options; to canvass alternative interpretations of scientific evidence; to garner support for “off-
label” indications; to get an opinion from colleagues viewed as having greater expertise in a 
particular subspecialty; or to gather opinions on rare patient presentations or adverse events.  
However, some physicians felt that overall, their specialist colleagues were not that influential on 
routine prescribing decisions that they made: 
 
There are times when you can prefer to run with the evidence and with your agreement 
with the patient and override colleagues opinions, but there are times when the evidence 
is early or less, or you’re prescribing off label, then you must take your peers with 
you.[Consultant 6] 
 
…we have two weekly meetings where we discuss patient management, we have 
monthly journal club, where we are obliged to discuss modern trends, but it would be 
impertinent to go out on a limb and prescribe because you think this is the way it should 
be done, without peer review. [Consultant 7] 
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Other important influences for the consultant cohort included: personal experience, the patient, 
and the pharmaceutical industry.  
3.8.1.3. Personal experience 
Personal experience was articulated in several ways.  Commonly it was described as drawing on 
knowledge built up through familiarity with a drug or situation.  This was exemplified by a 
subgroup of consultants, who each described their most frequent prescribing decisions as 
removal of drugs or “deprescribing”:   
 
And the other thing too is experience with a particular group of agents and, you know, I 
think I’m more likely to keep using things that I’ve used and feel comfortable with than 
using something that’s new just because it’s new. It’s more likely to be the opposite. I’d 
be more likely to stay with something that I was comfortable with, rather than change to 
something that’s new unless there was some specific advantage. [Consultant 3] 
 
The reason for consultation is to get rid of some drugs and so removal of drugs is just as 
important a prescribing issue as the institution of new drugs.  So removal of drugs 
doesn't require looking at a source of information.  It requires use of an experience or 
base of knowledge of what's inappropriate. [Consultant 7] 
 
The need to be self-critical about your own experience was also voiced:   
 
There is this background and backlog of experience and information that you keep on 
building on, but one learns from all the surprises you get from meta-analyses not to, and 
from the large scale clinical trials, how you can be so wrong.  We used to emphasise so 
much in osteoporosis prevention and treatment, the hormonal replacement therapy and 
in post-menopausal for women and all of the theoretical and the observational studies 
seem to support that and then came the Women’s Health Initiative major studies, which 
really arrested that…[Consultant 6] 
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Another way in which this influence was expressed was when they were sensitised to a 
particular safety concern because of past experience:  
  
…and it depends on how sensitised I’ve been about allergies. Like last week I had 
someone who had a disseminated rash and I suppose that raises your awareness at the 
time. [Consultant 2] 
 
According to one of the pharmacists, this influence was sometimes enacted in a wholesale 
manner in what was termed the “N=1 experience”: 
 
And that is the knee-jerk reaction: my nice patient nearly died because I didn’t do 
something, even if that was evidence based that I shouldn’t do it, I’m now going to do it 
because my last patient nearly died. [Pharmacist 1 specialist clinical pharmacist] 
 
3.8.1.4. Patient’s opinions 
Patient’s opinions about treatment options were actively sought according to most consultants, 
as they viewed this as a critical part of therapy selection.  Many saw this as a means of 
maximising adherence to treatment.  However, the practice most commonly articulated was that 
the consultant provided the evidence-based options to the patient for discussion, rather than the 
patient suggesting their own therapies.  Nevertheless, there were circumstances where patients’ 
treatment suggestions were viewed as influential, which had the effect of stimulating ethical 
stances among the doctors.  Patient influences appeared to be viewed either benignly or 
critically.  An example given of an appropriate influence was a patient undergoing chemotherapy 
who directs prescribing of anti-emetics and anti-diarrhoeals.  A more critical view was taken of 
lobby groups or community influences, which were perceived as patients “pressuring” doctors: 
 
Patients will often come in with cuttings from newspapers or a particular story they’ve 
heard on the TV, which they may have even taped so you can listen to it…The pressure 
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is not only [what] they put on you as individuals, but the pressure that they put on as a 
group. You know, as groups of lobby…groups of patients, so they are very agitated about 
particular types of treatment, so that’s one powerful influence.  [Consultant 5] 
 
Patient influence was generally regarded as a relatively weak influence by the other 
respondents, and again there was a tendency to see patient influence as either good or bad.  
Some respondents felt that patients in hospitals were far less likely to influence decisions than 
patients in the community.  In the hospitals, patients with chronic conditions were seen as more 
likely to influence prescribing decisions than patients with new or acute medical conditions, who 
may be too frightened to voice an opinion: 
 
Most of the time, it depends if the patients have chronic illnesses, long term chronic 
illnesses, they might say up the dose or down the dose… but when we issue a new drug 
because they all come in with acute illnesses from geriatrics, so actually, yes [they] tend 
not to[influence]. [JMO 3 PGY1] 
 
And they’re [the patients] quite frightened.  They don’t really usually get involved because 
you wouldn’t know the therapies and all that, so they’re really, for want of a better word, 
just put their hands in the doctor’s hands and just let him decide, which is fair enough I 
suppose. [RN 2] 
 
Patients were also perceived to influence prescribing decisions by reporting side effects of 
medicines and also refusing to take medicines. 
3.8.1.5. Pharmaceutical Industry 
Influence from pharmaceutical industry was consistently viewed by the consultant cohort as 
problematic, however there was a range of opinion about industry generally and great variance 
in beliefs as to whether industry influenced consultants personally.  For many, industry’s supply 
of drug information in the form of emailed conference alerts and online access to journals was 
seen to be useful and they viewed this benignly.  Industry sponsorship for conferences and for 
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continuing education activities was also viewed favourably by many.  An alternative view 
expressed by some who did not engage with these activities (and also by a few that did) was 
that through these seemingly ethical information support services, industry was most likely 
having a substantial subliminal influence.   
 
More broadly held criticism was expressed for what were viewed as the more blatant attempts to 
influence, such as the use of glossy brochures and visits by drug representatives.  However, 
these did not necessarily dissuade consultants from seeing representatives or minimising their 
exposure to industry.  The inference from their comments was that they felt they could detect 
attempts to influence and therefore outsmart industry; and some even seemed to derive 
satisfaction from doing this: 
 
By and large I think the pharmaceutical industry does provide me with information about 
the medications and about the role of medications in the clinical conditions. But I still 
make my own decisions as to whether - whether this drug may ultimately benefit my 
patient. [Consultant 1] 
 
We can see what's going on [at drug company sponsored meetings].  Half of the 
consultants have PhD's in pharmacology or drug-related clinical practice… It's a matter 
of recognising it [the influence].  The evidence still has to speak for itself.  If the drug 
doesn't work, it doesn't work. [Consultant 7] 
 
Opinions from the consultant cohort on whether industry influenced their prescribing behaviour 
varied widely and fell into four categories.  One group believed they had no influence: 
 
They don’t influence mine and I am sure they do influence people. I mean you can tell by 
the way that how persuasive they are… for example the statin, atorvastatin, and it’s only 
recently there’s been objective randomised studies and yet it was the best-selling statin 
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and that was because it was promoted by the representatives and there’s a way of 
promoting things [Consultant 4]. 
 
A second group believed they had a modest influence, tempered by perceived limited 
opportunities for influence in their specialty:   
 
I guess I would feel that in my area of expertise they’re probably not going to influence 
me particularly strongly. I wouldn’t be so stupid as to say they can’t influence you 
because of course they can. I mean even if it’s just by communicating with someone and 
talking about something that will probably influence what you do. I think it’s a fairly 
modest influence. [Consultant 3] 
 
A third group believed they sometimes had influence, but that the influence of scientific evidence 
ultimately overrode this:   
 
[My] prescribing…was a bit influenced or determined by pharmaceutical company giving 
samples and that sort of stuff, but eventually evidence has been taken over as the main 
determinant [Consultant 6] 
 
The last group thought that industry was highly influential and as a result minimised their 
exposure by not seeing drug representatives and not participating in drug company sponsored 
activities.  Despite minimising exposure, the invasiveness of industry’s promotional efforts was 
observed: 
 
I think they influence you largely just through their impact on their promotional material 
that they’re sending around on a regular basis. Even if you’re not reading it you see it. It’s 
just constantly around you, patients are telling you about it, other colleagues are telling 
you about it. It’s just actually, it’s very subtle,  because I don’t go to any company 
meetings or propaganda, but yet still I sort of almost know what they’re saying there 
anyway, so I must be hearing it even though I ‘m not there.[Consultant 5] 
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Aside from the consultant cohort, the other respondents were very aware of the presence of 
pharmaceutical industry at the teaching hospitals.  Nurses, pharmacists and JMOs cited drug-
company sponsored meetings, lunches, and frequent visits by drug representatives to senior 
medical staff as evidence of industry’s influence at each hospital.  It appeared that a common 
method used by representatives to see registrars in particular, was to provide them with journal 
articles and a cup of coffee.  However, respondents from the registrar cohort who met with drug 
representatives felt that industry did not influence their prescribing behaviour:  
 
… if I'm not busy and a drug rep pages, I will often go and see them… I know to take it 
with a grain of salt…I like it because I can get the articles.  Free coffee, is another reason 
to do it.  I don't know.  I just find at the moment, my time is so precious, if they can, and I 
do realise it's a one-sided point of view, but if they could provide a snapshot of ‘this is 
what the drug does’, ‘this is why’, and ‘here's an article from a reputable journal’.  It's 
useful. [Registrar 5] 
 
Some respondents provided specific examples of switches in brands of drugs at the hospitals, 
which they attributed to the concentrated efforts of drug representatives: 
   
We had been using Losecxxxv and all of a sudden everyone started changing to 
Somacxxxvi. And that was as a result of the rep being very active and he … Somac pads 
and things and lectures and lunches and things. So they have an influence. 
[Pharmacist 5] 
3.8.1.6. Other influences 
Several other influences were nominated by the consultant cohort, mainly in response to 
prompts:  
 
                                               
xxxv
 Tradename for omeprazole 
xxxvi
 Tradename for pantoprazole 
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Pharmacists were perceived as influential through their detection of drug interactions and 
prescribing errors.  These influences have been reviewed in more detail under their Role (3.3.4). 
Provision of drug bulletins from the pharmacy department was also mentioned as an influence.   
 
Nurses were seen as influential through their knowledge of the patient’s condition. This has also 
been reviewed previously under the Role of nurses (3.3.5). 
 
Drug cost was perceived by some consultants to be influential; but for most other medical 
respondents, apart from prescribing high-cost drugs (such as chemotherapy) cost was not taken 
into consideration routinely.  There appeared to be several reasons associated with this.  Firstly, 
some felt they lacked ready access to drug cost information; secondly, some felt that it was too 
difficult to incorporate this information into their decision; and thirdly, some thought that cost 
consideration of medicines in the hospital were the domain of the Drug Committee and/or the 
pharmacy department.  Although the self-reported knowledge of drug costs among the medical 
respondents was generally poor, consideration was given by some as to whether drugs initiated 
in the hospital were available on the Pharmaceutical Benefits Scheme (PBS).xxxvii  Cost was also 
considered by doctors when the information was presented to them in antibiotic sensitivity 
reports.  One doctor mentioned difficulty in locating drug cost information for non-PBS items  
(Figure 20).  
 
 
 
 
 
 
                                               
xxxvii
 List of medicines subsidised by the Australian Government. 
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Figure 20. Perspectives on drug cost 
 
Absolutely. If you have a situation and to my mind it’s a bit of a no-brainer, if you have two drugs 
that you consider of comparable efficacy and there is a significant difference of cost, I’d me 
much more likely to use the one that’s cheaper, but usually the differences in comparable drugs 
are fairly small because they know that it is going to play a role. [Consultant 3] 
 
If I knew what were the cheapest ones, I would, but I don’t know - I just don’t get around to 
looking up the costs on PBS or anything…. it’s not something that you think about and look 
down what’s the cost of this drug, no -I don’t actually do it. [Registrar 1] 
 
It should but it doesn’t. It’s too hard to think of that as well. In a hospital setting, I think one just 
prescribes what we think is the best thing. I think it’s…I mean it is vetted in a hospital. 
[Consultant 4] 
 
I am not so aware of it…and I must be honest, that's probably working in a public hospital…I 
know that goes on in the senior level, the Drug Committee, but I don't think residents or 
registrars have any concept of the cost of drugs. [Registrar 5] 
 
I think we try to prescribe things that the patient would be able to get on the PBS outside the 
hospital but, say they've got neuropathic pain or something, not all of them can get gabapentin 
outside the hospital ,so you try not to use it inside, cause if it works, they’re stuck.  
[JMO 6 PGY 2] 
 
I find it [cost of drugs not available on the PBS] extremely difficult to understand in MIMs That's 
one of the things I find difficult to understand, and how perhaps it might be different in different 
chemists and how it would vary. I do find that particularly difficult to understand.  Sometimes I 
have patients tell me what happens to them.  That's when I realise how much things cost. 
[Registrar 7] 
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3.8.2. Registrars  
As suggested under Roles (3.3.2), registrars predominately cited consultants as the strongest 
influences on their prescribing practice, but personal experience, protocols and/or scientific 
evidence were also major influences:  
 
[On strongest influences on his prescribing] Staff specialist and the protocols, which are 
written down usually by the department which includes the staff specialist [Registrar 6] 
 
As a registrar, we rely on the opinions of our consultant but more particularly the 
consultants of the respective fields.  For example,…you might have three cardiologists 
here and they may have three different ways of initiating therapy for a post AMI victim, 
but…you might think this guy is a pretty good, or a much better cardiologist than the 
other two, so you might be influenced by that to start. [Registrar 2] 
 
It would have to come from generally it would come from a combination of factors.  It 
would come from the evidence in the literature about the medications, which is probably 
the number one, but there must be some underlying thing about what you’ve seen done 
and how it turned out. [Registrar 7] 
 
Predominately, scientific evidence was drawn upon through their own reading of texts, published 
guidelines, journal articles (some provided by drug representatives), electronic databases (eg, 
UpToDate, Medline) or the internet.  However, as one registrar pointed out, knowledge was also 
acquired by integrating other interpretations of evidence: 
 
To get through physician training, generally you’ve built up a level of knowledge about 
things and the way people have presented things, particular things, which comes through 
their reading of journals.  And you may have heard it from several different people who 
have presented the same evidence.  And then general wider reading of journals…and 
journal clubs.  Just talking to people on the ward, they'll talk about the evidence for such 
and such and then you have to believe them otherwise you’d be reading 50 million 
journals.  So, it's a combination of what people tell you is the evidence and what you’ve 
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read yourself.  And often you feel comfortable about something if it’s been mentioned a 
couple of times. [Registrar 7] 
 
3.8.3. Junior doctors  
As indicated under Roles (3.3.3), the junior doctor cohort cited registrars and consultants as the 
strongest influences on their prescribing practice.  Some registrars also cited the important 
influence of peers when they were interns.  As mentioned previously, MIMS and the Therapeutic 
Guidelines were popular information resources for junior doctors, as was the Australian 
Medicines Handbook. Some junior doctors also mentioned using pharmacists as an information 
source, although pharmacists were not seen as a major influence on their prescribing decisions 
overall.  Specialised nurses were mentioned as being influential by a few JMOs: 
 
I think as an intern you learn from your registrar and as a registrar you learn from your 
consultant and it goes on [Registrar 4] 
 
I think lower down the totem pole you go, so for residents and JMO I think you find that it 
is frequently more to do with what they have heard.  So for example if I ask a registrar 
how do I treat this when I see a patient and he or she says this, this and this, well often I 
will adopt that as my way treating that patient, even though the books might, you know 
the textbooks might say something else.  Even the therapeutic guidelines might say 
something different, but whoever told me initially how to treat that problem I will tend to 
adopt that as my mode of doing it. [JMO 4 PGY 1] 
 
But generally, you look to your registrar for advice or for simpler things you might talk 
amongst yourselves  So it’s sort of group knowledge or peers and that that you respect, 
hopefully, then your registrar then maybe your consultant.[Registrar 2 advanced trainee] 
 
So, at the junior level, there’s a certain security about doing what authority figures say 
and do but it’s not the best thing to do and so while you do need that for security and just 
for practicality and in the interest of your patients, increasingly as a junior resident you 
should ask why? Is that true? What’s the evidence? [Consultant 6] 
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3.9. PRESCRIBING PROCESS IN THE TEACHING HOSPITALS 
To contextualise the focal behaviours that were identified as being susceptible to socio-cultural 
influence at the hospitals, the core steps of the prescribing process were defined based on the 
analysis of respondents’ accounts.  The WHO stepped model for rational drug treatment was 
used as a template16, so that the steps identified in this research could be compared with the 
“one-prescriber” model (Figure 21).  The model that was built from findings of this study is a 
representation only of how prescribing was perceived to occur at the hospitals.  It is constrained 
by the design of this study, the themes evoked by the respondents, the interpretations of the 
researcher (MP), and the inherent difficulty of diagrammatically representing a complex and 
dynamic process.  Acknowledging these limitations, the model serves to illustrate the complexity 
of the process in these settings.  It demonstrates the intricate division of responsibilities, the 
system’s reliance on human behaviours, and denotes the key practices susceptible to socio-
cultural and environmental forces. 
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Figure 21. Representation of Prescribing Process* 
 Decision/Action 
 
Key 
Player(s) 
Other 
Players 
Step One  Diagnose 
 
Registrar 
Consultant 
JMO 
Set treatment plan 
 
Registrar 
Consultant 
JMO 
Select treatment   
(ie, non-drug treatment; drug treatment; no treatment; 
consultation) 
Registrar 
Consultant 
JMO 
Patient 
Select drug  
efficacy, safety (main considerations) 
cost, patient acceptance (lesser considerations) 
Registrar 
Consultant 
JMO 
Patient 
Step Two  
 
MAKE 
PRIMARY  
DECISION(S) 
 
 
 
Verify suitability 
of drug selection for patient  
Registrar JMO 
Pharmacist 
Give verbal order to JMO Registrar  
Select dose and dosing schedule 
 (main considerations) 
Selection duration of therapy 
 (lesser consideration) 
JMO Registrar 
Verify verbal order 
Check with registrar and/or check dosing using texts, 
pharmacist 
JMO  
Step Three 
 
DETERMINE 
DOSE 
 
VERIFY 
ORDER 
 
CHART 
ORDER 
 
Chart medication order 
Advise nurse about order so treatment can be started 
? Advise patient about order 
JMO Registrar 
Check order  
for errors, legibility, legal compliance, drug 
interactions, drug availability, dosing, and sometimes 
suitability  
Pharmacist  
Check order  
for errors, legibility, legal compliance, and sometimes 
dosing 
Nurse  
Check order  
for errors, dosing, interactions 
Registrar  
Step Four 
 
CHECK AND 
REVIEW 
 
 
 
Check order  
Errors, dosing, interactions, missed doses 
Consultant  
If necessary, revise primary prescribing decision 
and select different drug and/or dosing 
Pharmacist 
JMO 
Registrar Step Four A 
IF NEEDED, 
REVISE  
DECISION 
If necessary, rechart medication order 
Advise nurse about revised order 
? Advise patient about revised order 
JMO Registrar 
Step Five 
 
EDUCATE 
PATIENT 
Give instructions, advice, information to patient Pharmacist 
?JMO 
 
Consultant 
Registrar 
Monitor results 
 
Nurse 
JMO  
Registrar 
 
Step Six 
 
MONITOR 
AND 
REVIEW 
Determine if further action required 
Stop; alter; continue drug treatment 
Registrar 
Consultant 
JMO 
* Based on analysis of respondents accounts 
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4. CHAPTER FOUR: DISCUSSION 
 
In this study, 43 health professionals working in two metropolitan teaching hospitals were 
interviewed to explore social and cultural factors influencing prescribing and the training of new 
prescribers at these sites.  The study attempted to explore influences on behaviours of decision-
makers and those involved in carrying out prescribing activities.  The basis for this scope of 
enquiry was the WHO normative model16, which depicts prescribing as a series of decisions and 
actions.  By examining the role of the key players in prescribing at the hospitals, from the 
perspectives of the various health professions involved, a representation was constructed of 
how prescribing takes place.  Through exploration of respondents’ perceptions of influences on 
prescribing and their belief systems associated with the process, an in-depth understanding of 
the socio-cultural forces affecting behaviours of the key players was developed, which is now 
discussed in relation to the literature.  
 
Prescribing at the teaching hospitals was a complex process consisting of multiple steps 
undertaken by several different health professionals of varying levels of experience from three 
different health care disciplines.  Key prescribing decisions associated with patient admissions 
were made, almost exclusively, by medical teams.  Prescribing was therefore chiefly 
characterised by factors influencing the behaviours of each member of these teams, such as: 
what knowledge sources they used; how they interacted with one another to make prescribing 
decisions; how they communicated decisions to patients and other health professionals; and 
how they set in motion prescribing decisions.  Behaviours of the doctors were influenced by 
factors relating to their individual characteristics (eg, knowledge, skills, experience); but also by 
a web of socio-cultural determinants inherent to the environment in which they worked.  This is 
consistent with theories suggesting that prescribers are influenced by a range of factors external 
to consideration of clinical and drug factors.101, 117 The non-biomedical determinants identified in 
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this study fell into five broad categories: structural characteristics; communication patterns; 
underlying assumptions; knowledge characteristics; and the work environment.  
4.1. STRUCTURAL CHARACTERISTICS 
4.1.1. Intra-professional collaboration and medical dominance 
Traditionally, research into determinants of prescribing in hospitals has assumed one  
decision-maker 30, 32, 114 (ie, the same model for general practice), and there has been scant 
acknowledgement or exploration of the effect of the relationships within medical teams on 
prescribing.  Furthermore, there has been little enquiry into the effect of their different identities 
on prescribing.113, 132 133 
 
The global characteristics of medical teams that shaped prescribing in the teaching hospitals 
were the closely tied values of intraprofessional collaboration and education.  There were two 
very strong relationships that influenced prescribing: the relationship between registrars and 
consultants, which was underlined by the way in which consultants saw their role as a reviewer 
or a mentor rather than a supervisor; and the relationship between the junior doctors and their 
registrars, which was exemplified by the ease that was expressed by junior doctors in 
questioning their senior colleagues.  This accords with other Australian studies of junior doctors, 
which have reported overall positive opinions of  junior doctors toward their immediate 
seniors.132, 262 The relationship between junior doctors and consultants was not close; however, 
this was viewed neither critical to the operation of the team nor to the training of the junior doctor 
in prescribing.  The two other relationships were the ones that were influential on prescribing 
because they determined what knowledge was used as the basis for decision-making, and how 
well the decision was carried out.  Dartnell makes a similar observation about these relational 
determinants of prescribing in hospitals, “the decision that is made will be the result of how 
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tightly the consultant manages his or her team, and how strictly the team adheres to the 
consultant’s framework.”91 
 
Due to competing work responsibilities, as voiced by the nurse and pharmacist cohorts, other 
health professions had little opportunity to be involved in shaping key decisions at the point of 
prescribing.  The main opportunities for nurses and pharmacists to effect prescribing were in 
revising or optimising decisions, where they worked collaboratively with either the junior doctor 
or registrar.  Whilst resource issues and staffing were cited by pharmacists and nurses as the 
main reasons for their lack of pro-active participation in prescribing decisions, there were few 
indications that inter-professional involvement in prescribing decisions was considered integral 
by doctors.  The medical respondents’ attitudes, however, did not appear to be based on any 
explicit desire to monopolise decision-making, indeed the value of multidisciplinary collaboration 
was strongly espoused by some, but related more to an underlying assumption by many that the 
active participation of non-medical professionals was not a fundamental part of prescribing 
practice.  Prescribing was the domain of those who diagnose. 
 
The control of many forms of health care delivery by the medical profession in Australia has long 
been recognised 263, and the dominance of the medical profession in multidisciplinary 
discussions in hospitals has also been observed in the UK. 264  Reasons put forward to explain 
medical dominance include the social power of the medical profession263 and perceptions of 
status differentials. 264  
 
In Australia, the potential for a professional power imbalance in prescribing is fuelled by doctors’ 
exclusive independent authority to prescribe.  In the UK, where the profile of pharmacists in 
prescribing is arguably higher than Australia (due to greater prescribing privileges 28), there has 
been the suggestion that pharmacists working in hospitals are conservative 54 and foster their 
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own low profile by giving verbal feedback to doctors rather than documenting their interventions 
in patient’s notes.89  This view of pharmacists is also apparent in US commentary, one medical 
observer labeling pharmacists as “unassuming colleagues”, who perform a “crucial, 
unglamorous function.”265 Conservatism of pharmacists’ behaviour was not obvious from our 
data; overall, the pharmacist cohort appeared confident in approaching and challenging doctors 
about problematic medication orders.  However, several pharmacists expressed underlying 
assumptions about the attitude of doctors toward their involvement in prescribing decisions; for 
example, one pharmacist felt that doctors saw the pharmacy service as dispensable; and 
another thought that they viewed pharmacists as police. 
 
There are strong theoretical arguments for inter-professional collaboration in prescribing 
decisions in hospitals 13, 266, although, outside of consultative teams (such as pain management 
and Total Parenteral Nutrition), not a lot of evaluation of its relative merit.  As our respondents 
indicated, good prescribing requires more than diagnostic skills; it requires drug knowledge, 
awareness of information resources, communication skills, engagement with the patient, 
monitoring skills, awareness of limitations, meticulousness and so on.  These are all skills well 
recognised by clinical pharmacologists and educators in prescribing.14, 20, 202  Therefore, by 
utilising the strengths of several disciplines, prescribing outcomes might be optimised and error 
rates reduced.  Such an effect was demonstrated by Leape et al who examined pharmacist 
participation on medical rounds in an intensive care unit and found that the pro-active role of a 
pharmacist resulted in a 66% drop in the rate of ordering ADEs, a drop which was not shown in 
a control unit. 149  In this study, pharmacists identified errors, provided drug use information, and 
recommended alternative therapy as part of their role during rounds. 
 
An additional benefit of a pharmacist’s active involvement in prescribing decisions is that they 
might act as a catalyst for more detailed discussion about proposed drug therapy and help to 
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raise the profile of dosing as a discussion point.  Dosing errors are the most common types of 
prescribing errors reported in Australian hospitals 36-38 and failure of checking systems to detect 
these errors in hospitals is one of the factors most commonly linked to adverse drug events in 
hospitals.44  In our study, it was noted that there were limited weekend pharmacy services at the 
two hospitals.  Arguably, this underlines the importance of discussing dosing at the time a 
prescribing decision is made and ensuring clear specification and systematic verification of 
dosing information.  Routine participation of a pharmacist in ward rounds may help to legitimise 
detailed discussion about dose between doctors at other times.  A counter argument to 
pharmacist involvement in decision-making is that it may remove pharmacists from their valued 
monitoring role.89, 170 
 
A further case for inter-professional decision-making is that nurses’ participation in ward rounds 
might improve information transfer about treatment plans and drug therapies.  Problems with 
communication of prescribing decisions between medical teams and nursing staff were noted in 
this study, and communication breakdowns in other studies have been linked to prescribing 
errors.34  Also, through their more intimate knowledge of the patient, nurse involvement in 
decisions might be expected to broaden discussion about suitability of drug selection. 
 
Of course, because teaching hospitals are acute care facilities, there are many circumstances 
where a joint discussion of drug treatment among disciplines is clearly inappropriate.  In our 
study, several registrars gave examples of how their priority was the acute needs of the patient 
rather than medicines for longer term clinical conditions.  However, the tendency in hospitals to 
focus on acute care and overlook chronic conditions has been linked to inappropriate 
prescribing.171  This has important negative ramifications.  For example, the elderly are frequent 
users of acute care settings, and have the highest rate of hospitalisation due to ADEs 46, largely 
due to drugs used to treat chronic conditions.  So there is a need to improve the model of 
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prescribing practice for chronic conditions in hospitals, and a further argument for widening the 
circle of those who make decisions about medicines. 
 
One proactive attempt to improve inter-professional collaboration in hospitals has been to 
introduce inter-professional clinical education of medical and pharmacy students.  In the UK, one 
method involved assigning interdisciplinary pairs of students clinical problems to solve.213  This 
was measured to be a successful educational intervention by the researchers; however, whether 
such interventions translate to effective collaboration in the hospital environment appears not to 
have been addressed in the literature.  As noted by the pharmacist cohort, this may depend 
upon a number of other facilitating factors, notably, staffing levels. 
4.1.2.  Medical hierarchy  
In addition to dominance of the medical profession in prescribing, there were suggestions that 
some pharmacists and junior doctors altered the way in which they queried prescribing decisions 
according to their perceptions of the approachability of individual consultants.  This appeared to 
be less of a problem among the nursing cohort, which may have been related to their greater 
average level of experience and confidence (although one of the nurses suggested that junior 
nursing staff sometimes had difficulty in questioning doctors about medication orders).  
Hesitancy to communicate information to superiors, because of not wanting to offend those in 
power has been linked to medical mishaps88, and not questioning the prescribing orders of 
superiors has been linked to prescribing errors.89  Whilst there were few explicit accounts given 
in our study where perceptions of hierarchy affected safety of prescribing, consciousness about 
status was arguably cultivated throughout the hospitals by the use of the terms “bosses” and 
“chain of command.”   
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4.1.3. Parallel practices and differing notion of responsibility 
The involvement of the three health professions in prescribing was characterised by parallel 
practices, which had implications for not only how prescribing decisions were made, but also in 
how they were enacted.  Apart from ward meetings in some clinical areas, there was little 
coordination of prescribing-related activities among the professions.  This picture is consistent 
with the empiric observations of others; as Avorn notes “hospital care has been seen as a series 
of separate and unrelated interactions between health care professionals and individual 
patients.”265   
 
Although independent checks on complex medicines management systems are seen as a vital 
safeguard 44, a lack of organised interaction and coordination among health professionals has 
been suggested to make health care systems more prone to errors.175  A lack of coordination 
and leadership was strongly conveyed in our study by respondents’ descriptions of how 
discharge prescriptions were handled.  Junior doctors were often rushed to write the 
prescriptions, transcription errors were common, and pharmacists were “chasing their tails” 
trying to work out what medicines patients were meant to be taking at home.   This depiction is 
consistent with high rates of pharmacists’ interventions for discharge prescriptions reported in 
Australian hospitals.66, 267 A further example of poor coordination of prescribing activities was 
patient education about medicines.  Whilst the need for education was voiced among the 
registrar and JMO cohorts, there did not appear to be a strong sense of responsibility for it or the 
need to coordinate education with that of pharmacists.  It was unclear whether the lack of 
ownership for this role was related to a perception that patient education was the domain of 
pharmacists.  Findings from a survey in another Australian hospital found that doctors were 
unaware of the pharmacist’s role in patient counseling about medicines.169 
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The separate nature of these prescribing activities undertaken by the three professions also 
appeared to feed into the conceptualisation by some respondents of discrete, but 
complementary professional responsibilities.  This view was more dominant among doctors. For 
instance, a number of doctors felt that if a medication order was written correctly, then it was the 
nurses’ professional responsibility to ensure that they understood it before administering the 
drug.  A differing view was that the professions shared in a singular organisational responsibility, 
which was exemplified by the belief that communicators should check to see that their message 
has been understood.  This view was implied more strongly in the nurse and pharmacist cohorts.  
As suggested, this conceptualisation saw greater accountability for communication.  It was also 
characterised by a broader understanding of organisational units, which were responsible for 
different aspects of medicines management.  A number of investigators have reported 
differences in attitudes of doctors and nurses to error reporting in hospitals.  Nurses were found 
to have much greater awareness of error-reporting systems 268, 269 and had greater confidence in 
the hospital system to handle reporting in a supportive manner.268 
 
In theory, greater systems awareness might be expected to assist in the detection of errors and 
identification of potential causes, and the canvassing of possible solutions.265, 270 However, 
findings from our study showed that greater systems awareness did not necessarily help to 
circumvent some prescribing errors from occurring.  Cumulative evidence from a range of 
respondents’ (nurses, pharmacists and junior doctors) suggested that time constraints placed 
upon the junior doctor to write discharge prescriptions were a major source of error, yet the 
respondents appeared powerless to do anything about this.  Whilst environmental and resource 
issues might have come into play (such as the increasing pressure on public hospitals to 
improve bed turnover) deductively, the situation also suggested a lack of leadership and 
recognition of the problem by those with power to do something about it.  This dilemma has 
been signaled by Barber 89, who argues that structural issues in secondary care contribute to 
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prescribing errors.  Because the power structure is created vertically by clinical area (the power 
being held by the medical profession), “there is rarely anybody with enough power or influence 
to lead on them [medicines] at a local level”.   
 
The different notions of responsibility were further characterised by competing values of constant 
vigilance and fear of errors versus collegiality and trust.  Although there were individuals in each 
cohort who conveyed a preoccupation with things “going wrong”, this theme was stronger and 
more consistent in the pharmacist and nurse cohorts.  Perhaps because of the great reliance 
placed upon them to detect errors, the pharmacist cohort has the strongest awareness of human 
fallibility, and by implication, probably the greatest level of distrust of others.  In particular, they 
cast a high index of suspicion over new interns; several pharmacists feeling (and also some 
junior doctors) that prescribing errors were more likely at the beginning of internship. 
   
Within their teams, doctors placed a high reliance on trust.  Senior doctors routinely gave junior 
doctors verbal medication orders, with the onus placed on the junior doctors to query if they 
didn’t understand.  There was an appreciation that new interns required more information than 
more experienced junior doctors; nevertheless, examples provided by pharmacists suggested 
that sometimes this judgment was flawed with too much trust being placed in junior doctors to 
hear and interpret the medication order correctly.  Accounts of prescribing errors provided by 
some junior doctors highlighted the problem of not being aware of deficiencies in their own 
knowledge base and so therefore not knowing the right questions to ask.  Absence or poor 
communication within medical teams has been identified by others as a cause of prescribing 
errors.34   On this issue, the 2001 Audit Commission report into medicines management of 
publicly funded hospitals in the UK states that “no one can pre-specify their own ignorance” and 
recommends continual training and competency assessments for all involved in the prescription 
and administration of medicines.     
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Another way in which the value of collegiality and trust was implied in our study was the way in 
which consultants relied on information provided by their registrars over the phone to review or 
to make prescribing decisions.  In private hospitals, this same trust was placed in nurses.  This 
trust depended on their assessment of the individual with whom they were communicating, with 
greater trust placed on some people (for example, ward nurses known to them) than others 
(agency nurses).   For those whom they doubted, they increased their vigilance.   
 
High reliability organisations have a collective preoccupation with the possibility of failure and 
operate on the premise that humans are fallible.  They also recognise human variability and 
compensate for it. 80  Human variability was appreciated by the senior doctor cohorts, which was 
implied by the way in which they adjusted their behaviour to cater for certain individuals.  
Nevertheless, arguably, this alone was not enough to safeguard against errors.  This 
vulnerability was acknowledged by a number of consultants. One consultant felt that this was the 
only way the system could work; however, another argued that “outcome was better than 
processing”, that informal policies although flawed had benefits for patient care and were better 
than restrictive policies of prescribing, which might lead to delays in patients receiving therapy.  
These benefits, he argued were difficult to measure. An extension of this argument might be that 
one of the problems with perceiving roles and responsibilities as core components of a 
medicines management system is that the system places greater emphasis on identifying and 
safeguarding against errors than on promoting or facilitating optimal prescribing.  The quality of 
prescribing in certain circumstances may be reliant on maintaining flexibilities within the system.  
 
From a patient safety perspective, however, the variance in notions of responsibility point to two 
potential targets for improvement in prescribing practices.  Firstly, examination of the mores of 
communication among medical staff; and secondly, greater awareness within this group of 
medicine management system failures and how they may occur.  The first area does not appear 
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to have been addressed in the literature; however, there are two recent educational strategies 
which have been designed to heighten awareness of safety systems in hospitals.  These include 
patient safety education, which has been integrated into the undergraduate curricula of all major 
health professions 211; and for junior doctors, an online training module, which accompanies the 
National In-patient Medication Chart.  In addition to providing instruction on how to use the chart, 
the module addresses patient harm that can result from problems in the prescribing process.271     
4.1.4. Lack of patient involvement in decisions 
Overall, prescribing decisions at the hospitals were not shaped by the patient’s opinion. 
Although the importance of involving patients in prescribing decisions was strongly recognised 
by the consultant cohort, this emphasis was not similarly conveyed by the other doctor cohorts.  
A patient-focused approach accords with recent thinking on best medicines use; for example, 
the QUM principles of the National Medicines Policy (“the primacy of the consumer”13), Barber’s 
goals of prescribing (“respect patient’s choices”19),  and with UK prescribing curricula for non-
doctors (“helping patients make informed decisions about treatment options”28).  The strongest 
case for including patients in decision-making about medicines is that ultimately, their view 
predominates anyway, because they can choose whether or not to take the medicine. 19, 91These 
values were strongly evoked by the consultant cohort, but why weren’t they realised in the other 
medical cohorts?  There may be several reasons.   
 
Firstly, in an acute care facility, a detailed conversation with a patient about the relative merits of 
different medicines may be either inappropriate or impossible. Accounts from most of the 
registrar cohort suggested that the bulk of their work involved acute care management.  In 
contrast, many of the consultants who were interviewed had predominately outpatient practices 
and managed chronic conditions.  Therefore, it is possible these differing practice profiles may 
have accounted for the variation in the way the two groups made prescribing decisions.  
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However, it is also possible that hospital-based doctors make assumptions about the desire of 
patients to be involved in prescribing decisions; a paternalistic attitude towards elderly patients 
in regard to their involvement in decisions has been reported. 171   
 
Secondly, qualitative findings from a UK study suggest that consultants by virtue of their 
experience may have a greater ability than their junior colleagues to see the bigger picture when 
they prescribe, are better able to look outside the hospital context, and to appreciate the social 
context of the patient and the need for follow up.  This insight was considered to explain why 
consultants in the study felt that patients should fully participate in prescribing decisions.  In 
contrast, interns (pre-registration house officers) who were interviewed had more simplistic 
schemas of prescribing, which were narrowed to medical care in the hospital setting.  They 
viewed patients as passive receptors of medicines and did not see them as active participants in 
prescribing decisions.113  The authors theorised that interns’ simple schemas may represent a 
way of coping for these inexperienced prescribers.  Findings of this study imply that 
incorporation of the bigger picture and therefore the patient’s perspective may be a 
developmental step for prescribers and that it is unrealistic to expect interns to expand their 
schemas without the benefit of experience. 
4.1.5. Competing interests of patient safety and supervision of junior doctors 
 
The way in which prescribing plans were enacted was heavily dependent on the prescribing 
competency of junior doctors.  Junior doctors played a pivotal role in prescribing at the hospitals 
because they were the principal prescription writers and were therefore responsible for setting in 
motion most prescribing decisions.  However, as a number of respondents emphasised, the 
fundamental reason why junior doctors were performing this function was so that they could 
learn.  This is an accepted model of medicines management systems in teaching hospitals in 
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Australia 9, as well as the UK202 and US71) whereby junior doctors are anticipated to gain 
prescribing skills by fulfilling this function in the system.   
 
On face value, this is a huge responsibility for inexperienced prescribers, as patient safety may 
depend heavily on their actions.  This weight was felt by some of the junior doctor cohort who 
were keen to express their respect for prescribing, and appreciation of medicines as poisons.  
Others were more influenced by the systems of checks on their prescribing practices and felt 
little risk or weight of responsibility.  The literature, however, indicates that despite safety nets, 
inexperience is linked to errors.71, 87  
 
Data from our study showed that the interests of junior doctors and medication safety competed 
in several ways; firstly, by the marked diminution of supervision and checks on the practice of 
junior doctors working on weekends.  Some medical respondents saw this as a learning 
opportunity for junior doctors; but several pharmacists voiced concerns about greater rates of 
error over this period, and one consultant also expressed reservations about the system of 
“rostered days off”, which at one hospital, allowed an even longer period for junior doctors to 
operate without high levels of checks and balances on their prescribing.  A further illustration of 
competing needs was the pressure placed upon registrars to manage patient care whilst 
supervising an inexperienced prescriber.  The acute needs of patients were by necessity the 
registrars’ priority, but this did have implications for the level of scrutiny they could give to 
medication chart review.  Another example was the disclosure by several junior doctors of 
difficulty they experienced in adjusting doses of opiates and aminoglycoside antibiotics for 
patient specific factors.  Of interest, these particular gaps in knowledge have been identified as 
contributors to error in UK and US studies. 34, 74  
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The challenges of dealing with these competing interests have been observed by others, as 
Tanna and Pitkin write, “How can consultant teams ensure a high standard of prescribing 
decision-making and care delivery to patients, despite the training phase that junior medical staff 
need to go through?”272  The authors’ answer was to set up structured onsite training programs 
for junior doctors in the form of pharmacist-led medication management clinics operated with 
close liaison with consultant-led teams.  A national effort to deal with this challenge is the new 
Australian Framework Curriculum for junior doctors, which among other competencies, sets out 
explicitly stated prescribing skills expected to be mastered by junior doctors.  These include 
specific competencies related to medication safety.217 
4.2. COMMUNICATION PATTERNS 
A number of communication patterns affecting transfer of information about prescribing 
decisions were identified in this research.  Many have already been explored: reliance on verbal 
communication of prescribing decisions within medical teams; poor communication by doctors to 
nurses about treatment plans and new medication orders; and lack of communication and 
coordination between doctors and pharmacists about patient education of medicines.  Numerous 
hospital systems rely on communication, and hence in addition to prescribing errors34, 
communication failures have been linked to many forms of medical errors in hospitals.82  One 
US study set out to analyse the root causes for communications failures and found that many 
were due to complex reasons, such as hierarchical differences, concerns with upward influence, 
conflicting roles and role ambiguity, and interpersonal power and conflict. 88    In our study, as 
stated previously, hierarchy or power consciousness was not a particularly strong theme; but 
there were indications that uncertainties about roles and responsibilities were factors influencing 
communication between different professions.  For example, a clinical nurse educator spoke 
about her problem of maintaining a high profile so that junior doctors knew to contact her first 
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when prescribing a drug with special drug administration requirements, so that she could then 
educate the ward nurses.   
 
Another potential reason is the sense of priority.  Health professionals working in hospitals have 
been shown to have very high communication loads (36.5 communication events per person per 
hour in one Australian Emergency Department 273), so there are pressures on staff to work out 
what communication is necessary in order that they can work effectively.  This comes down to a 
question of priority, which is discussed in further detail below. 
4.3. UNDERLYING ASSUMPTIONS 
Several common underlying assumptions pervaded the culture of prescribing at the hospitals.  
Firstly, there was the ever-present undercurrent that prescribing was a low priority task.  This 
interpretation was based on a steady accumulation of themes: the lack of time allocated by 
medical teams during ward rounds to ensure accurate ordering of medicines at the time a 
decision was made; the absence of patient involvement in decisions and uncertainties about 
responsibilities to educate patients about new medicines; the confusion concerning 
responsibilities for transcribing and pressures brought to bear by junior doctors to prescribe for 
patients they didn’t know; the mundane nature of transcribing making consciousness about the 
consequences of the task difficult to sustain; lack of discussion in medical teams about the 
specifics of medication orders, particularly dosage, indication for this patient, goals for this 
patient, duration of therapy and so on.     
 
This pervasive assumption about prescribing in teaching hospitals has been observed by 
others89, and has also been linked to prescribing errors in the UK.34  Discussing teaching 
hospitals in the UK, Barber writes, “…the small amount of teaching in undergraduate courses 
and the absence of teaching of doses to house officers (junior doctors), all send a message that 
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these issues are not particularly important.”89  Registrars interviewed in our study were aware 
that interns needed more specific information about dosage of drugs; but other data suggested 
that the dominant convention of prescribing at the hospitals was that junior doctors located 
dosage information.  In summary, it appeared unlikely that dosage information was routinely 
discussed in any length or level of detail at the study hospitals, and that Barber’s comments 
were reflective of practice at the hospitals. 
 
This highlights a second underlying assumption, which was if inexperienced people are 
uncertain, then they will ask.  Ramifications on prescribing of this assumption have already been 
discussed under notions of responsibility.  Encouraging people to ask, challenge and question 
was perceived to be a critical way of communicating, educating, honing critical evaluation skills, 
and ensuring accountability for decisions.  One of the consultants also described this custom as 
being part of a research-based approach to prescribing.  Nevertheless, as highlighted earlier, 
potential problems were identified when assumptions were made about the knowledge base of 
the receiver – that they would know what to ask.  This suggests a basic imbalance in 
communication: that the governing mantra of urging junior or inexperienced people to ask wasn’t 
being equalised by questioning from the transmitters of information to see that messages were 
understood.  The reason for this imbalance was suggested by one of the junior doctors, who 
indicated a reluctance of medical staff to appear condescending. 
 
A third underlying assumption was that high rates of prescribing error were an acceptable part of 
prescribing in teaching hospitals, which emanated from a strong sense of security in the 
checking systems in the hospital.  Others have reported a tendency for doctors to drop their 
guard when prescribing because of their reliance on error monitoring systems.34  In some 
respects, this highlights a case where systems awareness may impede prescribing performance.  
One possible reason for this is that the systems awareness was only partial.  Whilst most 
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respondents knew that intercepted incidents were common, many of the junior doctor cohort had 
never seen a collated report of incidents at their hospital and were therefore unaware of the 
rates and types of incidents that slip through the system. 
4.4. KNOWLEDGE CHARACTERISTICS 
Due to the trickle down effect noted by a number of respondents, the most influential form of 
knowledge on prescribing at the hospitals was that bestowed by consultants and conveyed to 
registrars.  Therefore, day to day, a crucial determinant of prescribing decisions was the social 
knowledge acquired by registrars based on their consultant’s knowledge base.  Similarly, 
qualitative studies of hospital doctors in the UK and Ireland have found that social knowledge is 
the most common form of “evidence” used by non-consultant doctors. 133 131 In one study, it was 
found to have an overriding effect on registrar’s prescribing decisions, eclipsing other forms of 
knowledge, which they may have felt were more advantageous.131  In our study, little conflict 
was reported surrounding registrars’ evaluation of different forms of knowledge.  Predominately, 
most of the registrar cohort appeared confident of the legitimacy of their consultant’s knowledge 
and held the belief that it was based on scientific evidence and their greater personal 
experience.  Differences in prescribing patterns of consultants’ working in the same field were 
attributed by some, to differences in interpretation of the scientific literature.   Also, unlike the UK 
study, although consultants were seen to be the leading influence on prescribing, it seemed that 
registrars (in the main, the advanced trainees) felt a reasonable level of prescribing autonomy 
and confidence to use other information sources, if they were able to justify their use to their 
consultants.  
 
In addition to the consultants’ knowledge base, the registrar cohort also integrated knowledge 
acquired from protocols and guidelines, electronic databases, their own reading of the scientific 
literature, and personal experience.  De Souza et al 133 found that hospital-based protocols and 
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formal guidelines had very little influence on the antimicrobial prescribing practices of non-
consultant doctors; informal guidelines and personal experience were utilised preferentially.  
This was not apparent in our study, where both registrars and junior doctors commonly cited 
their use of hospital-based protocols and externally developed guidelines, which were used 
either to supplement information provided by consultants, or used as the primary source of 
information.  In the case of hospital-based protocols, these were often developed or at least 
endorsed by their consultants anyway.  Awareness of protocols was illustrated by the commonly 
used expression that prescribing in certain clinical areas was “protocol driven.” 
 
In our study, junior doctors had a similar pattern of knowledge utilisation to registrars, in that the 
dominant influence on their prescribing was socially driven.  For the few independent prescribing 
decisions that they made, their registrar’s knowledge was seen to be the most influential factor 
and took precedence over other forms of evidence they located, including guidelines.  This 
finding marries with findings from another Australian study, which identified registrars as an 
important positive influence on interns’ prescribing practices.132  Despite this reliance on advice 
of registrars, as was the case for the registrar cohort, junior doctors had clear notions of the 
scientifically driven hierarchy of evidence and were keen to express their realisation of the 
scientific foundations for prescribing decisions.  
 
The dominance of social knowledge as the basis for most prescribing decisions in hospitals has 
several potential implications for the acquisition of prescribing skills.  Prosser and Walley 131 
argue that the grounding of scientific evidence in social processes is a legitimate means of 
making rational and appropriate prescribing decisions.  They found that although decisions were 
based on informally and locally constructed knowledge that this did “not imply the process is 
unreflective.” However, they did conclude that because of the mode of knowledge acquisition, 
the way in which doctors initiated new drugs was “distinct in content and structure” from the 
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desired cognitive sequence promoted as the normative for evidence-based practice. Therefore, 
arguably, the dominance of social knowledge as the model for behaviour adoption of junior 
doctors may reinforce habitual patterns of prescribing rather than promote cognitive and 
systematic contemplation of the pros and cons of treatment options.  Although habitual 
prescribing does not necessarily imply irrational prescribing 112, it is widely thought to leave 
prescribers vulnerable to influences which may cause inappropriate prescribing, such as 
pharmaceutical industry promotion.16  
 
This highlights another cultural characteristic of prescribing at the hospitals, which was the 
breadth and depth of consciousness about pharmaceutical industry.  Drug representatives 
appeared to have quite a high profile at both hospitals, particularly through their provision of 
journal articles to registrars and consultants, and their sponsorship of many meetings.   Although 
junior doctors did not appear to meet with representatives, they were aware that their registrars 
and consultants did.   Whilst many of the consultant cohort expressed self-awareness about the 
potential effect of industry on their behaviour; this was not apparent in the registrar cohort, who 
felt that they were immune to the effects. This naivety about the influence of industry has been 
reported by many others144, 145 and is potentially concerning given the apparent targeting by drug 
representatives of registrars at the hospitals.  
4.5. WORK ENVIRONMENT 
There were three main work environment factors identified that influenced prescribing at the 
teaching hospitals: interruptions, workload and stress. All of these have been linked to  
error.34, 175 Frequent interruption with paging has been found to interrupt patient care, and 
distraction caused by interruptions is considered an important cause for active error.175 In our 
study, busyness or workload were the most commonly cited contributors to prescribing error.  
This is consistent with findings from other studies.34, 81   
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Busyness, however, was also blamed for many other changes to the way in which prescribing 
activities were carried out in the hospitals.  One nurse spoke about the way that the hospital has 
changed throughout her career, with higher rates of bed turnover and an increased emphasis on 
acute care.  She ascribed this cause to the reason why pharmacists and nurses no longer had 
time to join doctors on ward rounds.  This theme was repeated by others: a pharmacist spoke of 
the irony of spending more time dispensing discharge prescriptions than on reviewing 
medication charts, another pharmacist felt that there was no longer any forum where she could 
sort out medication problems with junior doctors due to busyness; and a consultant felt that 
there were too many pressures on public hospitals and therefore prescribing had to compete 
with many other workload responsibilities.   
4.6. STUDY WEAKNESSES 
Whilst prescribing is a core treatment option for many clinical conditions, doctors are more than 
prescribers.  In this study we have purposely focused on one core element of their practice with 
no acknowledgement of the other essential roles doctors play in patient care in hospitals, many 
of which may be considered to have greater clinical urgency than making a prescribing decision 
or writing a medication order.  We have also looked at prescribing somewhat in isolation from 
other core components of medicines management.  Although prescribing is the chief function of 
doctors in the medicines management system, traditionally, the chief function of pharmacists is 
to dispense and supply medicines, and nurses’ primary role is to administer the medicines.  We 
have not addressed any of these functions, as our focus was on the ignition stage of the 
process.  We did, however, purposely examine opinions about patient education of medicines, 
because this was recognised as a key step in the WHO normative model of prescribing, and as 
addressed earlier, there are strong arguments for incorporating patient’s views in prescribing 
decisions and therefore commencing patient education at the time a decision is made.  
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A further limitation of the study design is that we did not incorporate the patient’s perspective.  
Whilst analyses of organisational culture have traditionally focused on health professionals 
alone, it is argued that patients are inextricably part of hospital culture, much more so than 
consumers of services in other organisations.274   Furthermore, as has already been discussed, 
patients play a pivotal role in prescribing and are the ultimate determinate of prescribing 
decisions; their influence has only recently formed the focus of enquiry into prescribing practices 
in hospitals.171 
 
Another weakness of this study is the potential bias of the researchers.   As detailed in Chapter 
Two, the primary researcher is a pharmacist who has worked in hospitals, and theoretically may 
have a bias towards reporting the behaviours of other health professions in particular lights.  
Furthermore, there was no external validation of results by non-pharmacists.  However, a 
counter argument to this charge is that the hospital environment consists of multiple systems 
and specialised processes.  The practices, behaviours and interrelationships governing 
prescribing culture are complicated, and having some prior understanding of the environment 
might be advantageous to the depth of exploration.   
 
The generalisability of the qualitative findings is keenly debated.243  In accordance with the views 
on of noted qualitative researchers 238, it is the belief of this researcher that the core concepts 
identified in this study have transferability to other teaching hospitals. However, the extent of 
representation may be best tested using quantitative techniques. 
4.7. AREAS FOR FUTURE RESEARCH 
 
One of the potential applications of findings from this study is to use the socio-cultural drivers, 
which were identified, to optimise the design and implementation of future prescribing 
improvement strategies in teaching hospitals.147  It is argued that this objective would be best 
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met by conducting a preliminary quantitative study at the proposed intervention site(s) to test the 
validity of factors from this study (ie, to see if the factors are representative of forces driving 
prescribing and prescriber education at other hospitals) and to assess their relative importance.   
 
CONCLUSION 
 
Prescribing at the teaching hospitals was shaped by a complex web of socio-cultural 
determinants inherent to the working environment.  Both the decisions and actions of the health 
professionals involved in prescribing were influenced by these forces.  These factors were 
predominately related to: the organisational structure of the prescribing process; the knowledge 
characteristics of the doctors; the communication patterns they used; the underlying 
assumptions they made about prescribing; and the hospital work environment itself.  
Consideration of these factors may be important for the design and implementation of strategies 
to improve the quality use of medicines in the hospitals, and also educational programs in 
prescribing for junior doctors. 
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DATE 
 
NAME 
Address 
Address 
 
 
Dear XXXX 
 
Research study: Exploring influences on prescribing in two teaching hospitals  
 
Chief Investigator: Prof Jo-anne Brien1, Co-researchers: Dr Beata Bajorek2 ; Meredith Page3 
 
We are writing to invite you to be part of a Steering Committee for a qualitative study designed to explore 
social and cultural influences on prescribing.  The study is being conducted by Meredith Page to meet the 
requirements for the degree of Masters of Pharmacy and will involve practitioners based at Royal North 
Shore Hospital and St Vincent's Hospital.  We already have the involvement of Professor Gillian Shenfield 
and Professor Ric Day. 
 
Background  
The quality use of medicines is a key factor in achieving optimal health outcomes. Between two to three 
percent of all hospital admissions in Australia are related to problems with medicines44, demonstrating the 
need for improved use of drugs in hospitals and the community. Whilst the proportion of admissions linked 
to prescribing practices in Australian hospitals is unknown, studies in UK and US hospitals indicate that 
prescribing problems are a major cause of preventable drug-related morbidity.57, 62Prescribing drugs is a 
high-risk and complex activity.  A thorough grounding in the evaluation of patient-related and drug-related 
factors is considered fundamental to prescriber training.16 Nevertheless, studies with experienced 
prescribers in the community have shown that the social environment can also have a substantive 
influence on prescribing practice.104, 118 Furthermore, recent studies in UK and US suggest that socio-
cultural factors in hospitals may contribute to prescribing errors and other medical errors.34, 88 Currently, 
the impact of the social environment on prescribing practices in Australian teaching hospitals is unclear.  
In two related Australian studies, interns nominated senior medical staff, nurses and pharmacists as the 
primary influence on their prescribing practice116, 204, yet little is known about the effect of attitudes, 
intended behaviours, values, and perceived influences of these professional stakeholders on prescribing 
practices.  It is hoped that an improved understanding of these influences may be used to optimise the 
effectiveness of future educational strategies to improve prescribing in teaching hospitals. 
 
Aim 
The aim of this project is to identify social and cultural factors in two teaching hospitals that affect 
prescribing behaviour generally and the way in which junior doctors learn to prescribe.   
  
Methods  
 Participants from each of the following groups across the two hospitals will be invited to take part: 1) 
consultants in medical specialties; 2) registrars in medical specialties; 3) pharmacists in medical 
wards; 4) registered nurses in medical wards; 5) interns or residents who are currently working in or 
have completed at least one medical term.  
 Participation in the study will involve semi-structured interviews of up to one-hour duration, and a short 
questionnaire to collate demographic data.  
 Transcripts of interviews will be analysed for themes using qualitative research techniques.    
 The study has been approved by the University of Sydney HREC and will be submitted to the St 
Vincent's Hospital and Northern Sydney Health HRECs. 
                                               
1
 Professor of Clinical Pharmacy (St Vincent's Hospital), Faculty of Pharmacy, University of Sydney 
2
 Lecturer in Pharmacy Practice, Faculty of Pharmacy, University Of Sydney; Research Associate, Departments of Aged Care & 
Rehabilitation, and Clinical Pharmacology, RNSH 
3
 Masters of Pharmacy candidate, Faculty of Pharmacy, University of Sydney 
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What we are requesting of you: 
Interview schedules for the five groups of health professionals have been developed based upon a 
literature review.  We wish to refine the interview schedules to ensure that the questions encompass 
current social, relational or cultural influences on prescribing at the two hospitals. 
 
Therefore, we are asking if you would be: 
 
 willing to provide comments via email on one or two of the interview schedules.  
   
 interested in participating in a pilot interview (may take up to one hour). 
 
If you are willing to be a part of our Steering Committee, please fax back this page to 8382 4219 or call 
Meredith Page on 8382 2053.  We will also be calling all invitees to verify receipt of this information. 
 
We appreciate your consideration of this invitation. If you have any questions regarding the study, please 
call Meredith Page on 8382 2053 or Jo-anne Brien on 8382 2605. 
 
Yours sincerely 
 
 
 
Professor Jo-anne Brien                Dr Beata Bajorek                                Meredith Page 
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Yes, I …………………………………………………………am willing to be on the Steering Committee for the 
research study 'Exploring influences on prescribing in two teaching hospitals'. 
  I am willing to provide comments via email 
  I am interested in participating in a pilot interview  
 
My email address is:……………………………………………………………………………………….. 
 
My preferred contact number is:…………………………………………………………………………. 
 
Signed………………………………………………………………Date ……………………….. 
Fax to 8382 4219 or call 8382 2053 
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Interview Topic Guide: Consultants and 
Registrars 
 
Comments: 
Research Objective 1 
 Improve understanding of workplace influences on prescribing in hospitals 
Q1 How does prescribing take place? 
 
1A Roles and relationships 
⇒ I’m going to begin by asking you about your perceptions of how prescribing takes place in this hospital, 
and firstly, I’d like to ask you about roles.. 
 
 Tell me about your role in ensuring patients in your care receive appropriate drug therapy? 
 
 
 Who else is involved? 
 
 
 How would you describe your relationship with them? 
 
 
 What do you see as being their roles?   
 
 
 What is your opinion on what they do? 
 
 
1B Communication Patterns 
⇒ Now, I’d like to ask you about how you communicate with other people involved in managing drug therapy 
 
  Day to day, what information is typically discussed with members of your team before a drug is prescribed?   
 
 
  Who says what? Can you provide an example of how a conversation might take place? 
 
 
 What information about prescribing a particular drug would you typically give to a JMO in order to communicate 
to them what you would like prescribed? 
 
 
 Can you provide an example? How is the information conveyed? 
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1C Roles and responsibilities 
⇒ Now, I’d like to focus on responsibilities you may associate with prescribing  
 
 i) In this hospital, who do you feel makes the majority of the prescribing decisions for your patients? 
 
 
 
 ii) In this hospital, who do you see as being responsible for ensuring that drugs are prescribed appropriately? 
 
 
 
 iii) What about pharmacists, nurses, D & T committee members, admin ? 
1D Information sources 
⇒ Now, I’d like ask you about sources of information you use when prescribing in this hospital 
 
  Day to day, what sources of information do you rely on the most for the majority of prescribing decisions that 
you make? 
 
 
Personal experience?  Colleagues/staff?  Written or electronic resources?   
 
 
 
 What is it about that source that you value? 
 
 
  
  What is your opinion of access to this resource and other resources? 
 
Q2 How is prescribing valued in the hospital? 
⇒ Now, I’d like ask you about your attitudes and feelings about prescribing 
 
 2A How would you describe the type of risk you feel when you prescribe?  What level of care? 
 
 
 
 2B How does this type of risk compare with other decisions you make regarding a patient’s care? 
 
 
 
 2C What feelings are engendered? 
 
 
 
 2D What skills do you think are required to prescribe competently? 
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Q3 How is prescribing defined? 
 
 3A How would you define prescribing? 
 
 
 3B What are the goals of prescribing? 
 
 
 3C What activities do you consider constitute good prescribing? 
 
Q4 What are the Influences on prescribing decisions? 
⇒Now, I’d like to ask you about influences on the way in which you prescribe in this hospital. 
 
 4A In the hospital, who or what do you consider to be the strongest influence on the decisions that you make 
when prescribing? 
 
 How would you describe the influence of: 
 
• 4B Medical Colleagues • 4E Pharmaceutical industry 
• 4C Nurses • 4F Patients 
• 4D Pharmacists 
 
• 4G Drug Cost 
 
Q5 What are the influences on prescribing errors? 
⇒Now, I’d like to ask you about influences on how well decisions that you may make are carried out 
 
 5A Ensuring that we get the best out of medicines is a challenge for everyone involved with managing medicines.  
Part of the challenge in hospitals is ensuring that the system for managing medications works.  Despite best 
efforts, things do go wrong, which is widely acknowledged in the literature.  Have you been in a situation where 
you prescribed a drug in good faith, but your patient did not receive the drug therapy as you intended due to 
perceived problems with your written prescription and instructions OR a misinterpretation of your prescription and 
instructions? Can you describe the experience? 
 
 
 5B Were there any (workplace) factors that you felt contributed to this episode? 
 
 5C What gaps in the system do you see that allow such errors to occur?  
 
 
 
 5D What do you think could be improved to reduce the likelihood of errors? 
 
 
 
 5E How well do you feel prescribing errors are handled in this hospital? How do you handle prescribing errors? 
 
 
Research Objective 2 
 Improve understanding of workplace influences on training in prescribing in hospitals 
  235 
Q6  What assumptions are made of prescribing skills of interns? 
 6A What skills in prescribing do you expect of an intern at the start of their internship? 
 
 
 
 6B How do you assess their competency to be confident that they are prescribing appropriately and safely? 
 
 
Q7 Influences on JMO prescribing 
 7A Which people were influential in teaching you to prescribe? 
 
 
 
 7B What type of influence do you think you have on the way JMOs prescribe? 
 
 
 
 
 7C What is you role in ensuring JMOs develop good prescribing habits? (supervisor, coach, mentor)  
 
 
 
 7D What do you see as being your responsibilities regarding JMO training in prescribing? 
 
 
 
 7E I am an intern starting at this hospital tomorrow in your team and I have concerns about my ability to prescribe 
safely and appropriately.  What advice about prescribing in this hospital would you provide? 
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Interview Guide: Pharmacists and Nurses 
 
Comments: 
Research Objective 1 
 Improve understanding of workplace influences on prescribing in hospitals 
Q1 How does prescribing take place? 
 
1A Roles and relationships 
⇒ I’m going to begin by asking you about your perceptions of how prescribing takes place in this hospital, 
and firstly, I’d like to ask you about roles. 
 
 Tell me about your current role in ensuring patients receive appropriate drug therapy in this hospital? 
 
 
 Who else is involved? 
 
 
 How would you describe your relationship with them? 
 
 
 What do you see as being their roles?   
 
 
 What is your opinion of what they do? 
 
 
1B Communication Patterns 
⇒ Now, I’d like to ask you about how you communicate with the other people involved in managing drug 
therapy 
 
 Day to day, what information is typically discussed before a drug is prescribed?   
 
 
 Who says what? Can you provide an example of how a conversation might take place? 
 
 
 What information about prescribing a particular drug would you typically give to a JMO in order to 
communicate to them what you would like prescribed? 
 
 
 Can you provide an example? How would you convey the information? 
 
 
 
1C Roles and responsibilities 
⇒ Now, I’d like to focus on responsibilities you may associate with prescribing  
 
 In this hospital, who do you feel makes the majority of the prescribing decisions for patients in your care? 
 
 
 
 In this hospital, who do you see as being responsible for ensuring that drugs are prescribed appropriately? 
 
 
 
 What about D & T committee members, hospital administration? 
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1D Information sources 
⇒ Now, I’d like ask you about sources of information you use when you provide input into prescribing. 
 
  Day to day, what sources of information do you rely on the most for the majority of prescribing decisions or 
decisions about drug therapy that you make? 
 
Personal experience?  Colleagues/staff?  Written or electronic resources?   
 
 
 What is it about that source that you value? 
 
  
  What is your opinion of access to this resource and other resources? 
Q2 How is prescribing valued in the hospital? 
⇒ Now, I’d like ask you about your attitudes and feelings about prescribing 
 
 2A How would you describe the type of risk associated with prescribing?  What level of care? 
 
 
 
 2C What feelings are engendered? 
 
 
 
 2D What skills do you think are required to prescribe competently? 
 
Q3 How is prescribing defined? 
 3A How would you define prescribing? 
 
 
 
 3B What are the goals of prescribing? 
 
 
 
 3C What activities do you consider constitute good prescribing? 
 
 
Q4 What are the influences on prescribing decisions in the hospital? 
⇒Now, I’d like to ask you about your perception of influences on prescribing behaviour in this hospital. 
 
 4A In the hospital, who or what do you consider to be the strongest influence on prescribing behaviour? 
 
 How would you describe the influence of: 
 
• 4B Medical staff – who? • 4E Pharmaceutical industry – what is your opinion about them?
• 4C Nurses • 4F Patients 
• 4D Pharmacists 
 
• 4G Drug Cost 
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Q5 What are the influences on prescribing errors? 
⇒Now, I’d like to ask you about influences on how well decisions that you may make are carried out 
 
 5A Ensuring that we get the best out of medicines is a challenge for everyone involved with managing 
medicines.  Part of the challenge in hospitals is ensuring that the system for managing medications works.  
Despite best efforts, things do go wrong, which is widely acknowledged in the literature.  Have you been in a 
situation where a drug was prescribed in good faith, but your patient did not receive the drug therapy as 
intended due to perceived problems with the prescription OR a misinterpretation of the prescription? Can you 
describe the experience? 
 
 
 5B Were there any (workplace) factors that you felt contributed to this episode? 
 
 5C What gaps in the system do you see that allow such errors to occur?  
 
 
 
 
 5D What do you think could be improved to reduce the likelihood of errors? 
 
 
 
 5E How well do you feel prescribing errors are handled in this hospital? How do you handle prescribing errors? 
 
 
Research Objective 2 
 Improve understanding of workplace influences on training of prescribing in hospitals 
Q6  What assumptions are made of prescribing skills of interns? 
 6A What skills in prescribing do you expect of an intern at the start of their internship? 
 
 
 
 6B How do you assess their competency to be confident that they are prescribing safely? 
 
 
 
  239 
Q7 Influences on JMO prescribing 
 
 7B What type of influence do you think you have on the way JMOs prescribe? 
 
 
 
 7C What is your role in ensuring JMOs develop good prescribing habits? (supervisor, coach, mentor)  
 
 
 
 7D What do you see as being your responsibilities regarding JMO training in prescribing? 
 
 
 
 7E I am an intern starting at this hospital tomorrow in your team and I have concerns about my ability to 
prescribe safely and appropriately.  What advice about prescribing in this hospital would you provide? 
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Interview Guide: JMOs 
 
Comments: 
Research Objective 1 
 Improve understanding of workplace influences on prescribing in hospitals 
Q1 How does prescribing take place? 
 
1A Roles and relationships 
⇒ I’m going to begin by asking you about your perceptions of how prescribing takes place in this hospital, 
and firstly, I’d like to ask you about roles. 
 
 Tell me about your current role in ensuring patients receive appropriate drug therapy in this hospital? 
 
 
 
  Who else is involved and what are their roles? 
 
 
 
  How would you describe your relationship with them? 
 
 
 
 What is your opinion of what they do? 
 
 
 
1B Communication Patterns 
⇒ Now, I’d like to ask you about how you communicate with the other people involved in managing drug 
therapy 
 
 Day to day, what information is typically discussed with members of your team before a drug is prescribed?  
How are discussions resolved  Who has the final say? 
 
 
 Who says what? Can you provide an example of how a conversation might take place? 
 
 
 What information about prescribing a particular drug would you typically receive from a registrar, consultant, 
nurse or pharmacist? How comfortable are you questioning consultants? 
 
 
 Can you provide an example? How is the information conveyed? 
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1C Roles and responsibilities 
⇒ Now, I’d like to focus on responsibilities you may associate with prescribing  
 
 In this hospital, who do you feel makes the majority of the prescribing decisions for your patients? 
 
 
 
 In this hospital, who do you see as being responsible for ensuring that drugs are prescribed appropriately? 
 
 
 
 What about pharmacists, nurses, D & T committee members, hospital administration ? 
1D Information sources 
⇒ Now, I’d like ask you about sources of information you use when making decisions about whether to 
prescribe or what drug to prescribe for patients in this hospital 
 
 Day to day, how do you typically make decisions about drug therapy? Who or what do you rely on the most 
for the majority of prescribing decisions that you make? 
 
 
Personal experience? Colleagues/staff? Written or electronic resources?   
 
 
 v) What is your opinion of access to resources? 
 
Q2 How is prescribing valued in the hospital? 
⇒ Now, I’d like ask you about your attitudes and feelings about prescribing 
 
 2A How would you describe the type of risk you feel when you prescribe?  What level of care? 
 
 
 
 2B How does this type of risk compare with other decisions you make regarding a patient’s care? 
 
 
 
 2C What feelings are engendered when you prescribe?  Does this vary in situations when you are 
transcribing a chart or writing up medications for a patient who isn’t yours? 
 
 
 
 2D What skills do you think are required to prescribe competently? 
 
 
Q3 How is prescribing defined? 
 3A How would you define prescribing? 
 
 
 
 3B What are the goals of prescribing? 
 
 
 
 3C What activities do you consider constitute good prescribing? 
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Q4 What are the Influences on prescribing decisions? 
⇒Now, I’d like to ask you about influences on the way in which you prescribe in this hospital. 
 
 4A In the hospital, who or what do you consider to be the strongest influence on the decisions that you make 
when prescribing? 
 
 How would you describe the influence of:   
 
• 4B Medical Colleagues • 4E Pharmaceutical industry – what is your opinion about them?
 
• 4C Nurses • 4F Patients 
• 4D Pharmacists 
 
• 4G Drug Cost 
Do you receive advice from them on prescribing? 
Q5 What are the influences on prescribing errors? 
⇒Now, I’d like to ask you about influences on how well decisions that you may make are carried out 
 
 5A Ensuring that we get the best out of medicines is a challenge for everyone involved with managing 
medicines.  Part of the challenge in hospitals is ensuring that the system for managing medications works.  
Despite best efforts, things do go wrong, which is widely acknowledged in the literature.  Have you been in a 
situation where you prescribed a drug in good faith, but your patient did not receive the drug therapy as you 
intended due to perceived problems with the prescription OR a misinterpretation of the prescription? Can you 
describe the experience? 
 
 
 
 5B Were there any (workplace) factors that you felt contributed to this episode? 
 
 5C What gaps in the system do you see that allow such errors to occur?  
 
 
 
 5D What do you think could be improved to reduce the likelihood of errors? 
 
 
 
 5E How well do you feel prescribing errors are handled in this hospital? How do you handle prescribing errors? 
 
 
Research Objective 2 
 Improve understanding of workplace influences on training of prescribing in hospitals 
Q6  What assumptions are made of prescribing skills of interns? 
 6C What training did you receive in prescribing as a student? 
 
 
 6A What prescribing skills do you feel you need at the start of the year? 
 
 
 6D When you started working in this hospital, how prepared for prescribing did you feel?  
 
 
 6E How would you describe the fit between your preparedness in prescribing and people’s assumptions of your 
skills? 
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Q7 Influences on JMO prescribing 
 
 
 7A Since starting work in this hospital, who or what has been influential in teaching you to prescribe? 
 
 
 
 
 7D Who do you see as being responsible for ensuring you receive training in prescribing?  
 
 
 
 
 7E I am an intern starting at this hospital tomorrow and I have concerns about my ability to prescribe safely and 
appropriately.  What advice about prescribing in this hospital would you provide? 
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  Date………..………………. 
Code………….…………….. 
Excel 
Questionnaire for research study: 
Exploring influences on prescribing in two teaching hospitals. 
 
The purpose of this questionnaire is to provide a context for your perceptions on prescribing, which will be 
explored in a subsequent interview. The survey is expected to take approximately five minutes to complete.  Your 
privacy whilst participating in this study will be maintained at all times.  The information you provide in this survey 
will be identifiable via numerical code only.  If you have any questions regarding this survey, please contact 
Meredith Page on 8382 2053 or Prof Jo-anne Brien on 8382 2605. Please tick a box to indicate your response. 
 
Q1. Demographics 
 
(a) Age 
 under 25 years 
 25 to 34 
 35 to 44 
 45 to 60 
 over 60 
(b) Gender 
 
 F 
 M 
 
 
 
Q2. Current Position 
 
(a) Which of the following descriptions best fits your current position in the hospital? 
 Please tick one box
 
 
 registered nurse 
 clinical nurse educator 
 clinical nurse consultant  
 
 
 ward pharmacist 
 specialist clinical pharmacist  
 
 
 
 intern (PGY1)  
 resident medical officer (PGY2) 
 senior resident medical officer 
 registrar 
 academic physician 
 visiting medical officer 
 visiting medical officer with  
academic affiliation 
 staff specialist 
 staff specialist with academic 
 affiliation
 other    Please describe……………………………………………………………………… 
 
(b) Which of the following terms best fits your specialisation / current area of practice/ or current medical 
rotation in this hospital: 
 
Please tick one box 
 
 Cardiology 
 Dermatology 
 Endocrinology 
 Gastroenterology 
 General medicine 
 Geriatrics 
 Haematology 
 Immunology 
 Infectious Diseases 
 Intensive Care 
 Neurology 
 Oncology 
 Palliative Care 
 Pharmacology 
 Psychiatry 
 Renal  
 Respiratory 
    
 Other.  Please name………………………………………………… ………………………. 
 
  
Q3. Work Experience  
 
(a) Number of years postgraduate: 
 less than 2 years 
 3-8  
 9-20 
 more than 20 
(b) Number of years working in hospitals: 
 less than 2 years 
 3-8 
 9-20 
 more than 20 
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Q4. Involvement in drug use interventions  
 
(a) Have you ever been a member or held an advisory position in: 
(i) a hospital drug and therapeutics committee?       Yes    No 
(ii) a state or national therapeutic advisory committee (eg, NSWTAG, NPS) ?   Yes    No 
(iii) an advisory committee set up by a pharmaceutical company?     Yes    No 
(iv) other committee or organisation with a substantial focus on medicine use?    Yes    No 
If yes, please name………………………………………………………………….. 
(b) Have you ever been involved in the development of: 
(i) drug-related clinical practice guideline(s) or clinical pathway     Yes    No 
(ii) drug-related hospital policy(ies) or protocol(s)      Yes    No 
(iii) other guidelines/policies/ protocols related to drug use     Yes    No 
If yes, please name………………………………………………………………….. 
(c) Have you ever been an investigator in a research project(s) involving: 
(i) a drug-related clinical trial         Yes    No 
(ii) a drug use evaluation project        Yes    No 
(iii) adverse drug reaction monitoring       Yes    No 
(iv) patient adherence/compliance project       Yes    No (v) 
other research project related to drug use       Yes    No 
If yes, please name………………………………………………………………….. 
   
**Junior Medical Officers**→ Go to Q6 
 
Q5. Involvement in education and training:  
 
(a)  In the last 12 months: 
 
(i) have you provided any lectures, tutorials or bedside training to medical students?   
      Yes    No → Go to Q5 (b). 
 
(ii) have you provided any such training in therapeutics, prescribing, drug administration or any other drug-
related activity?       Yes    No → Go to Q5 (b) 
 
 
 (b)  In the last 12 months: 
 
(i) have you provided any lectures, tutorials or bedside training to junior medical officers (PGY1 or PGY2)? 
       Yes    No→ Go to end of survey 
 
(ii) have you provided any such training in therapeutics, prescribing, drug administration or any other drug-
related activity?       Yes   No→ Go to end of survey 
 
 
Q6. For JMOs only: Which medical school did you attend? 
 
…………………………………………………………………………………………………………… 
 
 
 
 
Thank you for your time and effort in completing this survey 
 
Please return via internal mail in the envelope provided marked ‘CONFIDENTIAL’ to: 
 Meredith Page, Level 2, Xavier Building Therapeutics Centre, SVH OR 
 Meredith Page, Clinical Pharmacology, Level 11, Main Block, RNSH 
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Calling all JMOs – help needed please! 
 
Dear Doctor 
 
I am seeking your opinion about issues relating to medication prescribing as 
part of a study looking into factors that may influence prescribing in 
teaching hospitals.  
 
I am a postgraduate research student with the University of Sydney and will 
be interviewing junior medical officers, registrars, consultants, nurses and 
pharmacists to explore experiences, perceptions, as well as attitudes 
towards prescribing.  
 
What’s involved? Participation will involve completing a questionnaire 
(less than 5 mins) and taking part in a one-to-one interview (45 mins). 
 
When and where? Interviews will take place in September/October 2004 
and you can choose the time and location.  A room is also available for 
interviews on Level 11, Main Block, RNSH.  Unfortunately, no remuneration 
can be provided, but refreshments, including lunch if desired will be made 
available. 
 
Yes, I’d like to help.  Please contact Meredith Page on 8382 2053 or 
XXXXXX or email mpage@student.usyd.edu.au before  
29 October 2004.  This study has been approved by the Northern Sydney 
Health Human Research Ethics Committee. 
 
Thank you for your consideration of this invitation.  I appreciate your time 
and help. 
 
Yours sincerely 
 
 
 
Meredith Page 
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PARTICIPANT CONSENT FORM 
 
RESEARCH STUDY INTO: EXPLORING INFLUENCES ON PRESCRIBING IN TWO TEACHING 
HOSPITALS 
Chief Investigator:  Prof Jo-anne Brien1 ; Co-Researchers: Dr Beata Bajorek2, Meredith Page3 
 
 
I, ...........................................................................................................................................................  
[name] 
 
of ..........................................................................................................................................................  
[address] 
 
have read and understood the information for participants on the above named research study and have 
discussed it  
 
..............................................................................................................................................................  
[signature] 
 
I am aware of the procedures involved in the study, including any inconvenience, risk, discomfort or side 
effect, and of their implications. 
 
 
I freely choose to participate in this study and understand that I can withdraw without compromise at any 
time.  
 
 
I also understand that the research study is strictly confidential. 
 
 
I hereby agree to participate in this research study. 
 
 
Signature:............................................................................................................................................  
 
 
Name: ..................................................................................................................................................  
 
 
Date:.....................................................................................................................................................  
 
 
 
Signature of witness: .........................................................................................................................  
 
 
Name of witness:................................................................................................................................  
 
If you would like to know more at any stage, please feel free to contact Meredith Page on 8382 2053 or 
Prof Jo-anne Brien on 8382 2605. Any person with concerns or complaints about the conduct of a 
research study can contact the Manager for Ethics Administration, University of Sydney on (02) 
9351 4811. 
                                               
1
 Pharmacia and Upjohn Chair in Clinical Pharmacy (Faculty of Pharmacy, University of Sydney, based at St Vincent’s Hospital)  
2
 Lecturer in Pharmacy Practice, Faculty of Pharmacy, University of Sydney 
3
 Masters in Pharmacy candidate, Faculty of Pharmacy, University of Sydney 
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RESEARCH STUDY INTO: EXPLORING INFLUENCES ON PRESCRIBING IN TWO TEACHING 
HOSPITALS 
 
Chief Investigator:  Prof Jo-anne Brien1, Co-Researchers: Dr Beata Bajorek2, Meredith Page3 
 
PARTICIPANT INFORMATION SHEET 
 
You are invited to take part in a research study into exploring influences on prescribing in two teaching 
hospitals (St Vincent’s Hospital and Royal North Shore Hospital).  The objective is to identify social and 
cultural factors that may influence the prescribing process and the way in which junior doctors learn to 
prescribe.  In other words, to explore attitudes, intended behaviours and perceived influences of health 
professionals typically involved in prescribing or training in prescribing in two hospitals.  It is hoped that 
findings from the study will improve understanding of the influence of hospital culture on prescribing and 
be used to optimise the effectiveness of educational interventions to improve prescribing in teaching 
hospitals. This study is being conducted by Meredith Page to meet the requirements for the degree of 
Masters in Pharmacy under the supervision of Professor Jo-anne Brien of the Faculty of Pharmacy at the 
University of Sydney. 
 
If you agree to participate in this study, you will be requested to: 1) fill out a questionnaire, which will take 
approximately five minutes to complete; and to 2) participate in one semi-structured interview of up to one 
hour in duration. The interview will take place at a suitable location within the hospital that is convenient to 
you.  The interview will be recorded using a digital sound recorder and field notes may be written.  You will 
have the opportunity to withdraw or amend any information during or at the end of the interview.  You will 
also be given the opportunity to preview the interview transcript before it is used, if desired.  
 
All aspects of the study, including results, will be strictly confidential and only the investigator named 
above (ie, Meredith Page) will have access to information on participants except as required by law.  
Following collection, all data will be de-identified and coded numerically. All data will be stored on CD-
ROMs in a secure location in the Pharmacy Building at the University of Sydney for seven years after 
completion of the study. A report of the study may be submitted for publication, but individual participants 
will not be identifiable in such a report. 
 
While we intend that this research study furthers medical knowledge and may improve quality of 
prescribing and patient care in the future, it may not be of direct benefit to you.   
 
Participation in this study is entirely voluntary: you are not obliged to participate and - if you do participate 
- you can withdraw at any time.  There are no adverse consequences attached to not participating or 
withdrawing at any stage from the study. 
 
When you have read this information, Meredith Page will discuss it with you further and answer any 
questions you may have.  If you would like to know more at any stage, please feel free to contact Meredith 
Page (Master of Pharmacy candidate) on 8382 2053 or Prof Jo-anne Brien [Professor of Clinical 
Pharmacy (St Vincent’s Hospital), University of Sydney] on 8382 2605.   This information sheet is for you 
to keep. 
 
Any person with concerns or complaints about the conduct of a research study can contact the 
Manager for Ethics Administration, University of Sydney on (02) 9351 4811. 
 
 
 
 
 
                                               
1
 Professor of Clinical Pharmacy (St Vincent’s Hospital), Faculty of Pharmacy, University of Sydney 
2
 Lecturer in Pharmacy Practice, Faculty of Pharmacy, University of Sydney 
3
 Masters in Pharmacy candidate, Faculty of Pharmacy, University of Sydney 
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Interview: Introductory Preamble  
 
• I would like to introduce myself, my name is Meredith Page and I am a Masters research 
student at the University of Sydney. 
 
• The purpose of this interview is to find out about: 
o your experiences of prescribing in this hospital 
o your attitudes towards prescribing generally 
o your perceptions of workplace influences on prescribing, and 
the training of prescribers in this hospital.  
 
• The information that will be collected from your interview and others will hopefully 
improve understanding of social and cultural factors, which may influence prescribing 
behaviour in hospitals.  We hope that this information may be used to assist strategies to 
improve prescribing in hospitals. 
 
• The results of this study will form a thesis, which will be submitted as a Masters research 
project.  The results may also be published in peer-review journals and presented at 
relevant conferences.   
 
• All information that is collected either as part of this interview or from notes that I take will 
be de-identified and assigned a number.  This will ensure that the confidentiality of your 
comments will be maintained.  You will also have the opportunity to comment or withdraw 
any statements you wish at the end of the interview, after transcription of your interview 
and after collation of results.   
 
• I would like to remind you that your participation is entirely voluntary and you can 
withdraw from the interview at any time.   
 
• I would also like to emphasise that the purpose of this study is: 
 
 -  not to assess the way in which you prescribe, how well you make decisions or how 
well you do your job.   
 - I’m interested in your experience of how prescribing takes place in this hospital, and 
your opinions and your perceptions. 
 
• I am recording this interview because I won’t be able to write quickly enough to get all 
your comments down.  The recording is for the purposes of this research only.  
 
Do you have any comments before we start? 
 
 
• There are two parts to the interview: firstly, questions will be focused around prescribing 
generally, and then we’ll move onto questions about training new prescribers. 
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Data Handling Flow Chart 
 
(I) PRELIMINARY DATA ANALYSIS 
 
Post-Interview 
Review of field notes immediately post interview to identify and document provisional major themes    
 
(II) DATA MANAGEMENT 
 
Transcription of recorded interviews  
 
Proof reading of transcripts against recorded interview 
 
(III) CONTENT ANALYSIS 
 
Development of Coding Scheme  
Identification and labeling of categories or themes involving reiterative review of a third of the 
transcripts (MP) 
 
 
 
Comparing, clustering and organising categories into a hierarchical tree constantly comparing the 
properties of each category 
  
 
 
 Co-analysis of a strategic randomised selection of transcripts (10 transcripts dual analysed in total) to 
check on appropriateness, consistency and comprehensiveness of coding (BB, JB) 
 
 
Refinement of categories based on co-analysis of transcripts 
 
 
 
 
 
 
Coding Data (ie, indexing all transcripts) 
 
 Reiterative review of all transcripts using the coding scheme to comprehensively index all data 
relevant to research question 
 
 
 
 Continued refinement of categories    
 
 Drafting of thematic charts for each of the cohorts, synthesising each respondent’s meanings 
under each thematic category 
 
   
 Cross-sectional review of thematic charts to look for similarities and differences between the 
groups 
 
   
 
(IV) DATA INTERPRETATION 
 
   
 Creation of matrices (and models) to illuminate patterns of association, and the development of 
core concepts and explanatory accounts informed by theoretical frameworks from literature. 
 
 
 Review of analysis with original transcripts using deviant cases in order to verify and ground 
concepts developed with the data. 
  
 
 
